Nothing Special   »   [go: up one dir, main page]

KR102424458B1 - 2-aminocarbazole compound and use thereof - Google Patents

2-aminocarbazole compound and use thereof Download PDF

Info

Publication number
KR102424458B1
KR102424458B1 KR1020217016773A KR20217016773A KR102424458B1 KR 102424458 B1 KR102424458 B1 KR 102424458B1 KR 1020217016773 A KR1020217016773 A KR 1020217016773A KR 20217016773 A KR20217016773 A KR 20217016773A KR 102424458 B1 KR102424458 B1 KR 102424458B1
Authority
KR
South Korea
Prior art keywords
group
mmol
methyl
compound
methoxy
Prior art date
Application number
KR1020217016773A
Other languages
Korean (ko)
Other versions
KR20210068160A (en
Inventor
나오키 마츠모토
히로카즈 신야
Original Assignee
토소가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2013216683A external-priority patent/JP6311266B2/en
Priority claimed from JP2014028366A external-priority patent/JP2015071582A/en
Application filed by 토소가부시키가이샤 filed Critical 토소가부시키가이샤
Priority claimed from PCT/JP2014/073718 external-priority patent/WO2015034093A1/en
Publication of KR20210068160A publication Critical patent/KR20210068160A/en
Application granted granted Critical
Publication of KR102424458B1 publication Critical patent/KR102424458B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/54Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • H01L51/0059
    • H01L51/0072
    • H01L51/5056
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/15Hole transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

유기 EL 소자의 정공 수송 재료에 적합한 2-아미노카바졸 화합물 및 해당 화합물을 이용한 구동 전압, 발광 효율, 소자 수명이 우수한 유기 EL 소자를 제공한다. 하기 식 (1)로 표시되는 2-아미노카바졸 화합물:

Figure 112021063299657-pat00032

식 중, R은 수소 원자 또는 메틸기이고; R1 내지 R3 중 어느 하나는 4-다이벤조티에닐기, 4-다이벤조퓨라닐기, 9-페난트릴기 또는 하기 식 (2)의 치환기(R은, 수소 원자 또는 메틸기를 나타냄)이고, 나머지는 수소 원자 또는 메틸기이며; Ar1, Ar2는, 독립적으로, 탄소수 6 내지 18의 방향족 탄화수소기이고, 이들은 메틸기 또는 메톡시기를 가지고 있어도 된다:
Figure 112021063299657-pat00033
.Provided are a 2-aminocarbazole compound suitable for a hole transport material of an organic EL device, and an organic EL device having excellent driving voltage, luminous efficiency, and device life using the compound. A 2-aminocarbazole compound represented by the following formula (1):
Figure 112021063299657-pat00032

wherein R is a hydrogen atom or a methyl group; Any one of R 1 to R 3 is a 4-dibenzothienyl group, 4-dibenzofuranyl group, 9-phenanthryl group, or a substituent of the following formula (2) (R represents a hydrogen atom or a methyl group), and the rest is a hydrogen atom or a methyl group; Ar 1 and Ar 2 are independently an aromatic hydrocarbon group having 6 to 18 carbon atoms, which may have a methyl group or a methoxy group:
Figure 112021063299657-pat00033
.

Description

2-아미노카바졸 화합물 및 그의 용도{2-AMINOCARBAZOLE COMPOUND AND USE THEREOF}2-Aminocarbazole compounds and uses thereof

본 발명은, 2-아미노카바졸 화합물 및 그것을 이용한 유기 EL 소자에 관한 것이다.The present invention relates to a 2-aminocarbazole compound and an organic EL device using the same.

유기 EL 소자는, 유기박막을 1쌍의 전극 사이에 유지한 면발광형 소자이며, 박형 경량, 고시야각, 고속응답성 등의 특징을 지니고, 각종 표시소자에의 응용이 기대되고 있다. 또 최근에는, 휴대전화의 디스플레이 등, 일부 실용화도 시작되고 있다. 해당 유기 EL 소자는, 양극으로부터 주입된 정공과, 음극으로부터 주입된 전자가 발광층에서 재결합할 때에 발하는 광을 이용하는 것이며, 그 구조는 정공 수송층, 발광층, 전자 수송층 등을 적층한 다층 적층형이 주류이다. 여기에서, 정공 수송층이나 전자 수송층이라고 하는 전하 수송층은, 그것 자체는 발광하는 것은 아니지만, 발광층에의 전하 주입을 용이하게 하고, 또한, 발광층에 주입된 전하나 발광층에서 생성한 여기자의 에너지를 가둔다고 하는 역할을 하고 있다.The organic EL device is a surface light-emitting device in which an organic thin film is held between a pair of electrodes, has characteristics such as thin, light weight, high viewing angle, high-speed response, and the like, and is expected to be applied to various display devices. Moreover, in recent years, some practical applications, such as a display of a mobile phone, are also starting. The organic EL device uses light emitted when holes injected from an anode and electrons injected from a cathode recombine in a light emitting layer, and the structure of the organic EL device is a multilayer stack type in which a hole transport layer, a light emitting layer, an electron transport layer, etc. are stacked. Here, the charge transport layer called the hole transport layer or the electron transport layer does not emit light by itself, but facilitates charge injection into the light emitting layer and also traps the energy of charges injected into the light emitting layer or excitons generated in the light emitting layer. is playing a role

즉, 전하수송층은 유기 EL 소자의 저구동 전압화 및 발광 효율을 향상시키는 데 있어서 매우 중요한 역할을 담당하고 있다.That is, the charge transport layer plays a very important role in lowering the driving voltage and improving the luminous efficiency of the organic EL device.

정공 수송 재료에는, 적당한 이온화 포텐셜과 정공 수송 능력을 지니는 아민 화합물이 이용되고, 예를 들면, 4,4'-비스[N-(1-나프틸)-N-페닐아미노]바이페닐(이하, NPD로 약칭함)이 잘 알려져 있다. 그렇지만, NPD를 정공 수송층에 이용한 소자의 구동 전압, 발광 효율 및 내구성은 충분하지 않아, 새로운 재료의 개발이 요구되고 있다.As the hole transport material, an amine compound having an appropriate ionization potential and hole transport ability is used, for example, 4,4'-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (hereinafter, abbreviated as NPD) is well known. However, the driving voltage, luminous efficiency, and durability of a device using NPD for the hole transport layer are not sufficient, and development of a new material is required.

또한, 최근에는 발광층에 인광 발광 재료를 이용한 유기 EL 소자의 개발도 진행되고 있고, 인광 발광을 이용한 소자에서는, 3중항 준위가 높은 정공 수송 재료가 요구되고 있다. 3중항 준위라고 하는 점에서도 NPD는 충분하지 않고, 예를 들면, 녹색의 발광을 지니는 인광 발광 재료와 NPD를 조합시킨 유기 EL 소자에서는, 발광 효율이 저하되는 것이 보고되어 있다(예를 들면, 비특허문헌 1 참조).In recent years, development of an organic EL device using a phosphorescent light emitting material as a light emitting layer is also progressing, and a hole transporting material having a high triplet level is required for a device using phosphorescent light emission. It has been reported that NPD is not sufficient even in terms of the triplet level, and for example, in an organic EL device in which a green phosphorescent material and NPD are combined, the luminous efficiency decreases (for example, See Patent Document 1).

이러한 배경으로부터, 최근에는, 분자 내에 카바졸환을 도입한 아민 화합물이 보고되어 있다. 구체적으로는, 2-아미노카바졸 화합물을 들 수 있다(예를 들면, 특허문헌 1 내지 4 참조).From this background, recently, an amine compound in which a carbazole ring is introduced into a molecule has been reported. Specifically, a 2-aminocarbazole compound is mentioned (for example, refer patent documents 1 - 4).

특허문헌 1 및 2에서는, 각각, 피렌환, 안트라센환을 함유하는 2-아미노카바졸 화합물이 발광 재료의 용도로 개시되어 있다. 피렌환 또는 안트라센환을 함유하는 이들 화합물은, 피렌환 및 안트라센환 자체의 3중항 준위가 낮기 때문에, 녹색의 인광재료를 이용한 소자에서는, 높은 발광 효율을 얻을 수 없다.In Patent Documents 1 and 2, 2-aminocarbazole compounds each containing a pyrene ring and an anthracene ring are disclosed for use as a light emitting material. Since these compounds containing a pyrene ring or anthracene ring have low triplet levels of the pyrene ring and the anthracene ring themselves, high luminous efficiency cannot be obtained in an element using a green phosphorescent material.

한편에서, 특허문헌 3 및 4에서 개시되어 있는 2-아미노카바졸 화합물은, NPD보다 높은 3중항 준위를 지닌다. 이 때문에, 녹색 인광 재료를 이용한 소자에 있어서, 일반적으로, NPD보다도 높은 발광 효율을 나타내는 경향이 있는 것이 알려져 있다.On the other hand, the 2-aminocarbazole compounds disclosed in Patent Documents 3 and 4 have a triplet level higher than that of NPD. For this reason, it is known that an element using a green phosphorescent material generally tends to exhibit higher luminous efficiency than NPD.

또한, 다이벤조티오펜이나 다이벤조퓨란과 카바졸을 조합시킨 3-아미노카바졸 화합물도 개시되어 있다(예를 들면, 특허문헌 5).Moreover, the 3-aminocarbazole compound which combined dibenzothiophene, dibenzofuran, and carbazole is also disclosed (for example, patent document 5).

그러나, 유기 EL 소자에 대해서는, 더 한층의 저구동 전압화, 고발광 효율화, 장수명화 등이 요망되고 있어, 이를 위한 정공 수송성 재료의 개발이 요망되고 있다.However, for organic EL devices, further lower driving voltage, higher luminous efficiency, longer life, and the like are desired, and development of a hole transporting material for this purpose is desired.

[선행기술문헌][Prior art literature]

[특허문헌][Patent Literature]

(특허문헌 1) JP2008-078362 A (Patent Document 1) JP2008-078362 A

(특허문헌 2) JP2008-195841 A (Patent Document 2) JP2008-195841 A

(특허문헌 3) KR10-2009-0129799 A (Patent Document 3) KR10-2009-0129799 A

(특허문헌 4) JP2011-001349 A (Patent Document 4) JP2011-001349 A

(특허문헌 5) WO2011/122132 A(Patent Document 5) WO2011/122132 A

[비특허문헌][Non-patent literature]

(비특허문헌 1) Journal of Applied Physics, 2004년, 95권, 7798페이지(Non-Patent Document 1) Journal of Applied Physics, 2004, Volume 95, page 7798

본 발명은, 종래 공지의 2-아미노카바졸 화합물 또는 3-아미노카바졸 화합물에 비해서, 유기 EL 소자 수명을 현저하게 향상시키는 특정 화학구조를 가진 2-아미노카바졸 화합물을 제공하는 것을 목적으로 한다. 또한, 본 발명은, 해당 특정 화학 구조를 가진 2-아미노카바졸 화합물을 이용해서, 우수한 장수명을 지닌 유기 EL 소자를 제공하는 것을 목적으로 한다.An object of the present invention is to provide a 2-aminocarbazole compound having a specific chemical structure that significantly improves the lifespan of an organic EL device, compared to the conventionally known 2-aminocarbazole compound or 3-aminocarbazole compound. . Another object of the present invention is to provide an organic EL device having an excellent long life using the 2-aminocarbazole compound having the specific chemical structure.

본 발명자들은 예의 검토한 결과, 하기 식 (1)로 표시되는 신규 화합물인 2-아미노카바졸 화합물을 찾아내어, 본 발명을 완성시키기에 이르렀다. 즉, 본 발명은, 하기 식 (1)로 표시되는 2-아미노카바졸 화합물 및 그의 용도에 관한 것이다:MEANS TO SOLVE THE PROBLEM As a result of earnest examination, the present inventors found the 2-aminocarbazole compound which is a novel compound represented by following formula (1), and came to complete this invention. That is, the present invention relates to a 2-aminocarbazole compound represented by the following formula (1) and uses thereof:

Figure 112021063299657-pat00001
Figure 112021063299657-pat00001

(R은, 각각 독립적으로, 수소 원자 또는 메틸기를 나타낸다. R1 내지 R3 중 어느 하나는, 4-다이벤조티에닐기, 4-다이벤조퓨라닐기, 9-페난트릴기 또는 하기 식 (2)로 표시되는 치환기이며, 나머지는 수소 원자 또는 메틸기이다. Ar1 및 Ar2는, 각각 독립적으로, 탄소수 6 내지 18의 방향족 탄화수소기이며, 이들은 메틸기 또는 메톡시기를 가지고 있어도 된다.)(R each independently represents a hydrogen atom or a methyl group. Any one of R 1 to R 3 is a 4-dibenzothienyl group, a 4-dibenzofuranyl group, a 9-phenanthryl group, or the following formula (2) is a substituent represented by , and the remainder is a hydrogen atom or a methyl group. Ar 1 and Ar 2 are each independently an aromatic hydrocarbon group having 6 to 18 carbon atoms, and these may have a methyl group or a methoxy group.)

Figure 112021063299657-pat00002
Figure 112021063299657-pat00002

(R은 수소 원자 또는 메틸기를 나타낸다.)(R represents a hydrogen atom or a methyl group.)

본 발명의 2-아미노카바졸 화합물을 이용한 유기 EL 소자는, 종래 공지의 2-아미노카바졸 화합물 또는 3-아미노카바졸을 이용한 유기 EL 소자와 비교해서, 소자 수명이 현저하게 우수하다. 이 때문에, 본 발명의 2-아미노카바졸 화합물은, 내구성이 우수한 유기 EL 재료로서의 이용이 가능하다.The organic EL device using the 2-aminocarbazole compound of the present invention is remarkably superior in device lifetime compared to the organic EL device using the conventionally known 2-aminocarbazole compound or 3-aminocarbazole. For this reason, the 2-aminocarbazole compound of this invention can be utilized as an organic electroluminescent material excellent in durability.

또, 종래 공지의 정공 수송 재료인 NPD와 비교해도, 유기 EL 소자의 장수명화, 저구동 전압화 및 고발광 효율화가 가능하다.Moreover, compared with NPD which is a conventionally well-known hole transport material, the life span of an organic electroluminescent element can be made long, a low driving voltage, and high luminous efficiency can be improved.

즉, 본 발명에 따르면, 소비 전력이 낮고, 소자 수명이 우수한 유기 EL 소자를 제공할 수 있다.That is, according to the present invention, an organic EL device having low power consumption and excellent device lifetime can be provided.

상기 식 (1)로 표시되는 2-아미노카바졸 화합물에 있어서, R(식 (2)의 R을 포함함)은, 각각 독립적으로, 수소 원자 또는 메틸기를 나타낸다. 또, 정공 수송 특성 및 원료입수의 용이성의 점에 있어서, R이 모두 수소 원자인 것이 바람직하다.In the 2-aminocarbazole compound represented by the formula (1), R (including R in the formula (2)) each independently represents a hydrogen atom or a methyl group. Moreover, it is preferable that all R are hydrogen atoms from the point of a hole transport characteristic and the easiness of availability of a raw material.

상기 식 (1)로 표시되는 2-아미노카바졸 화합물에 있어서, R1 내지 R3 중 어느 하나는, 4-다이벤조티에닐기, 4-다이벤조퓨라닐기, 9-페난트릴기 또는 하기 식 (2)로 표시되는 치환기이며, 나머지는 수소 원자 또는 메틸기이다:In the 2-aminocarbazole compound represented by the formula (1), any one of R 1 to R 3 is a 4-dibenzothienyl group, a 4-dibenzofuranyl group, a 9-phenanthryl group, or a formula ( 2) is a substituent represented by, the remainder being a hydrogen atom or a methyl group:

Figure 112021063299657-pat00003
Figure 112021063299657-pat00003

(R은 수소 원자 또는 메틸기를 나타낸다.)(R represents a hydrogen atom or a methyl group.)

또, 정공 수송 특성 및 원료입수의 용이성의 점에 있어서, R1 내지 R3 중 어느 하나는, 4-다이벤조티에닐기, 4-다이벤조퓨라닐기, 9-페난트릴기 또는 상기 식 (2)로 표시되는 치환기이며, 나머지는 수소 원자인 것이 바람직하다.Further, in view of hole transport characteristics and ease of raw material availability, any one of R 1 to R 3 is a 4-dibenzothienyl group, 4-dibenzofuranyl group, 9-phenanthryl group, or Formula (2) It is a substituent represented by , and the remainder is preferably a hydrogen atom.

상기 식 (1)로 표시되는 2-아미노카바졸 화합물에 있어서, Ar1 및 Ar2는, 각각 독립적으로, 탄소수 6 내지 18의 방향족 탄화수소기를 나타내고, 이들은 메틸기, 메톡시기를 가지고 있어도 된다.In the 2-aminocarbazole compound represented by the formula (1), Ar 1 and Ar 2 each independently represent an aromatic hydrocarbon group having 6 to 18 carbon atoms, and these may have a methyl group or a methoxy group.

Ar1 및 Ar2에 있어서의 탄소수 6 내지 18의 방향족 탄화수소기(이들은 메틸기 또는 메톡시기를 가지고 있어도 됨)로서는, 특별히 한정되는 것은 아니지만, 예를 들면, 페닐기, 바이페닐릴기, 터페닐릴기, 나프틸기, 플루오레닐기, 페난트릴기, 벤조플루오레닐기(이들은 메틸기 또는 메톡시기를 가지고 있어도 됨) 등을 들 수 있다.Although it does not specifically limit as a C6-C18 aromatic hydrocarbon group (they may have a methyl group or a methoxy group) in Ar< 1 > and Ar< 2 >, For example, For example, a phenyl group, a biphenylyl group, a terphenylyl group, naph a tyl group, a fluorenyl group, a phenanthryl group, a benzofluorenyl group (these may have a methyl group or a methoxy group), etc. are mentioned.

Ar1 및 Ar2의 구체예로서는, 페닐기, 4-메틸페닐기, 3-메틸페닐기, 2-메틸페닐기, 2,4-다이메틸페닐기, 2,5-다이메틸페닐기, 3,4-다이메틸페닐기, 3,5-다이메틸페닐기, 2,6-다이메틸페닐기, 2,3,5-트라이메틸페닐기, 2,3,6-트라이메틸페닐기, 3,4,5-트라이메틸페닐기, 4-메톡시페닐기, 3-메톡시페닐기, 2-메톡시페닐기, 2-메틸-4-메톡시페닐기, 2-메틸-5-메톡시페닐기, 3-메틸-4-메톡시페닐기, 3-메틸-5-메톡시페닐기, 2-메톡시-4-메틸페닐기, 3-메톡시-4-메틸페닐기, 2,4-다이메톡시페닐기, 2,5-다이메톡시페닐기, 2,6-다이메톡시페닐기, 3,4-다이메톡시페닐기, 3,5-다이메톡시페닐기, 3,4,5-트라이메톡시페닐기, 4-바이페닐릴기, 3-바이페닐릴기, 2-바이페닐릴기, 2-메틸-1,1'-바이페닐-4-일기, 3-메틸-1,1'-바이페닐-4-일기, 2'-메틸-1,1'-바이페닐-4-일기, 3'-메틸-1,1'-바이페닐-4-일기, 4'-메틸-1,1'-바이페닐-4-일기, 2,6-다이메틸-1,1'-바이페닐-4-일기, 2,2'-다이메틸-1,1'-바이페닐-4-일기, 2,3'-다이메틸-1,1'-바이페닐-4-일기, 2,4'-다이메틸-1,1'-바이페닐-4-일기, 3,2'-다이메틸-1,1'-바이페닐-4-일기, 2',3'-다이메틸-1,1'-바이페닐-4-일기, 2',4'-다이메틸-1,1'-바이페닐-4-일기, 2',5'-다이메틸-1,1'-바이페닐-4-일기, 2',6'-다이메틸-1,1'-바이페닐-4-일기, p-터페닐기, m-터페닐기, o-터페닐기, 1-나프틸기, 2-나프틸기, 2-메틸나프탈렌-1-일기, 4-메틸나프탈렌-1-일기, 6-메틸나프탈렌-2-일기, 2-안트릴기, 9-안트릴기, 1-트라이페닐레닐기, 2-트라이페닐레닐기, 2-플루오레닐기, 9,9-다이메틸-9H-플루오렌-2-일기, 9-페난트릴기, 2-페난트릴기, 벤조플루오레닐기, 플루오란테닐기, 피레닐기, 크라이세닐기 등을 예시할 수 있지만, 이들로 한정되는 것은 아니다.Specific examples of Ar 1 and Ar 2 include a phenyl group, 4-methylphenyl group, 3-methylphenyl group, 2-methylphenyl group, 2,4-dimethylphenyl group, 2,5-dimethylphenyl group, 3,4-dimethylphenyl group, 3,5-dimethylphenyl group, 2,6-dimethylphenyl group, 2,3,5-trimethylphenyl group, 2,3,6-trimethylphenyl group, 3,4,5-trimethylphenyl group, 4-methoxy Phenyl group, 3-methoxyphenyl group, 2-methoxyphenyl group, 2-methyl-4-methoxyphenyl group, 2-methyl-5-methoxyphenyl group, 3-methyl-4-methoxyphenyl group, 3-methyl-5- Methoxyphenyl group, 2-methoxy-4-methylphenyl group, 3-methoxy-4-methylphenyl group, 2,4-dimethoxyphenyl group, 2,5-dimethoxyphenyl group, 2,6-dimethoxyphenyl group , 3,4-dimethoxyphenyl group, 3,5-dimethoxyphenyl group, 3,4,5-trimethoxyphenyl group, 4-biphenylyl group, 3-biphenylyl group, 2-biphenylyl group, 2- Methyl-1,1'-biphenyl-4-yl group, 3-methyl-1,1'-biphenyl-4-yl group, 2'-methyl-1,1'-biphenyl-4-yl group, 3'- Methyl-1,1'-biphenyl-4-yl group, 4'-methyl-1,1'-biphenyl-4-yl group, 2,6-dimethyl-1,1'-biphenyl-4-yl group, 2,2'-dimethyl-1,1'-biphenyl-4-yl group, 2,3'-dimethyl-1,1'-biphenyl-4-yl group, 2,4'-dimethyl-1, 1'-biphenyl-4-yl group, 3,2'-dimethyl-1,1'-biphenyl-4-yl group, 2',3'-dimethyl-1,1'-biphenyl-4-yl group , 2',4'-dimethyl-1,1'-biphenyl-4-yl group, 2',5'-dimethyl-1,1'-biphenyl-4-yl group, 2',6'-di Methyl-1,1'-biphenyl-4-yl group, p-terphenyl group, m-terphenyl group, o-terphenyl group, 1-naphthyl group, 2-naphthyl group, 2-methylnaphthalen-1-yl group, 4- Methylnaphthalen-1-yl group, 6-methylnaphthalen-2-yl group, 2-anthryl group, 9-anthryl group, 1-triphenylenyl group, 2-triphenylenyl group, 2-fluorenyl group, 9, 9-dimethyl-9H-fluoren-2-yl group, 9-phenanthryl group, 2-phenanthryl group, benzofluorenyl group, fluoranthenyl group, pyrenyl group, chrysenyl group and the like can be exemplified, is not limited to

정공 수송 특성의 점에 있어서, 본 발명의 식 (1)로 표시되는 2-아미노카바졸 화합물에 있어서의 Ar1 및 Ar2로서는, 각각 독립적으로, 메틸기 또는 메톡시기를 가지고 있어도 되는 페닐기, 메틸기 또는 메톡시기를 가지고 있어도 되는 나프틸기, 메틸기 또는 메톡시기를 가지고 있어도 되는 페난트릴기, 메틸기 또는 메톡시기를 가지고 있어도 되는 바이페닐릴기, 메틸기 또는 메톡시기를 가지고 있어도 되는 터페닐기 또는 메틸기 또는 메톡시기를 가지고 있어도 되는 플루오레닐기인 것이 바람직하다. 또한, Ar1 및 Ar2로서는, 각각 독립적으로, 페닐기, 4-메틸페닐기, 1-나프틸기, 9-페난트릴기, 4-바이페닐릴기, p-터페닐-4-일기, m-터페닐-4-일기 또는 9,9-다이메틸-9H-플루오렌-2-일기인 것이 보다 바람직하다.In terms of hole transport properties, Ar 1 and Ar 2 in the 2-aminocarbazole compound represented by Formula (1) of the present invention are each independently a phenyl group, which may have a methyl group or a methoxy group, a methyl group, or It has a naphthyl group which may have a methoxy group, a phenanthryl group which may have a methyl group or a methoxy group, a biphenylyl group which may have a methyl group or a methoxy group, a terphenyl group which may have a methyl group or a methoxy group, or a methyl group or a methoxy group It is preferable that it is a fluorenyl group which may exist. In addition, as Ar 1 and Ar 2 , each independently represents a phenyl group, a 4-methylphenyl group, a 1-naphthyl group, a 9-phenanthryl group, a 4-biphenylyl group, a p-terphenyl-4-yl group, and a m-terphenyl group. A -4-yl group or a 9,9-dimethyl-9H-fluoren-2-yl group is more preferable.

상기 식 (1)로 표시되는 2-아미노카바졸 화합물은, 유기 EL 소자의 발광층에 있어서의 발광 호스트 재료, 정공 수송층에 있어서의 정공 수송 재료, 또는 정공 주입층에 있어서의 정공 수송 재료(특별히 한정되지 않지만, 이들 재료를 일괄하여, 유기 EL 소자용 재료라고도 함)로서 사용할 수 있다. 또, 상기 식 (1)로 표시되는 2-아미노카바졸 화합물은, 정공 수송 특성이나 소자 수명의 점에서, 고순도인 것이 바람직하다.The 2-aminocarbazole compound represented by the formula (1) is a light emitting host material in a light emitting layer of an organic EL device, a hole transport material in a hole transport layer, or a hole transport material in a hole injection layer (specifically limited). However, these materials can be collectively used as a material for an organic EL device). Moreover, it is preferable that the 2-aminocarbazole compound represented by the said Formula (1) is high purity from the point of a hole transport characteristic and element lifetime.

상기 식 (1)로 표시되는 2-아미노카바졸 화합물을 유기 EL 소자의 정공 주입층 및/또는 정공 수송층으로서 사용할 때의 발광층에는, 종래부터 사용되고 있는, 공지의 형광 또는 인광 발광 재료를 사용할 수 있다. 발광층은 1종류의 발광 재료만으로 형성되어 있어도, 호스트 재료 중에 1종류 이상의 발광 재료가 도핑되어 있어도 된다.For the light emitting layer when the 2-aminocarbazole compound represented by the formula (1) is used as a hole injection layer and/or a hole transport layer of an organic EL device, a conventionally used fluorescent or phosphorescent light emitting material can be used. . The light-emitting layer may be formed of only one type of light-emitting material, or one or more types of light-emitting materials may be doped in the host material.

상기 식 (1)로 표시되는 2-아미노카바졸 화합물을 함유하는 정공 주입층 및/또는 정공 수송층을 형성할 때에는, 필요에 따라서 2종류 이상의 재료를 함유 또는 적층시켜도 되고, 예를 들면, 산화 몰리브덴 등의 산화물, 7,7,8,8-테트라사이아노퀴노다이메탄, 2,3,5,6-테트라플루오로-7,7,8,8-테트라사이아노퀴노다이메탄, 헥사사이아노헥사아자트라이페닐렌 등의 공지의 전자수용성 재료를 함유 또는 적층시켜도 된다.When forming the hole injection layer and/or the hole transport layer containing the 2-aminocarbazole compound represented by the formula (1), two or more types of materials may be contained or laminated as needed, for example, molybdenum oxide oxides such as 7,7,8,8-tetracyanoquinodimethane, 2,3,5,6-tetrafluoro-7,7,8,8-tetracyanoquinodimethane, hexacyanohexa A known electron-accepting material such as azatriphenylene may be contained or laminated.

또한, 본 발명의 상기 식 (1)로 표시되는 2-아미노카바졸 화합물은, 유기 EL 소자의 발광층으로서도 사용할 수 있다. 상기 식 (1)로 표시되는 2-아미노카바졸 화합물을 유기 EL 소자의 발광층으로서 사용할 경우에는, 아릴아민 화합물을 단독으로 사용하거나, 공지의 발광 호스트 재료에 도핑해서 사용하거나, 또는 공지의 발광 도펀트(dopant)를 도핑해서 사용할 수 있다.Moreover, the 2-aminocarbazole compound represented by the said Formula (1) of this invention can be used also as a light emitting layer of an organic electroluminescent element. When the 2-aminocarbazole compound represented by the above formula (1) is used as a light emitting layer of an organic EL device, the arylamine compound is used alone, is doped into a known light emitting host material, or is a known light emitting dopant. (dopant) can be used by doping.

상기 식 (1)로 표시되는 2-아미노카바졸 화합물을 함유하는 정공 주입층, 정공 수송층 또는 발광층을 형성하는 방법으로서는, 예를 들면, 진공증착법, 스핀 코트법, 캐스트법 등의 공지의 방법을 적용할 수 있다.As a method of forming a hole injection layer, a hole transport layer or a light emitting layer containing the 2-aminocarbazole compound represented by the formula (1), for example, a known method such as a vacuum deposition method, a spin coating method, a casting method can be applied.

본 발명의 상기 식 (1)로 표시되는 2-아미노카바졸 화합물을 포함해서 이루어진 유기 전계발광 소자용의 박막의 제조 방법은, 특별히 제한은 없지만, 진공증착법에 의한 성막이 가능하다. 진공증착법에 의한 성막은, 범용의 진공증착장치를 이용하는 것에 의해 행할 수 있다. 진공증착법으로 막을 형성할 때의 진공조의 진공도는, 유기 전계발광 소자 제작의 제조 택트 타임이나 제조 비용을 고려하면, 일반적으로 이용되는 확산 펌프, 터보분자 펌프, 크라이오펌프 등에 의해 도달하는 것이 가능하다. 진공도로서는, 1×10-2 내지 1×10-6㎩ 정도가 바람직하고, 1×10-4 내지 1×10-6㎩이 보다 바람직하다.Although there is no restriction|limiting in particular in the manufacturing method of the thin film for organic electroluminescent element which consists of the 2-aminocarbazole compound represented by said Formula (1) of this invention, The film-forming by the vacuum deposition method is possible. Film formation by the vacuum deposition method can be performed by using a general-purpose vacuum deposition apparatus. The vacuum degree of the vacuum chamber when the film is formed by the vacuum deposition method can be reached by generally used diffusion pumps, turbomolecular pumps, cryopumps, etc., in consideration of the manufacturing tact time and manufacturing cost of manufacturing the organic electroluminescent device. . The degree of vacuum is preferably about 1×10 -2 to 1×10 -6 Pa, and more preferably 1×10 -4 to 1×10 -6 Pa.

증착 속도는, 형성하는 막의 두께에 따르지만, 0.005 내지 1.0㎚/초가 바람직하고, 0.01 내지 0.3㎚/초가 보다 바람직하다. 또, 본 발명의 상기 식 (1)로 표시되는 2-아미노카바졸 화합물은 내열성이 높기 때문에, 고속 성막 시에 있어서도 열분해를 일으키기 어려워, 소자 성능에의 영향도 작다.Although vapor deposition rate depends on the thickness of the film|membrane to form, 0.005-1.0 nm/sec is preferable and 0.01-0.3 nm/sec is more preferable. Moreover, since the 2-aminocarbazole compound represented by the said Formula (1) of this invention has high heat resistance, it is hard to generate|occur|produce thermal decomposition also at the time of high-speed film-forming, and the influence on element performance is also small.

본 발명의 효과가 얻어지는 유기 EL 소자의 기본적인 구조로서는, 기판, 양극, 정공 주입층, 정공 수송층, 발광층, 전자 수송층 및 음극을 포함한다.The basic structure of the organic EL device in which the effect of the present invention is obtained includes a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and a cathode.

유기 EL 소자의 양극 및 음극은, 전기적인 도체를 개재시켜 전원에 접속되어 있다. 양극과 음극 사이에 전위를 가함으로써, 유기 EL 소자는 작동한다.The anode and the cathode of the organic EL element are connected to a power supply via an electrical conductor. By applying an electric potential between the anode and the cathode, the organic EL device operates.

정공은 양극으로부터 유기 EL 소자 내에 주입되고, 전자는 음극에서 유기 EL 소자 내에 주입된다.Holes are injected into the organic EL element from the anode, and electrons are injected into the organic EL element from the cathode.

유기 EL 소자는 전형적으로는 기판에 피복되고, 양극 또는 음극은 기판과 접촉할 수 있다. 기판과 접촉하는 전극은 편의상, 하측 전극이라 불린다. 일반적으로는, 하측 전극은 양극이지만, 본 발명의 유기 EL 소자에 있어서는, 그러한 형태로 한정되는 것은 아니다.The organic EL device is typically coated on a substrate, and an anode or cathode may be in contact with the substrate. The electrode in contact with the substrate is referred to as a lower electrode for convenience. Generally, a lower electrode is an anode, but in the organic electroluminescent element of this invention, it is not limited to such a form.

기판은, 의도되는 발광 방향에 따라서, 광투과성 또는 불투명해도 된다. 광투과 특성은, 기판을 통해서 일렉트로루미네슨스(electroluminescence) 발광에 의해 확인할 수 있다. 일반적으로는, 투명 유리 또는 플라스틱이 기판으로서 이용된다. 기판은, 다중의 재료층을 포함하는 복합 구조이어도 된다. 일렉트로루미네슨스 발광을, 양극을 통해서 확인할 경우, 양극은 해당 발광을 통과시키거나 또는 실질적으로 통과시키는 것으로 형성된다.The substrate may be transmissive or opaque depending on the intended light emission direction. The light transmission characteristic can be confirmed by electroluminescence light emission through the substrate. In general, transparent glass or plastic is used as the substrate. The substrate may have a composite structure including multiple material layers. When electroluminescent light emission is identified through an anode, the anode is formed by passing or substantially passing the light emission therethrough.

본 발명에 있어서 사용되는 일반적인 투명 애노드(양극) 재료는, 특별히 한정되는 것은 아니지만, 인듐-주석산화물(ITO), 인듐-아연산화물(IZO), 산화 주석 등을 들 수 있다. 그 밖의 금속 산화물, 예를 들면 알루미늄 또는 인듐·도핑형 산화주석, 마그네슘-인듐 산화물 또는 니켈-텅스텐 산화물도 사용가능하다. 이들 산화물에 부가해서, 금속 질화물인, 예를 들면, 질화갈륨, 금속 셀렌화물인, 예를 들면, 셀렌화아연, 또는 금속황화물인, 예를 들면, 유화 아연을 양극으로서 사용할 수 있다.The general transparent anode (anode) material used in the present invention is not particularly limited, and examples thereof include indium-tin oxide (ITO), indium-zinc oxide (IZO), and tin oxide. Other metal oxides such as aluminum or indium-doped tin oxide, magnesium-indium oxide or nickel-tungsten oxide can also be used. In addition to these oxides, a metal nitride, for example, gallium nitride, a metal selenide, for example, zinc selenide, or a metal sulfide, for example, zinc emulsification, can be used as the anode.

양극은, 플라즈마 증착된 플루오로카본으로 개질할 수 있다. 음극을 통해서만 일렉트로루미네슨스 발광이 확인될 경우, 양극의 투과 특성은 중요하지 않고, 투명, 불투명 또는 반사성의 임의의 전기 전도성 재료를 사용할 수 있다. 이 용도를 위한 도체의 일례로서는, 금, 이리듐, 몰리브덴, 팔라듐, 백금 등을 들 수 있다.The anode can be modified with plasma-deposited fluorocarbon. When electroluminescence emission is confirmed only through the cathode, the transmissive property of the anode is not important, and any electrically conductive material, transparent, opaque or reflective, may be used. Gold, iridium, molybdenum, palladium, platinum, etc. are mentioned as an example of the conductor for this use.

양극과 발광층 사이에는, 정공 주입층이나 정공 수송층이라고 하는 정공 수송성의 층을 복수층 형성할 수 있다. 정공 주입층이나 정공 수송층은, 양극으로부터 주입된 정공을 발광층에 전달하는 기능을 지니고, 이들 층을 양극과 발광층 사이에 개재시킴으로써, 보다 낮은 전계에서 많은 정공을 발광층에 주입할 수 있다.Between the anode and the light emitting layer, a plurality of hole transporting layers such as a hole injection layer and a hole transport layer can be formed. The hole injection layer or the hole transport layer has a function of transferring holes injected from the anode to the light emitting layer, and by interposing these layers between the anode and the light emitting layer, many holes can be injected into the light emitting layer at a lower electric field.

본 발명의 유기 EL 소자에 있어서, 정공 수송층 및/또는 정공 주입층은, 상기 식 (1)로 표시되는 2-아미노카바졸 화합물을 포함하는 것이다.In the organic EL device of the present invention, the hole transport layer and/or the hole injection layer contain the 2-aminocarbazole compound represented by the formula (1).

정공 수송층 및/또는 정공 주입층에는, 상기 식 (1)로 표시되는 2-아미노카바졸 화합물과 함께, 공지의 정공 수송 재료 및/또는 정공 주입 재료 중에서 임의의 것을 선택해서 조합시켜서 이용할 수 있다.For the hole transport layer and/or the hole injection layer, it can be used in combination with the 2-aminocarbazole compound represented by the formula (1), selecting any one from known hole transport materials and/or hole injection materials.

공지의 정공 주입 재료 및 정공 수송 재료로서는, 예를 들면 트라이아졸 유도체, 옥사다이아졸 유도체, 이미다졸 유도체, 폴리아릴알칸 유도체, 피라졸린 유도체 및 피라졸론 유도체, 페닐렌 다이아민 유도체, 아릴아민 유도체, 아미노 치환 칼콘 유도체, 옥사졸 유도체, 스타이릴안트라센 유도체, 플루오레논 유도체, 하이드라존 유도체, 스틸벤 유도체, 실라잔 유도체, 아닐린계 공중합체, 전기 전도성 고분자 올리고머, 티오펜 올리고머 등을 들 수 있다.Known hole injection materials and hole transport materials include, for example, triazole derivatives, oxadiazole derivatives, imidazole derivatives, polyarylalkane derivatives, pyrazoline derivatives and pyrazolone derivatives, phenylene diamine derivatives, arylamine derivatives, and amino-substituted chalcone derivatives, oxazole derivatives, styrylanthracene derivatives, fluorenone derivatives, hydrazone derivatives, stilbene derivatives, silazane derivatives, aniline copolymers, electrically conductive polymer oligomers, and thiophene oligomers.

정공 주입 재료 및 정공 수송 재료로서는, 상기의 것을 사용할 수 있지만, 포르피린화합물, 방향족 제삼급 아민 화합물, 스타이릴아민 화합물 등의 사용도 가능하고, 특히 방향족 제삼급 아민 화합물을 이용하는 것이 바람직하다.As the hole injecting material and the hole transporting material, those described above can be used, but a porphyrin compound, an aromatic tertiary amine compound, a styrylamine compound, etc. can also be used, and it is particularly preferable to use an aromatic tertiary amine compound.

상기 방향족 제삼급 아민 화합물 및 스타이릴아민 화합물의 대표예로서는, N,N,N',N'-테트라페닐-4,4'-다이아미노페닐, N,N'-다이페닐-N,N'-비스(3-메틸페닐)-[1,1'-바이페닐]-4,4'-다이아민(TPD), 2,2-비스(4-다이-p-톨릴아미노페닐)프로판, 1,1-비스(4-다이-p-톨릴아미노페닐)사이클로헥산, N,N,N',N'-테트라-p-톨릴-4,4'-다이아미노바이페닐, 1,1-비스(4-다이-p-톨릴아미노페닐)-4-페닐사이클로헥산, 비스(4-다이메틸아미노-2-메틸페닐)페닐메탄, 비스(4-다이-p-톨릴아미노페닐)페닐메탄, N,N'-다이페닐-N,N'-다이(4-메톡시페닐)-4,4'-다이아미노바이페닐, N,N,N',N'-테트라페닐-4,4'-다이아미노다이페닐에터, 4,4'-비스(다이페닐아미노)쿼드리페닐, N,N,N-트라이(p-톨릴)아민, 4-(다이-p-톨릴아미노)-4'-[4-(다이-p-톨릴아미노)스타이릴]스틸벤, 4-N,N-다이페닐아미노-(2-다이페닐비닐)벤젠, 3-메톡시-4'-N,N-다이페닐아미노스틸벤젠, N-페닐카바졸, 4,4'-비스[N-(1-나프틸)-N-페닐아미노]바이페닐(NPD), 4,4',4"-트리스[N-(3-메틸페닐)-N-페닐아미노]트라이페닐아민(MTDATA) 등을 들 수 있다.Representative examples of the aromatic tertiary amine compound and the styrylamine compound include N,N,N',N'-tetraphenyl-4,4'-diaminophenyl, N,N'-diphenyl-N,N'- Bis(3-methylphenyl)-[1,1'-biphenyl]-4,4'-diamine (TPD), 2,2-bis(4-di-p-tolylaminophenyl)propane, 1,1- Bis(4-di-p-tolylaminophenyl)cyclohexane, N,N,N',N'-tetra-p-tolyl-4,4'-diaminobiphenyl, 1,1-bis(4-di -p-tolylaminophenyl)-4-phenylcyclohexane, bis(4-dimethylamino-2-methylphenyl)phenylmethane, bis(4-di-p-tolylaminophenyl)phenylmethane, N,N'-di Phenyl-N,N'-di(4-methoxyphenyl)-4,4'-diaminobiphenyl, N,N,N',N'-tetraphenyl-4,4'-diaminodiphenylether , 4,4'-bis(diphenylamino)quadriphenyl, N,N,N-tri(p-tolyl)amine, 4-(di-p-tolylamino)-4'-[4-(di- p-tolylamino) styryl] stilbene, 4-N,N-diphenylamino-(2-diphenylvinyl)benzene, 3-methoxy-4'-N,N-diphenylaminostilbenzene, N- Phenylcarbazole, 4,4′-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (NPD), 4,4′,4″-tris[N-(3-methylphenyl)-N -phenylamino]triphenylamine (MTDATA) etc. are mentioned.

또한, p형-Si, p형-SiC 등의 무기화합물도, 정공 주입 재료 및 정공 수송 재료로서 사용할 수 있다.In addition, inorganic compounds such as p-Si and p-SiC can also be used as the hole injecting material and the hole transporting material.

정공 주입층 및/또는 정공 수송층은, 상기 재료의 1종 또는 2종 이상으로 이루어진 1층 구조이어도 되고, 동일 조성 또는 이종 조성의 복수층으로 이루어진 적층구조이어도 된다.The hole injection layer and/or the hole transport layer may have a single-layer structure composed of one or two or more of the above materials, or a laminate structure composed of multiple layers of the same composition or different compositions.

유기 EL 소자의 발광층은, 인광재료 또는 형광재료를 포함하고, 이 영역에서 전자·정공쌍이 재결합된 결과로서 발광을 일으킨다.The light emitting layer of the organic EL element contains a phosphorescent material or a fluorescent material, and emits light as a result of recombination of electron-hole pairs in this region.

발광층은, 저분자 및 폴리머 쌍방을 포함하는 단일재료로 형성되어 있어도 되지만, 보다 일반적으로는, 게스트 화합물로 도핑된 호스트 재료로 형성되어 있고, 발광은 주로 도펀트로부터 일어나, 임의의 색을 지닐 수 있다.The light emitting layer may be formed of a single material containing both a low molecular weight and a polymer, but is more generally formed of a host material doped with a guest compound, and light emission mainly occurs from a dopant, and can have any color.

발광층의 호스트 재료로서는, 상기 식 (1)로 표시되는 2-아미노카바졸 화합물을 이용할 수 있고, 그 밖의 화합물로서는, 예를 들면, 바이페닐기, 플루오레닐기, 트라이페닐실릴기, 카바졸기, 피레닐기 또는 안트라닐기를 지니는 화합물을 들 수 있다. 구체적으로는, DPVBi(4,4'-비스(2,2-다이페닐비닐)-1,1'-바이페닐), BCzVBi(4,4'-비스(9-에틸-3-카바조비닐렌)1,1'-바이페닐), TBADN(2-tert-뷰틸-9,10-다이(2-나프틸)안트라센), ADN(9,10-다이(2-나프틸)안트라센), CBP(4,4'-비스(카바졸-9-일)바이페닐), CDBP(4,4'-비스(카바졸-9-일)-2,2'-다이메틸바이페닐),또는 9,10-비스(바이페닐)안트라센 등을 들 수 있다.As the host material of the light emitting layer, the 2-aminocarbazole compound represented by the formula (1) can be used, and as other compounds, for example, a biphenyl group, a fluorenyl group, a triphenylsilyl group, a carbazole group, and a pyrethane group and compounds having a nyl group or an anthranyl group. Specifically, DPVBi(4,4'-bis(2,2-diphenylvinyl)-1,1'-biphenyl), BCzVBi(4,4'-bis(9-ethyl-3-carbazovinylene) ) 1,1'-biphenyl), TBADN (2-tert-butyl-9,10-di (2-naphthyl) anthracene), ADN (9,10-di (2-naphthyl) anthracene), CBP ( 4,4'-bis(carbazol-9-yl)biphenyl), CDBP (4,4'-bis(carbazol-9-yl)-2,2'-dimethylbiphenyl), or 9,10 -bis(biphenyl)anthracene etc. are mentioned.

발광층 내의 호스트 재료로서는, 하기에 정의하는 전자 수송 재료, 상기에 정의한 정공 수송 재료, 정공·전자 재결합을 돕는(서포트) 별도의 재료, 또는 이들 재료의 조합이어도 된다.The host material in the light emitting layer may be an electron transporting material defined below, a hole transporting material defined above, another material that assists (supporting) hole/electron recombination, or a combination of these materials.

형광 도펀트의 일례로서는, 안트라센, 테트라센, 잔텐, 페릴렌, 루브렌, 쿠마린, 로다민, 퀴나크리돈, 다이사이아노메틸렌피란 화합물, 티오피란 화합물, 폴리메틴 화합물, 피릴륨 또는 티아피릴륨 화합물, 플루오렌 유도체, 페리플란텐(periflanthene)유도체, 인데노페릴렌 유도체, 비스(아지닐)아민 붕소화합물, 비스(아지닐)메탄 화합물, 카보스타이릴 화합물 등을 들 수 있다.Examples of the fluorescent dopant include anthracene, tetracene, xanthene, perylene, rubrene, coumarin, rhodamine, quinacridone, dicyanomethylenepyran compound, thiopyran compound, polymethine compound, pyrylium or thiapyrylium compound. , fluorene derivatives, periflanthene derivatives, indenoperylene derivatives, bis(azinyl)amine boron compounds, bis(azinyl)methane compounds, carbostyryl compounds, and the like.

인광 도펀트의 일례로서는, 알루미늄, 이리듐, 백금, 팔라듐, 오스뮴 등의 전이금속의 유기 금속 착체를 들 수 있다.Examples of the phosphorescent dopant include organometallic complexes of transition metals such as aluminum, iridium, platinum, palladium, and osmium.

도펀트의 일례로서, Alq3(트리스(8-하이드록시퀴놀린)알루미늄)), DPAVBi (4,4'-비스[4-(다이-파라-톨릴아미노)스타이릴]바이페닐), 페릴렌, Ir(PPy)3(트리스(2-페닐피리딘)이리듐(III) 또는 FlrPic(비스(3,5-다이플루오로-2-(2-피리딜)페닐-(2-카복시피리딜)이리듐(III)등을 들 수 있다.As an example of a dopant, Alq 3 (tris(8-hydroxyquinoline)aluminum))), DPAVBi (4,4′-bis[4-(di-para-tolylamino)styryl]biphenyl), perylene, Ir (PPy) 3 (tris(2-phenylpyridine)iridium(III) or FlrPic(bis(3,5-difluoro-2-(2-pyridyl)phenyl-(2-carboxypyridyl)iridium(III) and the like.

전자 수송성 재료로서는, 알칼리 금속 착체, 알칼리 토금속 착체, 토금속 착체 등을 들 수 있다. 알칼리 금속 착체, 알칼리 토금속 착체,또는 토금속 착체로서는, 예를 들면, 8-하이드록시퀴놀리나토리튬(Liq), 비스(8-하이드록시퀴놀리나토)아연, 비스(8-하이드록시퀴놀리나토)구리, 비스(8-하이드록시퀴놀리나토)망간, 트리스(8-하이드록시퀴놀리나토)알루미늄, 트리스(2-메틸-8-하이드록시퀴놀리나토)알루미늄, 트리스(8-하이드록시퀴놀리나토)갈륨, 비스(10-하이드록시벤조[h]퀴놀리나토)베릴륨, 비스(10-하이드록시벤조[h]퀴놀리나토)아연, 비스(2-메틸-8-퀴놀리나토)클로로갈륨, 비스(2-메틸-8-퀴놀리나토)(o-크레졸라토)갈륨, 비스(2-메틸-8-퀴놀리나토)-1-나프톨라토알루미늄, 비스(2-메틸-8-퀴놀리나토)-2-나프톨라토갈륨 등을 들 수 있다.Examples of the electron-transporting material include alkali metal complexes, alkaline earth metal complexes, and earth metal complexes. Examples of the alkali metal complex, alkaline earth metal complex, or earth metal complex include 8-hydroxyquinolinatolithium (Liq), bis(8-hydroxyquinolinato)zinc, and bis(8-hydroxyquinolinato). ) Copper, bis(8-hydroxyquinolinato)manganese, tris(8-hydroxyquinolinato)aluminum, tris(2-methyl-8-hydroxyquinolinato)aluminum, tris(8-hydroxyquinolinato)aluminum Nolinato) gallium, bis (10-hydroxybenzo [h] quinolinato) beryllium, bis (10-hydroxybenzo [h] quinolinato) zinc, bis (2-methyl-8-quinolinato) chloro Gallium, bis(2-methyl-8-quinolinato)(o-crezolato)gallium, bis(2-methyl-8-quinolinato)-1-naphtolatoaluminum, bis(2-methyl-8-qui nolinato)-2-naphtolatogallium; and the like.

발광층과 전자 수송층 사이에, 캐리어 밸런스를 개선시킬 목적으로, 정공 저지층을 형성해도 된다. 정공 저지층으로서 바람직한 화합물은, BCP(2,9-다이메틸-4,7-다이페닐-1,10-페난트롤린), Bphen(4,7-다이페닐-1,10-페난트롤린), BAlq(비스(2-메틸-8-퀴놀리놀라토)-4-(페닐페놀라토)알루미늄) 또는 비스(10-하이드록시벤조[h]퀴놀리나토)베릴륨)을 들 수 있다.Between the light emitting layer and the electron transport layer, a hole blocking layer may be formed for the purpose of improving carrier balance. Preferred compounds as the hole blocking layer are BCP (2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline), Bphen (4,7-diphenyl-1,10-phenanthroline) , BAlq (bis(2-methyl-8-quinolinolato)-4-(phenylphenollato)aluminum) or bis(10-hydroxybenzo[h]quinolinato)beryllium).

본 발명의 유기 EL 소자에 있어서는, 전자 주입성을 향상시키고, 소자 특성(예를 들면, 발광 효율, 정전압 구동 또는 고내구성)을 향상시킬 목적으로, 전자 주입층을 형성해도 된다.In the organic EL device of the present invention, an electron injection layer may be formed in order to improve electron injection properties and improve device characteristics (eg, luminous efficiency, constant voltage driving, or high durability).

전자 주입층으로서 바람직한 화합물로서는, 플루오레논, 안트라퀴노다이메탄, 다이페노퀴논, 티오피란다이옥사이드, 옥사졸, 옥사다이아졸, 트라이아졸, 이미다졸, 페릴렌테트라카복실산, 플루오레닐리덴메탄, 안트라퀴노다이메탄, 안트론 등을 들 수 있다.Preferred compounds for the electron injection layer include fluorenone, anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylenetetracarboxylic acid, fluorenylidenemethane, anthraqui. Nodimethane, anthrone, etc. are mentioned.

또한, 위에 기재된 금속 착체나 알칼리 금속 산화물, 알칼리 토류 산화물, 희토류 산화물, 알칼리 금속 할로겐화물, 알칼리 토류 할로겐화물, 희토류 할로겐화물, SiO2, AlO, SiN, SiON, AlON, GeO, LiO, LiON, TiO, TiON, TaO, TaON, TaN, C등의 각종 산화물, 질화물 및 산화 질화물과 같은 무기 화합물 등도 사용할 수 있다.In addition, the above-described metal complexes, alkali metal oxides, alkaline earth oxides, rare earth oxides, alkali metal halides, alkaline earth halides, rare earth halides, SiO 2 , AlO, SiN, SiON, AlON, GeO, LiO, LiON, TiO , TiON, TaO, TaON, TaN, various oxides such as C, and inorganic compounds such as nitrides and oxynitrides can also be used.

발광이 양극을 통해서만 확인될 경우, 본 발명에 있어서 사용되는 음극은, 임의의 전기 전도성 재료로 형성할 수 있다. 바람직한 음극 재료로서는, 나트륨, 나트륨-칼륨 합금, 마그네슘, 리튬, 마그네슘/구리 혼합물, 마그네슘/은 혼합물, 마그네슘/알루미늄 혼합물, 마그네슘/인듐 혼합물, 알루미늄/산화 알루미늄(Al2O3) 혼합물, 인듐, 리튬/알루미늄 혼합물, 희토류 금속 등을 들 수 있다.When light emission is confirmed only through the anode, the cathode used in the present invention can be formed of any electrically conductive material. Preferred negative electrode materials include sodium, sodium-potassium alloy, magnesium, lithium, magnesium/copper mixture, magnesium/silver mixture, magnesium/aluminum mixture, magnesium/indium mixture, aluminum/aluminum oxide (Al 2 O 3 ) mixture, indium, lithium/aluminum mixtures, rare earth metals, and the like.

또한, 상기 식 (1)로 표시되는 2-아미노카바졸 화합물의 구체예로서, 하기의 식 (1A)로 표시되는 2-아미노카바졸 화합물, 및 식 (1B)로 표시되는 2-아미노카바졸 화합물을 나타낼 수 있다.Further, as specific examples of the 2-aminocarbazole compound represented by the formula (1), the 2-aminocarbazole compound represented by the following formula (1A) and the 2-aminocarbazole compound represented by the formula (1B) compounds can be represented.

하기 식 (1A)로 표시되는 2-아미노카바졸 화합물에 대해서, 이하에 설명한다.The 2-aminocarbazole compound represented by the following formula (1A) will be described below.

Figure 112021063299657-pat00004
Figure 112021063299657-pat00004

(R1A 내지 R7A는, 각각 독립적으로, 수소 원자 또는 메틸기를 나타낸다. Ar1 및 Ar2는, 각각 독립적으로, 탄소수 6 내지 18의 방향족 탄화수소기이며, 이들은 메틸기 또는 메톡시기를 가지고 있어도 된다. R8A 및 R9A는, 어느 한쪽이 하기 식 (2A)로 표시되는 기이고, 다른 쪽이 수소 원자이다.)(R 1A to R 7A each independently represents a hydrogen atom or a methyl group. Ar 1 and Ar 2 are each independently an aromatic hydrocarbon group having 6 to 18 carbon atoms, and these may have a methyl group or a methoxy group. One of R 8A and R 9A is a group represented by the following formula (2A), and the other is a hydrogen atom.)

Figure 112021063299657-pat00005
Figure 112021063299657-pat00005

(R10A는 수소 원자 또는 메틸기를 나타낸다.)(R 10A represents a hydrogen atom or a methyl group.)

상기 식 (1A)로 표시되는 2-아미노카바졸 화합물은, 상기 식 (1)의 R1 또는 R2 중 한쪽이 상기 식 (2)의 기이고, 다른 쪽이 수소 원자인 화합물이며, R3은 수소 원자 또는 메틸기이다.The 2-aminocarbazole compound represented by the formula (1A) is a compound in which one of R 1 or R 2 in the formula (1) is a group of the formula (2), and the other is a hydrogen atom, R 3 is a hydrogen atom or a methyl group.

상기 식 (1A)로 표시되는 2-아미노카바졸 화합물에 있어서, R1A 내지 R7A는, 각각 독립적으로, 수소 원자 또는 메틸기를 나타낸다. 또, 정공 수송 특성 및 원료입수의 용이성의 점에 있어서, R1A, R2A, R4A, R5A, R6A 및 R7A는 수소 원자인 것이 바람직하고, R1A 내지 R7A는 모두 수소 원자인 것이 보다 바람직하다.In the 2-aminocarbazole compound represented by the formula (1A), R 1A to R 7A each independently represent a hydrogen atom or a methyl group. Further, in terms of hole transport characteristics and the ease of obtaining raw materials, R 1A , R 2A , R 4A , R 5A , R 6A and R 7A are preferably hydrogen atoms, and R 1A to R 7A are all hydrogen atoms. more preferably.

상기 식 (1A)로 표시되는 2-아미노카바졸 화합물에 있어서, Ar1 및 Ar2는, 각각 독립적으로, 탄소수 6 내지 18의 방향족 탄화수소기를 나타내고, 이들은 메틸기, 메톡시기를 가지고 있어도 된다. Ar1 및 Ar2에 있어서의 탄소수 6 내지 18의 방향족 탄화수소기로서는, 특별히 한정되는 것은 아니지만, 예를 들면, 페닐기, 바이페닐릴기, 터페닐릴기, 나프틸기, 플루오레닐기, 페난트릴기, 벤조플루오레닐기(이들 기는, 메틸기 또는 메톡시기를 가지고 있어도 되고, 치환기의 수에 대해서는 특별히 한정되지 않음) 등을 들 수 있다.In the 2-aminocarbazole compound represented by the formula (1A), Ar 1 and Ar 2 each independently represent an aromatic hydrocarbon group having 6 to 18 carbon atoms, and these may have a methyl group or a methoxy group. Although it does not specifically limit as a C6-C18 aromatic hydrocarbon group in Ar< 1 > and Ar< 2 >, For example, a phenyl group, a biphenylyl group, a terphenylyl group, a naphthyl group, a fluorenyl group, a phenanthryl group, benzo fluorenyl group (these groups may have a methyl group or a methoxy group, and the number of substituents is not specifically limited) etc. are mentioned.

Ar1 및 Ar2의 구체예로서는, 페닐기, 4-메틸페닐기, 3-메틸페닐기, 2-메틸페닐기, 2,4-다이메틸페닐기, 2,5-다이메틸페닐기, 3,4-다이메틸페닐기, 3,5-다이메틸페닐기, 2,6-다이메틸페닐기, 2,3,5-트라이메틸페닐기, 2,3,6-트라이메틸페닐기, 3,4,5-트라이메틸페닐기, 4-메톡시페닐기, 3-메톡시페닐기, 2-메톡시페닐기, 2-메틸-4-메톡시페닐기, 2-메틸-5-메톡시페닐기, 3-메틸-4-메톡시페닐기, 3-메틸-5-메톡시페닐기, 2-메톡시-4-메틸페닐기, 3-메톡시-4-메틸페닐기, 2,4-다이메톡시페닐기, 2,5-다이메톡시페닐기, 2,6-다이메톡시페닐기, 3,4-다이메톡시페닐기, 3,5-다이메톡시페닐기, 3,4,5-트라이메톡시페닐기, 4-바이페닐릴기, 3-바이페닐릴기, 2-바이페닐릴기, 2-메틸-1,1'-바이페닐-4-일기, 3-메틸-1,1'-바이페닐-4-일기, 2'-메틸-1,1'-바이페닐-4-일기, 3'-메틸-1,1'-바이페닐-4-일기, 4'-메틸-1,1'-바이페닐-4-일기, 2,6-다이메틸-1,1'-바이페닐-4-일기, 2,2'-다이메틸-1,1'-바이페닐-4-일기, 2,3'-다이메틸-1,1'-바이페닐-4-일기, 2,4'-다이메틸-1,1'-바이페닐-4-일기, 3,2'-다이메틸-1,1'-바이페닐-4-일기, 2',3'-다이메틸-1,1'-바이페닐-4-일기, 2',4'-다이메틸-1,1'-바이페닐-4-일기, 2',5'-다이메틸-1,1'-바이페닐-4-일기, 2',6'-다이메틸-1,1'-바이페닐-4-일기, p-터페닐기, m-터페닐기, o-터페닐기, 1-나프틸기, 2-나프틸기, 2-메틸나프탈렌-1-일기, 4-메틸나프탈렌-1-일기, 6-메틸나프탈렌-2-일기, 2-안트릴기, 9-안트릴기, 2-플루오레닐기, 9,9-다이메틸-9H-플루오렌-2-일기, 9-페난트릴기, 2-페난트릴기, 벤조플루오레닐기, 플루오란테닐기, 피레닐기, 크라이세닐기 등을 예시할 수 있지만, 이들로 한정되는 것은 아니다.Specific examples of Ar 1 and Ar 2 include a phenyl group, 4-methylphenyl group, 3-methylphenyl group, 2-methylphenyl group, 2,4-dimethylphenyl group, 2,5-dimethylphenyl group, 3,4-dimethylphenyl group, 3,5-dimethylphenyl group, 2,6-dimethylphenyl group, 2,3,5-trimethylphenyl group, 2,3,6-trimethylphenyl group, 3,4,5-trimethylphenyl group, 4-methoxy Phenyl group, 3-methoxyphenyl group, 2-methoxyphenyl group, 2-methyl-4-methoxyphenyl group, 2-methyl-5-methoxyphenyl group, 3-methyl-4-methoxyphenyl group, 3-methyl-5- Methoxyphenyl group, 2-methoxy-4-methylphenyl group, 3-methoxy-4-methylphenyl group, 2,4-dimethoxyphenyl group, 2,5-dimethoxyphenyl group, 2,6-dimethoxyphenyl group , 3,4-dimethoxyphenyl group, 3,5-dimethoxyphenyl group, 3,4,5-trimethoxyphenyl group, 4-biphenylyl group, 3-biphenylyl group, 2-biphenylyl group, 2- Methyl-1,1'-biphenyl-4-yl group, 3-methyl-1,1'-biphenyl-4-yl group, 2'-methyl-1,1'-biphenyl-4-yl group, 3'- Methyl-1,1'-biphenyl-4-yl group, 4'-methyl-1,1'-biphenyl-4-yl group, 2,6-dimethyl-1,1'-biphenyl-4-yl group, 2,2'-dimethyl-1,1'-biphenyl-4-yl group, 2,3'-dimethyl-1,1'-biphenyl-4-yl group, 2,4'-dimethyl-1, 1'-biphenyl-4-yl group, 3,2'-dimethyl-1,1'-biphenyl-4-yl group, 2',3'-dimethyl-1,1'-biphenyl-4-yl group , 2',4'-dimethyl-1,1'-biphenyl-4-yl group, 2',5'-dimethyl-1,1'-biphenyl-4-yl group, 2',6'-di Methyl-1,1'-biphenyl-4-yl group, p-terphenyl group, m-terphenyl group, o-terphenyl group, 1-naphthyl group, 2-naphthyl group, 2-methylnaphthalen-1-yl group, 4- Methylnaphthalen-1-yl group, 6-methylnaphthalen-2-yl group, 2-anthryl group, 9-anthryl group, 2-fluorenyl group, 9,9-dimethyl-9H-fluoren-2-yl group, 9-phenanthryl group, 2-phenanthryl group, benzofluorenyl group, fluoranthenyl group, pyrenyl group, chrysenyl group and the like can be exemplified, but the present invention is not limited thereto.

정공 수송 특성의 점에 있어서, 본 발명의 식 (1A)로 표시되는 2-아미노카바졸 화합물에 있어서의 Ar1 및 Ar2로서는, 각각 독립적으로, 메틸기 또는 메톡시기를 가지고 있어도 되는 페닐기, 메틸기 또는 메톡시기를 가지고 있어도 되는 바이페닐릴기, 메틸기 또는 메톡시기를 가지고 있어도 되는 터페닐기 또는 메틸기 또는 메톡시기를 가지고 있어도 되는 플루오레닐기인 것이 바람직하고, 페닐기, 4-바이페닐릴기, p-터페닐-4-일기, m-터페닐-4-일기 또는 9,9-다이메틸-9H-플루오렌-2-일기인 것이 보다 바람직하다.In terms of hole transport properties, Ar 1 and Ar 2 in the 2-aminocarbazole compound represented by the formula (1A) of the present invention are each independently a phenyl group which may have a methyl group or a methoxy group, a methyl group, or It is preferably a biphenylyl group which may have a methoxy group, a methyl group or a terphenyl group which may have a methoxy group, or a fluorenyl group which may have a methyl group or a methoxy group, a phenyl group, 4-biphenylyl group, p-terphenyl- A 4-yl group, a m-terphenyl-4-yl group, or a 9,9-dimethyl-9H-fluoren-2-yl group is more preferable.

이하에, 식 (1A)로 표시되는 2-아미노카바졸 화합물의 바람직한 예를 나타내지만, 이들 화합물로 한정되는 것은 아니다.Although the preferable example of the 2-aminocarbazole compound represented by Formula (1A) is shown below, it is not limited to these compounds.

Figure 112021063299657-pat00006
Figure 112021063299657-pat00006

Figure 112021063299657-pat00007
Figure 112021063299657-pat00007

Figure 112021063299657-pat00008
Figure 112021063299657-pat00008

이들 화합물 중, 3중항 준위 및 정공 수송 특성의 점에 있어서, 화합물(A25), 화합물(A26), 화합물(A27), 화합물(A28), 화합물(A29), 화합물(A47) 또는 화합물(A53)이 보다 바람직하다.Among these compounds, in terms of triplet level and hole transport properties, compound (A25), compound (A26), compound (A27), compound (A28), compound (A29), compound (A47), or compound (A53) This is more preferable.

Figure 112021063299657-pat00009
Figure 112021063299657-pat00009

상기 식 (1A)로 표시되는 2-아미노카바졸 화합물은, 예를 들면, 2번 위치가 할로겐화된 9H-카바졸화합물을 원료로서 이용해서, 공지의 방법(Tetrahedron Letters, 1998년, 제39권, 2367페이지)에 의해 합성할 수 있다. 구체적으로는, 하기 경로에 의해 합성할 수 있다.The 2-aminocarbazole compound represented by the formula (1A) can be prepared by a known method (Tetrahedron Letters, 1998, Vol. 39) using, for example, a 9H-carbazole compound having the 2-position halogenated as a raw material. , page 2367) can be synthesized. Specifically, it can be synthesized by the following route.

식 (3A)로 표시되는 2번 위치가 할로겐화된 9H-카바졸화합물과, 식 (4A)로 표시되는 할로겐 원자를 가지는 화합물을, 염기의 존재 하, 구리 촉매 또는 팔라듐 촉매를 이용해서 반응시켜, 식 (5A)로 표시되는 2-할로겐화-9-치환 카바졸 화합물을 얻는다. 또한, 얻어진 식 (5A)로 표시되는 2-할로겐화-9-치환 카바졸 화합물과, 식 (6A)로 표시되는 2급 아민 화합물을, 염기의 존재 하, 구리 촉매 또는 팔라듐 촉매를 이용해서 반응시킨다.A 9H-carbazole compound in which the 2-position represented by the formula (3A) is halogenated and a compound having a halogen atom represented by the formula (4A) are reacted in the presence of a base using a copper catalyst or a palladium catalyst, A 2-halogenated-9-substituted carbazole compound represented by the formula (5A) is obtained. Further, the obtained 2-halogenated-9-substituted carbazole compound represented by the formula (5A) and the secondary amine compound represented by the formula (6A) are reacted in the presence of a base using a copper catalyst or a palladium catalyst .

Figure 112021063299657-pat00010
Figure 112021063299657-pat00010

(Ar1, Ar2, 및 R1A 내지 R9A는, 상기 식 (1)과 같은 정의를 나타낸다. A 및 B는, 각각 독립적으로, 할로겐 원자(요오드, 브로민, 염소 또는 플루오린)를 나타낸다.)(Ar 1 , Ar 2 , and R 1A to R 9A have the same definitions as in Formula (1) above. A and B each independently represent a halogen atom (iodine, bromine, chlorine or fluorine). .)

식 (3A)로 표시되는 화합물은, 일반 공지의 방법(예를 들면, 일본국 공개 특허 제2011-1349호)에 의거해서 합성할 수 있다.The compound represented by Formula (3A) can be synthesize|combined based on a general well-known method (For example, Unexamined-Japanese-Patent No. 2011-1349).

식 (4A)로 표시되는 화합물은, 일반 공지의 방법(예를 들면, WO2008-013399)에 의거해서 합성할 수 있다.The compound represented by Formula (4A) can be synthesize|combined based on a general well-known method (for example, WO2008-013399).

식 (6A)로 표시되는 화합물은, 시판되고 있는 화합물을 이용할 수도 있고, 일반 공지의 방법에 의거해서 합성할 수도 있다.A commercially available compound may be used for the compound represented by Formula (6A), and it can also synthesize|combine it based on a general well-known method.

본 발명의 상기 식 (1A)로 표시되는 2-아미노카바졸 화합물은, 유기 EL 소자의 발광층, 정공 수송층 또는 정공 주입층의 재료로서 사용할 수 있다. 또, 상기 식 (1A)로 표시되는 2-아미노카바졸 화합물은, 정공 수송 특성이나 소자 수명의 점에서, 고순도인 것이 바람직하다.The 2-aminocarbazole compound represented by the formula (1A) of the present invention can be used as a material for a light emitting layer, a hole transport layer, or a hole injection layer of an organic EL device. Further, the 2-aminocarbazole compound represented by the formula (1A) is preferably of high purity in terms of hole transport properties and device lifetime.

상기 식 (1A)로 표시되는 2-아미노카바졸 화합물을, 유기 EL 소자의 정공 주입층 및/또는 정공 수송층으로서 사용할 때의 발광층에는, 종래부터 사용되고 있는 공지의 형광 또는 인광 발광 재료를 사용할 수 있다. 발광층은 1종류의 발광 재료만으로 형성되어 있어도, 호스트 재료 중에 1종류 이상의 발광 재료가 도핑되어 있어도 된다.For the light emitting layer when the 2-aminocarbazole compound represented by the formula (1A) is used as a hole injection layer and/or a hole transport layer of an organic EL device, a conventionally used fluorescent or phosphorescent light emitting material can be used. . The light-emitting layer may be formed of only one type of light-emitting material, or one or more types of light-emitting materials may be doped in the host material.

상기 식 (1A)로 표시되는 2-아미노카바졸 화합물로 이루어진 정공 주입층 및/또는 정공 수송층을 형성할 때에는, 필요에 따라서 2종류 이상의 재료를 함유 또는 적층시켜도 되고, 예를 들면, 산화 몰리브덴 등의 산화물, 7,7,8,8-테트라사이아노퀴노다이메탄, 2,3,5,6-테트라플루오로-7,7,8,8-테트라사이아노퀴노다이메탄, 헥사사이아노헥사아자트라이페닐렌 등의 공지의 전자수용성 재료를 함유 또는 적층시켜도 된다.When forming the hole injection layer and/or the hole transport layer made of the 2-aminocarbazole compound represented by the formula (1A), two or more types of materials may be contained or laminated as needed, for example, molybdenum oxide, etc. Oxide of, 7,7,8,8-tetracyanoquinodimethane, 2,3,5,6-tetrafluoro-7,7,8,8-tetracyanoquinodimethane, hexacyanohexaaza A known electron-accepting material such as triphenylene may be contained or laminated.

상기 식 (1A)로 표시되는 2-아미노카바졸 화합물을 유기 EL 소자의 발광층으로서 사용할 경우에는, 해당 2-아미노카바졸 화합물을 단독으로 사용하거나, 공지의 발광 호스트 재료에 도핑해서 사용하거나, 또는 공지의 발광 도펀트를 도핑해서 사용할 수 있다.When the 2-aminocarbazole compound represented by the formula (1A) is used as a light emitting layer of an organic EL device, the 2-aminocarbazole compound is used alone, or doped with a known light emitting host material, or A known light emitting dopant can be doped and used.

상기 식 (1A)로 표시되는 2-아미노카바졸 화합물을 함유하는 정공 주입층, 정공 수송층 또는 발광층을 형성하는 방법으로서는, 예를 들면, 진공증착법, 스핀 코트법, 캐스트법 등의 공지의 방법을 적용할 수 있다.As a method of forming a hole injection layer, a hole transport layer or a light emitting layer containing the 2-aminocarbazole compound represented by the formula (1A), for example, a known method such as a vacuum deposition method, a spin coating method, a casting method can be applied.

다음에, 하기 식 (1B)로 표시되는 2-아미노카바졸 화합물에 대해서, 이하에 설명한다.Next, the 2-aminocarbazole compound represented by the following formula (1B) will be described below.

Figure 112021063299657-pat00011
Figure 112021063299657-pat00011

(R1B 내지 R3B 중 어느 하나는, 4-다이벤조티에닐기, 4-다이벤조퓨라닐기 또는 9-페난트릴기이고, 나머지는 수소 원자이다. Ar1 및 Ar2는, 각각 독립적으로, 탄소수 6 내지 18의 방향족 탄화수소기이고, 이들은 메틸기 또는 메톡시기를 가지고 있어도 된다.)(Any one of R 1B to R 3B is a 4-dibenzothienyl group, a 4-dibenzofuranyl group or a 9-phenanthryl group, and the rest is a hydrogen atom. Ar 1 and Ar 2 are each independently, each having a carbon number It is an aromatic hydrocarbon group of 6-18, and these may have a methyl group or a methoxy group.)

상기 식 (1B)로 표시되는 2-아미노카바졸 화합물은, 상기 식 (1)의 R의 일부가 수소 원자이고, R1 내지 R3 중 어느 하나가 4-다이벤조티에닐기, 4-다이벤조퓨라닐기 또는 9-페난트릴기이며, 나머지는 수소 원자인 화합물을 나타낸다.In the 2-aminocarbazole compound represented by the formula (1B), a part of R in the formula (1) is a hydrogen atom, and any one of R 1 to R 3 is a 4-dibenzothienyl group, or 4-dibenzo represents a compound of a furanyl group or a 9-phenanthryl group, and the remainder is a hydrogen atom.

상기 식 (1B)로 표시되는 2-아미노카바졸 화합물에 있어서, Ar1 및 Ar2는, 각각 독립적으로, 탄소수 6 내지 18의 방향족 탄화수소기이며, 이들은 메틸기 또는 메톡시기를 가지고 있어도 된다.In the 2-aminocarbazole compound represented by the formula (1B), Ar 1 and Ar 2 are each independently an aromatic hydrocarbon group having 6 to 18 carbon atoms, and these may have a methyl group or a methoxy group.

Ar1 및 Ar2에 있어서의 탄소수 6 내지 18의 방향족 탄화수소기로서는, 특별히 한정되는 것은 아니지만, 예를 들면, 페닐기, 바이페닐릴기, 터페닐릴기, 나프틸기, 플루오레닐기, 페난트릴기, 벤조플루오레닐기, 트라이페닐레닐기, 플루오란테닐기(이들의 치환기는, 메틸기 또는 메톡시기를 가지고 있어도 되고, 해당 메틸기 또는 메톡시기의 수에 대해서는 특별히 한정되지 않음) 등을 들 수 있다.Although it does not specifically limit as a C6-C18 aromatic hydrocarbon group in Ar< 1 > and Ar< 2 >, For example, a phenyl group, a biphenylyl group, a terphenylyl group, a naphthyl group, a fluorenyl group, a phenanthryl group, benzo A fluorenyl group, a triphenylenyl group, a fluoranthenyl group (These substituents may have a methyl group or a methoxy group, and the number of the said methyl group or a methoxy group is not specifically limited.) etc. are mentioned.

Ar1 및 Ar2의 구체예로서는, 페닐기, 4-메틸페닐기, 3-메틸페닐기, 2-메틸페닐기, 2,4-다이메틸페닐기, 2,5-다이메틸페닐기, 3,4-다이메틸페닐기, 3,5-다이메틸페닐기, 2,6-다이메틸페닐기, 2,3,5-트라이메틸페닐기, 2,3,6-트라이메틸페닐기, 3,4,5-트라이메틸페닐기, 4-메톡시페닐기, 3-메톡시페닐기, 2-메톡시페닐기, 2-메틸-4-메톡시페닐기, 2-메틸-5-메톡시페닐기, 3-메틸-4-메톡시페닐기, 3-메틸-5-메톡시페닐기, 2-메톡시-4-메틸페닐기, 3-메톡시-4-메틸페닐기, 2,4-다이메톡시페닐기, 2,5-다이메톡시페닐기, 2,6-다이메톡시페닐기, 3,4-다이메톡시페닐기, 3,5-다이메톡시페닐기, 3,4,5-트라이메톡시페닐기, 4-바이페닐릴기, 3-바이페닐릴기, 2-바이페닐릴기, 2-메틸-1,1'-바이페닐-4-일기, 3-메틸-1,1'-바이페닐-4-일기, 2'-메틸-1,1'-바이페닐-4-일기, 3'-메틸-1,1'-바이페닐-4-일기, 4'-메틸-1,1'-바이페닐-4-일기, 2,6-다이메틸-1,1'-바이페닐-4-일기, 2,2'-다이메틸-1,1'-바이페닐-4-일기, 2,3'-다이메틸-1,1'-바이페닐-4-일기, 2,4'-다이메틸-1,1'-바이페닐-4-일기, 3,2'-다이메틸-1,1'-바이페닐-4-일기, 2',3'-다이메틸-1,1'-바이페닐-4-일기, 2',4'-다이메틸-1,1'-바이페닐-4-일기, 2',5'-다이메틸-1,1'-바이페닐-4-일기, 2',6'-다이메틸-1,1'-바이페닐-4-일기, p-터페닐기, m-터페닐기, o-터페닐기, 1-나프틸기, 2-나프틸기, 2-메틸나프탈렌-1-일기, 4-메틸나프탈렌-1-일기, 6-메틸나프탈렌-2-일기, 2-안트릴기, 9-안트릴기, 1-트라이페닐레닐기, 2-트라이페닐레닐기, 2-플루오레닐기, 9,9-다이메틸-9H-플루오렌-2-일기, 9-페난트릴기, 2-페난트릴기, 벤조플루오레닐기, 플루오란테닐기, 피레닐기, 크라이세닐기 등을 예시할 수 있지만, 이들로 한정되는 것은 아니다.Specific examples of Ar 1 and Ar 2 include a phenyl group, 4-methylphenyl group, 3-methylphenyl group, 2-methylphenyl group, 2,4-dimethylphenyl group, 2,5-dimethylphenyl group, 3,4-dimethylphenyl group, 3,5-dimethylphenyl group, 2,6-dimethylphenyl group, 2,3,5-trimethylphenyl group, 2,3,6-trimethylphenyl group, 3,4,5-trimethylphenyl group, 4-methoxy Phenyl group, 3-methoxyphenyl group, 2-methoxyphenyl group, 2-methyl-4-methoxyphenyl group, 2-methyl-5-methoxyphenyl group, 3-methyl-4-methoxyphenyl group, 3-methyl-5- Methoxyphenyl group, 2-methoxy-4-methylphenyl group, 3-methoxy-4-methylphenyl group, 2,4-dimethoxyphenyl group, 2,5-dimethoxyphenyl group, 2,6-dimethoxyphenyl group , 3,4-dimethoxyphenyl group, 3,5-dimethoxyphenyl group, 3,4,5-trimethoxyphenyl group, 4-biphenylyl group, 3-biphenylyl group, 2-biphenylyl group, 2- Methyl-1,1'-biphenyl-4-yl group, 3-methyl-1,1'-biphenyl-4-yl group, 2'-methyl-1,1'-biphenyl-4-yl group, 3'- Methyl-1,1'-biphenyl-4-yl group, 4'-methyl-1,1'-biphenyl-4-yl group, 2,6-dimethyl-1,1'-biphenyl-4-yl group, 2,2'-dimethyl-1,1'-biphenyl-4-yl group, 2,3'-dimethyl-1,1'-biphenyl-4-yl group, 2,4'-dimethyl-1, 1'-biphenyl-4-yl group, 3,2'-dimethyl-1,1'-biphenyl-4-yl group, 2',3'-dimethyl-1,1'-biphenyl-4-yl group , 2',4'-dimethyl-1,1'-biphenyl-4-yl group, 2',5'-dimethyl-1,1'-biphenyl-4-yl group, 2',6'-di Methyl-1,1'-biphenyl-4-yl group, p-terphenyl group, m-terphenyl group, o-terphenyl group, 1-naphthyl group, 2-naphthyl group, 2-methylnaphthalen-1-yl group, 4- Methylnaphthalen-1-yl group, 6-methylnaphthalen-2-yl group, 2-anthryl group, 9-anthryl group, 1-triphenylenyl group, 2-triphenylenyl group, 2-fluorenyl group, 9, 9-dimethyl-9H-fluoren-2-yl group, 9-phenanthryl group, 2-phenanthryl group, benzofluorenyl group, fluoranthenyl group, pyrenyl group, chrysenyl group and the like can be exemplified, is not limited to

Ar1 및 Ar2는, 정공 수송 특성의 점에 있어서, 각각 독립적으로, 메틸기 또는 메톡시기를 가지고 있어도 되는 페닐기, 메틸기 또는 메톡시기를 가지고 있어도 되는 나프틸기, 메틸기 또는 메톡시기를 가지고 있어도 되는 페난트릴기, 메틸기 또는 메톡시기를 가지고 있어도 되는 바이페닐릴기, 메틸기 또는 메톡시기를 가지고 있어도 되는 터페닐기 또는 메틸기 또는 메톡시기를 가지고 있어도 되는 플루오레닐기인 것이 바람직하고, 페닐기, 4-메틸페닐기, 1-나프틸기, 9-페난트릴기, 4-바이페닐릴기, p-터페닐-4-일기, m-터페닐-4-일기 또는 9,9-다이메틸-9H-플루오렌-2-일기인 것이 보다 바람직하다.Ar 1 and Ar 2 are each independently a phenyl group which may have a methyl group or a methoxy group, a naphthyl group which may have a methyl group or a methoxy group, a phenanthryl which may have a methyl group or a methoxy group, in terms of hole transport properties It is preferably a biphenylyl group which may have a group, a methyl group or a methoxy group, a terphenyl group which may have a methyl group or a methoxy group, or a fluorenyl group which may have a methyl group or a methoxy group, a phenyl group, a 4-methylphenyl group, 1- naphthyl group, 9-phenanthryl group, 4-biphenylyl group, p-terphenyl-4-yl group, m-terphenyl-4-yl group, or 9,9-dimethyl-9H-fluoren-2-yl group more preferably.

이하에, 식 (1B)로 표시되는 2-아미노카바졸 화합물의 바람직한 예를 나타내지만, 이들 화합물로 한정되는 것은 아니다.Although the preferable example of the 2-aminocarbazole compound represented by Formula (1B) is shown below, it is not limited to these compounds.

Figure 112021063299657-pat00012
Figure 112021063299657-pat00012

Figure 112021063299657-pat00013
Figure 112021063299657-pat00013

Figure 112021063299657-pat00014
Figure 112021063299657-pat00014

Figure 112021063299657-pat00015
Figure 112021063299657-pat00015

Figure 112021063299657-pat00016
Figure 112021063299657-pat00016

Figure 112021063299657-pat00017
Figure 112021063299657-pat00017

Figure 112021063299657-pat00018
Figure 112021063299657-pat00018

Figure 112021063299657-pat00019
Figure 112021063299657-pat00019

이들 화합물 중, 3중항 준위 및 정공 수송 특성의 점에 있어서, 화합물(B2), 화합물(B5), 화합물(B25), 화합물(B26), 화합물(B27), 화합물(B28), 화합물(B29), 화합물(B34), 화합물(B46), 화합물(B53), 화합물(B77), 화합물(B79), 화합물(B103), 화합물(B106), 화합물(B122) 또는 화합물(B138)이 보다 바람직하다.Among these compounds, compound (B2), compound (B5), compound (B25), compound (B26), compound (B27), compound (B28), compound (B29) in terms of triplet level and hole transport properties , compound (B34), compound (B46), compound (B53), compound (B77), compound (B79), compound (B103), compound (B106), compound (B122) or compound (B138) is more preferable.

Figure 112021063299657-pat00020
Figure 112021063299657-pat00020

상기 식 (1B)로 표시되는 2-아미노카바졸 화합물은, 예를 들면, 2번 위치가 할로겐화된 9H-카바졸 화합물을 원료로서 이용해서, 공지의 방법(Tetrahedron Letters, 1998년, 제39권, 2367페이지)에 의해 합성할 수 있다.The 2-aminocarbazole compound represented by the formula (1B) is prepared by a known method (Tetrahedron Letters, 1998, vol. 39) using, for example, a 9H-carbazole compound having the 2-position halogenated as a raw material. , page 2367) can be synthesized.

구체적으로는, 하기의 경로에 의해 합성할 수 있다.Specifically, it can be synthesized by the following route.

Figure 112021063299657-pat00021
Figure 112021063299657-pat00021

(R1B 내지 R3B, Ar1 및 Ar2는, 상기 식 (1B)과 같은 정의를 나타낸다. A 및 B는, 각각 독립적으로, 할로겐 원자(요오드, 브로민, 염소 또는 플루오린)를 나타낸다.)(R 1B to R 3B , Ar 1 and Ar 2 have the same definitions as in Formula (1B) above. A and B each independently represent a halogen atom (iodine, bromine, chlorine or fluorine). )

상기 경로와 같이, 식 (2B)로 표시되는 2번 위치가 할로겐화된 9H-카바졸화합물과, 식 (3B)로 표시되는 할로겐 원자를 가진 화합물을, 염기의 존재 하, 구리 촉매 또는 팔라듐 촉매를 이용해서 반응시켜, 식 (4B)로 표시되는 2-할로겐화-9-치환 카바졸 화합물을 얻는다.As in the above route, the 9H-carbazole compound in which the 2-position represented by the formula (2B) is halogenated and the compound having a halogen atom represented by the formula (3B) are reacted with a copper catalyst or a palladium catalyst in the presence of a base. and reacted to obtain a 2-halogenated-9-substituted carbazole compound represented by the formula (4B).

또한, 얻어진 식 (4B)로 표시되는 2-할로겐화-9-치환 카바졸 화합물과, 식 (5B)로 표시되는 2급 아민 화합물을, 염기의 존재 하, 구리 촉매 또는 팔라듐 촉매를 이용해서 반응시킨다.Further, the obtained 2-halogenated-9-substituted carbazole compound represented by the formula (4B) and the secondary amine compound represented by the formula (5B) are reacted in the presence of a base using a copper catalyst or a palladium catalyst .

식 (2B)로 표시되는 화합물은, 일반 공지의 방법(예를 들면, 일본국 공개 특허 제2011-1349호)에 의거해서 합성할 수 있다.The compound represented by Formula (2B) can be synthesize|combined based on a general well-known method (For example, Unexamined-Japanese-Patent No. 2011-1349).

식 (3B)로 표시되는 화합물은, 일반 공지의 방법(예를 들면, WO2009-133007 및 Chemistry Letters, 2011년, 40권, 1050페이지)에 의거해서 합성할 수 있다.The compound represented by Formula (3B) can be synthesize|combined based on a general well-known method (For example, WO2009-133007 and Chemistry Letters, 2011, Vol. 40, page 1050).

식 (5B)로 표시되는 화합물은, 시판되고 있는 화합물을 이용할 수도 있고, 일반 공지의 방법에 의거해서 합성할 수도 있다.A commercially available compound can also be used for the compound represented by Formula (5B), and it can also synthesize|combine it based on a general well-known method.

본 발명의 상기 식 (1B)로 표시되는 2-아미노카바졸 화합물은, 유기 EL 소자의 발광층, 정공 수송층 또는 정공 주입층으로서 사용할 수 있다. 즉, 식 (1B)로 표시되는 화합물은, 발광 재료, 발광 호스트 재료, 정공 수송 재료 또는 정공 주입 재료로서 유효하게 이용할 수 있다.The 2-aminocarbazole compound represented by the formula (1B) of the present invention can be used as a light emitting layer, a hole transport layer, or a hole injection layer of an organic EL device. That is, the compound represented by Formula (1B) can be effectively used as a light emitting material, a light emitting host material, a hole transport material, or a hole injection material.

또, 해당 화합물은, 정공 수송 특성이나 유기 EL 소자 수명의 점에서, 고순도인 것이 바람직하다. 증류, 승화 정제, 재결정화, 실리카겔 크로마토그래피 등, 일반 공지의 수법에 의해 정제하고, 고순도화할 수 있다.Moreover, it is preferable that this compound is high purity from the point of a hole transport characteristic or organic electroluminescent element lifetime. Distillation, sublimation purification, recrystallization, silica gel chromatography, etc. can refine|purify by a well-known method, and can achieve high purity.

상기 식 (1B)로 표시되는 2-아미노카바졸 화합물을, 유기 EL 소자의 정공 주입층 및/또는 정공 수송층으로서 사용할 때의 발광층에는, 종래부터 사용되고 있는 공지의 형광 또는 인광 발광 재료를 사용할 수 있다. 발광층은 1종류의 발광 재료만으로 형성되어 있어도, 호스트 재료 중에 1종류 이상의 발광 재료가 도핑되어 있어도 된다.For the light emitting layer when the 2-aminocarbazole compound represented by the above formula (1B) is used as a hole injection layer and/or a hole transport layer of an organic EL device, a conventionally used fluorescent or phosphorescent light emitting material can be used. . The light-emitting layer may be formed of only one type of light-emitting material, or one or more types of light-emitting materials may be doped in the host material.

상기 식 (1B)로 표시되는 2-아미노카바졸 화합물을 함유하는 정공 주입층 및/또는 정공 수송층을 형성할 때에는, 필요에 따라서 2종류 이상의 재료를 함유 또는 적층시켜도 된다. 예를 들면, 산화 몰리브덴 등의 산화물, 7,7,8,8-테트라사이아노퀴노다이메탄, 2,3,5,6-테트라플루오로-7,7,8,8-테트라사이아노퀴노다이메탄, 헥사사이아노헥사아자트라이페닐렌 등의 공지의 전자수용성 재료를 함유 또는 적층시켜도 된다.When forming the hole injection layer and/or the hole transport layer containing the 2-aminocarbazole compound represented by the formula (1B), two or more types of materials may be contained or laminated as needed. For example, oxides such as molybdenum oxide, 7,7,8,8-tetracyanoquinodimethane, 2,3,5,6-tetrafluoro-7,7,8,8-tetracyanoquinodimethane A known electron-accepting material such as methane or hexacyanohexaazatriphenylene may be contained or laminated.

상기 식 (1B)로 표시되는 2-아미노카바졸 화합물을 유기 EL 소자의 발광층으로서 사용할 경우에는, 해당 2-아미노카바졸 화합물을 단독으로 사용하거나, 공지의 발광 호스트 재료에 도핑해서 사용하거나, 또는 공지의 발광 도펀트를 도핑해서 사용할 수 있다.When the 2-aminocarbazole compound represented by the formula (1B) is used as a light emitting layer of an organic EL device, the 2-aminocarbazole compound is used alone, or doped with a known light emitting host material, or A known light emitting dopant can be doped and used.

상기 식 (1B)로 표시되는 2-아미노카바졸 화합물을 함유하는 정공 주입층, 정공 수송층 또는 발광층을 형성하는 방법으로서는, 예를 들면, 진공증착법, 스핀 코트법, 캐스트법 등의 공지의 방법을 적용할 수 있다.As a method of forming a hole injection layer, a hole transport layer or a light emitting layer containing the 2-aminocarbazole compound represented by the formula (1B), for example, a known method such as a vacuum deposition method, a spin coating method, a casting method can be applied.

[실시예][Example]

이하, 본 발명을 실시예에 의거해서 더욱 상세히 설명하지만, 본 발명은 이들 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail based on Examples, but the present invention is not limited by these Examples.

1H-NMR 및 13C-NMR 측정은, 내부표준으로 테트라메틸실란을 이용해서, 바리안사 제품 Gemini200을 이용해서 행하였다. 1 H-NMR and 13 C-NMR measurements were performed using Gemini200 manufactured by Varian Corporation using tetramethylsilane as an internal standard.

FDMS(전계 이탈 질량 분석) 측정은, 히다치세이사큐쇼(日立製作所)사 제품 M-80B를 이용해서 행하였다. 유기 EL 소자의 발광 특성은, 제작한 소자에, 설정된 직류 전류를 인가하고, 탑콘사 제품인 LUMINANCE METER(BM-9)의 휘도계를 이용해서 측정하고, 평가하였다.The FDMS (field escape mass spectrometry) measurement was performed using M-80B manufactured by Hitachi Seisakusho Corporation. The light emitting characteristics of the organic EL element were measured and evaluated using a luminance meter of LUMINANCE METER (BM-9) manufactured by Topcon, by applying a set direct current to the produced element.

합성예 1A(2-클로로-9-(4-(1-나프틸)페닐)카바졸의 합성)Synthesis Example 1A (synthesis of 2-chloro-9- (4- (1-naphthyl) phenyl) carbazole)

질소 기류 하, 50㎖의 3구 플라스크에, 2-클로로카바졸 5.2g(26.0m㏖), 1-브로모-4-(1-나프틸)벤젠 7.7g(27.3m㏖), 탄산 칼륨 5.2g(38.2m㏖), o-자일렌 25㎖, 아세트산 팔라듐 61㎎(0.27m㏖) 및 트라이(tert-뷰틸)포스핀 193㎎(0.95m㏖)을 첨가하고, 140℃에서 18시간 교반하였다. 실온까지 냉각 후, 순수 30㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:2))로 정제하여, 2-클로로-9-(4-(1-나프틸)페닐)카바졸의 백색 분말을 8.7g(21.5m㏖) 단리하였다(수율 83%).In a 50 ml three-necked flask under a nitrogen stream, 5.2 g (26.0 mmol) of 2-chlorocarbazole, 7.7 g (27.3 mmol) of 1-bromo-4-(1-naphthyl) benzene, 5.2 of potassium carbonate g (38.2 mmol), o-xylene 25 ml, palladium acetate 61 mg (0.27 mmol) and tri(tert-butyl) phosphine 193 mg (0.95 mmol) were added, and the mixture was stirred at 140° C. for 18 hours. . After cooling to room temperature, 30 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:2)) to obtain 8.7 g of a white powder of 2-chloro-9-(4-(1-naphthyl)phenyl)carbazole. (21.5 mmol) was isolated (yield 83%).

화합물의 동정은, 1H-NMR 측정 및 13C-NMR 측정에 의해 행하였다(이하, 마찬가지이다).Identification of the compound was performed by 1 H-NMR measurement and 13 C-NMR measurement (hereinafter the same applies).

1H-NMR(CDCl3)δ(ppm); 8.10(d, 1H), 8.03(d, 2H), 7.87-7.95(m, 2H), 7.70(d, 2H), 7.40-7.62(m, 9H), 7.20-7.34(m, 2H) 1 H-NMR (CDCl 3 )δ (ppm); 8.10(d, 1H), 8.03(d, 2H), 7.87-7.95(m, 2H), 7.70(d, 2H), 7.40-7.62(m, 9H), 7.20-7.34(m, 2H)

13C-NMR(CDCl3)δ(ppm); 140.93, 140.74, 139.85, 138.62, 135.67, 133.38, 131.28, 131.15, 130.98, 127.94, 127.61, 126.64, 126.26, 125.87, 125.80, 125.49, 125.27, 124.94, 122.38, 121.55, 120.71, 120.01, 119.81, 109.61, 109.52 13 C-NMR (CDCl 3 )δ (ppm); 140.93, 140.74, 139.85, 138.62, 135.67, 133.38, 131.28, 131.15, 130.98, 127.94, 127.61, 126.64, 126.26, 125.87, 125.80, 125.49, 125.27, 124.94, 122.38, 121.55, 10.12.

합성예 2A(2-클로로-9-(4-(2-메틸나프탈렌-1-일)페닐)카바졸의 합성)Synthesis Example 2A (synthesis of 2-chloro-9-(4-(2-methylnaphthalen-1-yl)phenyl)carbazole)

질소 기류 하, 50㎖의 3구 플라스크에, 2-클로로카바졸 1.5g(7.7m㏖), 1-브로모-4-(2-메틸나프탈렌-1-일)벤젠 2.3g(7.7m㏖), 탄산 칼륨 1.5g(10.8m㏖), o-자일렌 10㎖, 아세트산 팔라듐 17㎎(0.07m㏖) 및 트라이(tert-뷰틸)포스핀 54㎎(0.27m㏖)을 첨가하고, 140℃에서 13시간 교반하였다. 실온까지 냉각 후, 순수 10㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:2))로 정제하여, 2-클로로-9-(4-(2-메틸나프탈렌-1-일)페닐)카바졸의 백색 분말을 1.9g(4.6m㏖) 단리하였다(수율 59%).In a 50 ml three-necked flask under a nitrogen stream, 1.5 g (7.7 mmol) of 2-chlorocarbazole, 2.3 g (7.7 mmol) of 1-bromo-4- (2-methylnaphthalen-1-yl) benzene , potassium carbonate 1.5 g (10.8 mmol), o-xylene 10 ml, palladium acetate 17 mg (0.07 mmol) and tri(tert-butyl) phosphine 54 mg (0.27 mmol) were added, and at 140 ° C. The mixture was stirred for 13 hours. After cooling to room temperature, 10 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (mixed solvent of toluene and hexane (volume ratio = 1:2)) to give 2-chloro-9-(4-(2-methylnaphthalen-1-yl)phenyl)carbazole as a white color. 1.9 g (4.6 mmol) of the powder was isolated (yield 59%).

1H-NMR(CDCl3)δ(ppm); 8.12(d, 1H), 8.06(d, 1H), 7.81-7.90(m, 2H), 7.65(d, 2H), 7.23-7.55(m, 11H), 2.36(s, 3H) 1 H-NMR (CDCl 3 )δ (ppm); 8.12 (d, 1H), 8.06 (d, 1H), 7.81-7.90 (m, 2H), 7.65 (d, 2H), 7.23-7.55 (m, 11H), 2.36 (s, 3H)

13C-NMR(CDCl3)δ(ppm); 140.89, 140.74, 139.00, 136.51, 135.41, 132.83, 132.32, 131.50, 131.35, 131.22, 128.14, 127.39, 127.16, 126.39, 125.76, 125.62, 125.38, 124.46, 122.36, 121.55, 120.71, 120.00, 119.79, 109.58, 109.48, 20.58 13 C-NMR (CDCl 3 )δ (ppm); 140.89, 140.74, 139.00, 136.51, 135.41, 132.83, 132.32, 131.50, 131.35, 131.22, 128.14, 127.39, 127.16, 126.39, 125.76, 125.62, 125.38, 124.46, 119.79, 124.46, 119.79, 120.71, 12.55, 120.48. 121.55 20.58

합성예 3A(2-클로로-9-(3-(1-나프틸)페닐)카바졸의 합성)Synthesis Example 3A (synthesis of 2-chloro-9- (3- (1-naphthyl) phenyl) carbazole)

질소 기류 하, 100㎖의 3구 플라스크에, 2-클로로카바졸 5.9g(29.43m㏖), 1-브로모-3-(1-나프틸)벤젠 8.3g(29.4m㏖), 탄산 칼륨 5.6g(41.2m㏖), o-자일렌 35㎖, 아세트산 팔라듐 66㎎(0.29m㏖) 및 트라이(tert-뷰틸)포스핀 207㎎(1.0m㏖)을 첨가하고, 140℃에서 15시간 교반하였다. 실온까지 냉각 후, 순수 30㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:2))로 정제하여, 2-클로로-9-(3-(1-나프틸)페닐)카바졸의 백색 분말을 7.6g(18.8m㏖) 단리하였다(수율 63%).In a 100 ml three-necked flask under a nitrogen stream, 5.9 g (29.43 mmol) of 2-chlorocarbazole, 8.3 g (29.4 mmol) of 1-bromo-3-(1-naphthyl) benzene, 5.6 of potassium carbonate g (41.2 mmol), o-xylene 35 ml, palladium acetate 66 mg (0.29 mmol) and tri(tert-butyl) phosphine 207 mg (1.0 mmol) were added, and the mixture was stirred at 140° C. for 15 hours. . After cooling to room temperature, 30 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:2)) to obtain 7.6 g of a white powder of 2-chloro-9-(3-(1-naphthyl)phenyl)carbazole. (18.8 mmol) was isolated (yield 63%).

화합물의 동정은, FDMS 측정에 의해 행하였다(이하, 마찬가지이다).Identification of the compound was performed by FDMS measurement (the same applies hereafter).

FDMS(m/z); 403(M+)FDMS (m/z); 403 (M+)

합성예 4A(2-클로로-9-(3-(2-메틸나프탈렌-1-일)페닐)카바졸의 합성)Synthesis Example 4A (synthesis of 2-chloro-9- (3- (2-methylnaphthalen-1-yl) phenyl) carbazole)

질소 기류 하, 50㎖의 3구 플라스크에, 2-클로로카바졸 5.3g(26.3m㏖), 1-브로모-3-(2-메틸나프탈렌-1-일)벤젠 7.8g(26.3m㏖), 탄산 칼륨 5.1g(36.8m㏖), o-자일렌 25㎖, 아세트산 팔라듐 59㎎(0.26m㏖) 및 트라이(tert-뷰틸)포스핀 185㎎(0.92m㏖)을 첨가하고, 140℃에서 14시간 교반하였다. 실온까지 냉각 후, 순수 20㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:2))로 정제하여, 2-클로로-9-(3-(2-메틸나프탈렌-1-일)페닐)카바졸의 백색 분말을 10.5g(25.1m㏖) 단리하였다(수율 95%).5.3 g (26.3 mmol) of 2-chlorocarbazole, 7.8 g (26.3 mmol) of 2-chlorocarbazole, 1-bromo-3-(2-methylnaphthalen-1-yl) benzene in a 50 ml three-necked flask under a nitrogen stream , potassium carbonate 5.1 g (36.8 mmol), o-xylene 25 ml, palladium acetate 59 mg (0.26 mmol) and tri(tert-butyl) phosphine 185 mg (0.92 mmol) were added, and at 140 ° C. The mixture was stirred for 14 hours. After cooling to room temperature, 20 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (mixed solvent of toluene and hexane (volume ratio = 1:2)) to give 2-chloro-9-(3-(2-methylnaphthalen-1-yl)phenyl)carbazole white 10.5 g (25.1 mmol) of the powder was isolated (95% yield).

1H-NMR(CDCl3)δ(ppm); 8.02(d, 1H), 7.95(d, 1H), 7.64-7.83(m, 3H), 7.14-7.58(m, 12H), 2.33(s, 3H) 1 H-NMR (CDCl 3 )δ (ppm); 8.02(d, 1H), 7.95(d, 1H), 7.64-7.83(m, 3H), 7.14-7.58(m, 12H), 2.33(s, 3H)

13C-NMR(CDCl3)δ(ppm); 141.48, 140.87, 140.65, 136.79, 136.29, 132.69, 132.26, 131.55, 131.28, 129.61, 129.19, 128.16, 127.49, 127.28, 125.82, 125.76, 125.29, 125.05, 124.54, 122.43, 121.59, 120.75, 120.05, 119.85, 109.54, 20.64 13 C-NMR (CDCl 3 )δ (ppm); 141.48, 140.87, 140.65, 136.79, 136.29, 132.69, 132.26, 131.55, 131.28, 129.61, 129.19, 128.16, 127.49, 127.28, 125.82, 125.76, 125.29, 125.05, 124.05, 119.75. 20.64

합성예 1B(2-클로로-9-(4-(4-다이벤조티에닐)페닐)카바졸의 합성)Synthesis Example 1B (synthesis of 2-chloro-9- (4- (4-dibenzothienyl) phenyl) carbazole)

질소 기류 하, 200㎖의 3구 플라스크에, 2-클로로카바졸 7.1g(35.5m㏖), 1-브로모-4-(4-다이벤조티에닐)벤젠 12.0g(35.5m㏖), 탄산 칼륨 9.8g(71.0m㏖), o-자일렌 100㎖, 아세트산 팔라듐 239㎎(1.0m㏖) 및 트라이(tert-뷰틸)포스핀752㎎(3.7m㏖)을 첨가하고, 140℃에서 14시간 교반하였다. 실온까지 냉각 후, 순수 60㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:2))로 정제하여, 2-클로로-9-(4-(4-다이벤조티에닐)페닐)카바졸의 백색 분말을 14.0g(30.5m㏖) 단리하였다(수율 86%).In a 200 ml three-necked flask under a nitrogen stream, 7.1 g (35.5 mmol) of 2-chlorocarbazole, 12.0 g (35.5 mmol) of 1-bromo-4-(4-dibenzothienyl) benzene, carbonic acid Potassium 9.8g (71.0mmol), o-xylene 100ml, palladium acetate 239mg (1.0mmol) and tri(tert-butyl)phosphine 752mg (3.7mmol) were added, and it was 140 degreeC for 14 hours. stirred. After cooling to room temperature, 60 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (mixed solvent of toluene and hexane (volume ratio = 1:2)), and white powder of 2-chloro-9-(4-(4-dibenzothienyl)phenyl)carbazole 14.0 g (30.5 mmol) was isolated (yield 86%).

FDMS(m/z); 459(M+)FDMS (m/z); 459 (M+)

1H-NMR(CDCl3)δ(ppm); 7.96-8.15(m,4H), 7.89(d, 2H), 7.79-7.83(m, 1H), 7.37-7.60(m,8H), 7.12-7.32(m, 3H) 1 H-NMR (CDCl 3 )δ (ppm); 7.96-8.15(m,4H), 7.89(d, 2H), 7.79-7.83(m, 1H), 7.37-7.60(m,8H), 7.12-7.32(m, 3H)

13C-NMR(CDCl3)δ(ppm); 140.82, 140.65, 139.52, 138.95, 137.96, 136.26, 135.96, 135.38, 135.25, 131.33, 129.39, 127.76, 126.68, 126.50, 125.86, 124.78, 124.06, 122.43, 122.17, 121.63, 121.35, 120.73, 120.42, 120.12, 119.85, 109.63, 109.56. 13 C-NMR (CDCl 3 )δ (ppm); 140.82, 140.65, 139.52, 138.95, 137.96, 136.26, 135.96, 135.38, 135.25, 131.33, 129.39, 127.76, 126.68, 126.50, 125.86, 124.78, 124.06, 122.43, 122. 109.63, 109.56.

합성예 2B(2-클로로-9-(4-(4-다이벤조퓨라닐)페닐)카바졸의 합성)Synthesis Example 2B (synthesis of 2-chloro-9- (4- (4-dibenzofuranyl) phenyl) carbazole)

질소 기류 하, 50㎖의 3구 플라스크에, 2-클로로카바졸 3.0g(14.9m㏖), 1-브로모-4-(4-다이벤조퓨라닐)벤젠 4.8g(14.9m㏖), 탄산 칼륨 4.1g(29.8m㏖), o-자일렌 25㎖, 아세트산 팔라듐 67㎎(0.29m㏖) 및 트라이(tert-뷰틸)포스핀 210㎎(1.0m㏖)을 첨가하고, 140℃에서 6시간 교반하였다. 실온까지 냉각 후, 순수 10㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:2))로 정제하여, 2-클로로-9-(4-(4-다이벤조퓨라닐)페닐)카바졸의 백색 분말을 5.4g(12.1m㏖) 단리하였다(수율 81%).In a 50 ml three-necked flask under a nitrogen stream, 3.0 g (14.9 mmol) of 2-chlorocarbazole, 4.8 g (14.9 mmol) of 1-bromo-4-(4-dibenzofuranyl) benzene, carbonic acid Potassium 4.1g (29.8mmol), o-xylene 25ml, palladium acetate 67mg (0.29mmol) and tri(tert-butyl)phosphine 210mg (1.0mmol) were added, and it was 140 degreeC for 6 hours. stirred. After cooling to room temperature, 10 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (mixed solvent of toluene and hexane (volume ratio = 1:2)), and white powder of 2-chloro-9-(4-(4-dibenzofuranyl)phenyl)carbazole was isolated 5.4 g (12.1 mmol) (yield 81%).

FDMS(m/z); 443(M+)FDMS (m/z); 443 (M+)

1H-NMR(CDCl3)δ(ppm); 7.90-8.11(m,6H), 7.62(d,4H), 7.08-7.49(m,8H) 1 H-NMR (CDCl 3 )δ (ppm); 7.90-8.11(m,6H), 7.62(d,4H), 7.08-7.49(m,8H)

13C-NMR(CDCl3)δ(ppm); 155.69, 152.81, 140.89, 140.71, 136.02, 135.41, 131.31, 129.83, 126.94, 126.57, 126.26, 125.82, 124.68, 124.21, 123.64, 122.91, 122.47, 122.41, 121.59, 120.69, 120.29, 120.07, 119.81, 119.68, 111.43, 109.67, 109.59 13 C-NMR (CDCl 3 )δ (ppm); 155.69, 152.81, 140.89, 140.71, 136.02, 135.41, 131.31, 129.83, 126.94, 126.57, 126.26, 125.82, 124.68, 124.21, 123.64, 122.91, 122.47, 122.41, 119.81.29, 120.69, 120.81. 109.67, 109.59

합성예 3B(2-클로로-9-(3-(4-다이벤조티에닐)페닐)카바졸의 합성)Synthesis Example 3B (synthesis of 2-chloro-9- (3- (4-dibenzothienyl) phenyl) carbazole)

질소 기류 하, 200㎖의 3구 플라스크에, 2-클로로카바졸 5.6g(28.4m㏖), 1-브로모-3-(4-다이벤조티에닐)벤젠 9.6g(28.4m㏖), 탄산 칼륨 7.8g(56.8m㏖), o-자일렌 80㎖, 아세트산 팔라듐 191㎎(0.80m㏖) 및 트라이(tert-뷰틸)포스핀 601㎎(2.9m㏖)을 첨가하고, 140℃에서 10시간 교반하였다. 실온까지 냉각 후, 순수 50㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:2))로 정제하여, 2-클로로-9-(3-(4-다이벤조티에닐)페닐)카바졸의 백색 분말을 10.0g(21.8m㏖) 단리하였다(수율 77%).In a 200 ml three-necked flask under a nitrogen stream, 5.6 g (28.4 mmol) of 2-chlorocarbazole, 9.6 g (28.4 mmol) of 1-bromo-3-(4-dibenzothienyl) benzene, carbonic acid Potassium 7.8 g (56.8 mmol), o-xylene 80 ml, palladium acetate 191 mg (0.80 mmol), and tri(tert-butyl) phosphine 601 mg (2.9 mmol) were added, and 10 hours at 140° C. stirred. After cooling to room temperature, 50 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (mixed solvent of toluene and hexane (volume ratio = 1:2)), and white powder of 2-chloro-9-(3-(4-dibenzothienyl)phenyl)carbazole 10.0 g (21.8 mmol) was isolated (yield 77%).

FDMS(m/z); 459(M+)FDMS (m/z); 459 (M+)

합성예 4B(2-클로로-9-(3-(4-다이벤조퓨라닐)페닐)카바졸의 합성)Synthesis Example 4B (synthesis of 2-chloro-9- (3- (4-dibenzofuranyl) phenyl) carbazole)

질소 기류 하, 100㎖의 3구 플라스크에, 2-클로로카바졸 6.0g(29.8m㏖), 1-브로모-3-(4-다이벤조퓨라닐)벤젠 9.6g(29.8m㏖), 탄산 칼륨 8.2g(59.6m㏖), o-자일렌 50㎖, 아세트산 팔라듐 134㎎(0.58m㏖) 및 트라이(tert-뷰틸)포스핀 420㎎(2.0m㏖)을 첨가해서 140℃에서 8시간 교반하였다. 실온까지 냉각 후, 순수 30㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:2))로 정제하여, 2-클로로-9-(3-(4-다이벤조퓨라닐)페닐)카바졸의 백색 분말을 11.2g(25.3m㏖) 단리하였다(수율 85%).In a 100 ml three-necked flask under a nitrogen stream, 6.0 g (29.8 mmol) of 2-chlorocarbazole, 9.6 g (29.8 mmol) of 1-bromo-3-(4-dibenzofuranyl) benzene, carbonic acid Potassium 8.2 g (59.6 mmol), o-xylene 50 ml, palladium acetate 134 mg (0.58 mmol) and tri(tert-butyl) phosphine 420 mg (2.0 mmol) were added, and stirred at 140° C. for 8 hours. did. After cooling to room temperature, 30 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (mixed solvent of toluene and hexane (volume ratio = 1:2)), and white powder of 2-chloro-9-(3-(4-dibenzofuranyl)phenyl)carbazole 11.2 g (25.3 mmol) was isolated (yield 85%).

FDMS(m/z); 443(M+)FDMS (m/z); 443 (M+)

합성예 5B(2-나이트로-5-(4-다이벤조티에닐)-4'-클로로바이페닐의 합성[하기 합성 경로 참조])Synthesis Example 5B (Synthesis of 2-nitro-5-(4-dibenzothienyl)-4'-chlorobiphenyl [see the following synthesis route])

질소 기류 하, 300㎖의 3구 플라스크에, 2-나이트로-5,4'-다이클로로바이페닐 10.6g(39.8m㏖), 4-다이벤조티오펜보론산 10.0g(43.8m㏖), 테트라키스(트라이페닐포스핀)팔라듐 0.46g(0.39m㏖), 테트라하이드로퓨란 50㎖ 및 40중량%의 인산3칼륨 수용액 52.8g(99.6m㏖)을 가하고, 10시간 가열 환류하였다. 실온까지 냉각한 후, 물층과 유기층을 분액시키고, 유기층을 포화 염화 암모니아 수용액과 포화 염화나트륨 수용액으로 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 용매를 증류 제거하였다. 얻어진 잔사에 톨루엔을 첨가하고, 실리카겔 칼럼 크로마토그래피(톨루엔)로 정제시킴으로써, 2-나이트로-5-(4-다이벤조티에닐)-4'-클로로바이페닐의 황색 분말을 11.1g(26.7m㏖) 단리하였다(수율 67%).In a nitrogen stream, in a 300 ml three-necked flask, 10.6 g (39.8 mmol) of 2-nitro-5,4'-dichlorobiphenyl, 10.0 g (43.8 mmol) of 4-dibenzothiophenboronic acid, 0.46 g (0.39 mmol) of tetrakis (triphenylphosphine) palladium, 50 ml of tetrahydrofuran and 52.8 g (99.6 mmol) of a 40% by weight aqueous solution of tripotassium phosphate were added, followed by heating and refluxing for 10 hours. After cooling to room temperature, the water layer and the organic layer were separated, and the organic layer was washed with a saturated aqueous ammonia chloride solution and a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. Toluene was added to the obtained residue and purified by silica gel column chromatography (toluene) to obtain 11.1 g (26.7 m) of a yellow powder of 2-nitro-5-(4-dibenzothienyl)-4'-chlorobiphenyl. mol) isolated (yield 67%).

1H-NMR(CDCl3); 8.15-8.21(m, 2H), 8.02(d, 1H), 7.77-7.86(m, 3H), 7.30-7.60(m,8H) 1 H-NMR (CDCl 3 ); 8.15-8.21 (m, 2H), 8.02 (d, 1H), 7.77-7.86 (m, 3H), 7.30-7.60 (m, 8H)

13C-NMR(CDCl3); 147.48, 144.50, 138.55, 137.76, 136.15, 135.38, 135.25, 134.92, 134.10, 133.71, 131.13, 128.82, 128.47, 127.69, 126.75, 126.48, 124.81, 124.57, 124.26, 122.16, 121.37, 121.26 13 C-NMR (CDCl 3 ); 147.48, 144.50, 138.55, 137.76, 136.15, 135.38, 135.25, 134.92, 134.10, 133.71, 131.13, 128.82, 128.47, 127.69, 126.75, 126.48, 124.81, 124.5726, 124.26, 121.37, 122.

합성예 6B(2-클로로-6-(4-다이벤조티에닐)카바졸의 합성[하기 합성 경로 참조])Synthesis Example 6B (Synthesis of 2-chloro-6- (4-dibenzothienyl) carbazole [see the following synthetic route])

질소 기류 하, 200㎖의 3구 플라스크에, 합성예 5B에서 얻어진 2-나이트로-5-(4-다이벤조티에닐)-4'-클로로바이페닐 10.6g(25.5m㏖), 트라이페닐포스핀 16.7g(63.8m㏖) 및 o-다이클로로벤젠 60㎖를 주입하고, 150℃에서 24시간 교반하였다. 감압 하에 o-다이클로로벤젠을 증류 제거하고, 이어서, 얻어진 잔사에 톨루엔을 첨가하고, 실리카겔 칼럼 크로마토그래피(톨루엔)로 정제하였다. 얻어진 옅은 황색 분말을 더욱 헥산으로 세정하고, 2-클로로-6-(4-다이벤조티에닐)카바졸의 옅은 황색 분말을 5.0g(13.0m㏖) 단리하였다(수율 51%).10.6 g (25.5 mmol) of 2-nitro-5-(4-dibenzothienyl)-4'-chlorobiphenyl obtained in Synthesis Example 5B, triphenylphosphate in a 200 ml three-necked flask under a nitrogen stream Pin 16.7g (63.8mmol) and o-dichlorobenzene 60ml were injected, and the mixture was stirred at 150°C for 24 hours. o-dichlorobenzene was distilled off under reduced pressure, and then toluene was added to the obtained residue, followed by purification by silica gel column chromatography (toluene). The obtained pale yellow powder was further washed with hexane, and 5.0 g (13.0 mmol) of a pale yellow powder of 2-chloro-6-(4-dibenzothienyl)carbazole was isolated (yield 51%).

1H-NMR(아세톤-d6); 8.50(s, 1H), 8.27-8.38(m, 2H), 8.22(d, 1H), 7.93-7.98(m, 1H), 7.82(d, 1H), 7.71(d, 1H), 7.54-7.65(m, 3H), 7.47-7.56(m, 2H), 7.23(d, 1H) 1 H-NMR (acetone-d 6 ); 8.50(s, 1H), 8.27-8.38(m, 2H), 8.22(d, 1H), 7.93-7.98(m, 1H), 7.82(d, 1H), 7.71(d, 1H), 7.54-7.65( m, 3H), 7.47-7.56 (m, 2H), 7.23 (d, 1H)

13C-NMR(아세톤-d6); 141.89, 140.88, 140.02, 138.52, 137.64, 136.87, 136.59, 132.68, 131.74, 127.91, 127.66, 126.96, 126.14, 125.28, 123.61, 123.30, 122.62, 122.57, 122.22, 120.81, 120.57, 120.08, 112.17, 111.67 13 C-NMR (acetone-d 6 ); 141.89, 140.88, 140.02, 138.52, 137.64, 136.87, 136.59, 132.68, 131.74, 127.91, 127.66, 126.96, 126.14, 125.28, 123.61, 123.30, 122.62, 122.57, 122.22, 120.81, 120.57, 111.81, 120.57

합성예 7B(2-클로로-6-(4-다이벤조티에닐)-9-페닐카바졸의 합성[하기 합성 경로 참조])Synthesis Example 7B (Synthesis of 2-chloro-6-(4-dibenzothienyl)-9-phenylcarbazole [see the following synthetic route])

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 6B에서 얻어진 2-클로로-6-(4-다이벤조티에닐)카바졸 4.5g(11.7m㏖), 브로모벤젠 2.0g(12.9m㏖), 탄산 칼륨 3.2g(23.4m㏖), o-자일렌 25㎖, 아세트산 팔라듐 52㎎(0.23m㏖) 및 트라이(tert-뷰틸)포스핀 165㎎(0.81m㏖)을 첨가하고, 140℃에서 14시간 교반하였다. 실온까지 냉각 후, 순수 20㎖를 가하고, 유기층을 분리하였다. 유기층을 순수, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 용매를 증류 제거하였다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하여, 2-클로로-6-(4-다이벤조티에닐)-9-페닐카바졸의 담황색 분말을 5.0g(10.8m㏖) 단리하였다(수율 92%).4.5 g (11.7 mmol) of 2-chloro-6- (4-dibenzothienyl) carbazole obtained in Synthesis Example 6B, 2.0 g (12.9 mmol) of bromobenzene in a 50 mL three-necked flask under a nitrogen stream ), potassium carbonate 3.2 g (23.4 mmol), o-xylene 25 ml, palladium acetate 52 mg (0.23 mmol) and tri(tert-butyl) phosphine 165 mg (0.81 mmol) were added, and 140 ° C. was stirred for 14 hours. After cooling to room temperature, 20 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with pure water and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and a pale yellow powder of 2-chloro-6-(4-dibenzothienyl)-9-phenylcarbazole 5.0 g (10.8 mmol) was isolated (yield 92%).

1H-NMR(CDCl3); 8.44(s, 1H), 8.13-8.21(m, 2H), 8.06(d, 1H)7.76-7.85(m, 2H), 7.39-7.68(m, 11H), 7.27(d, 1H) 1 H-NMR (CDCl 3 ); 8.44(s, 1H), 8.13-8.21(m, 2H), 8.06(d, 1H) 7.76-7.85(m, 2H), 7.39-7.68(m, 11H), 7.27(d, 1H)

13C-NMR(CDCl3); 141.40, 140.41, 139.09, 138.47, 137.01, 136.46, 135.67, 135.41, 132.59, 131.53, 129.59, 127.50, 126.62, 126.55, 126.22, 126.11, 124.65, 123.84, 122.65, 122.10, 121.44, 121.26, 120.80, 120.18, 119.54, 109.72, 109.58 13 C-NMR (CDCl 3 ); 141.40, 140.41, 139.09, 138.47, 137.01, 136.46, 135.67, 135.41, 132.59, 131.53, 129.59, 127.50, 126.62, 126.55, 126.22, 126.11, 124.65, 123.84, 121.26, 122.80, 120. 109.72, 109.58

Figure 112021063299657-pat00022
Figure 112021063299657-pat00022

합성예 8B(2-클로로-9-(4-(9-페난트릴)페닐)카바졸의 합성)Synthesis Example 8B (synthesis of 2-chloro-9- (4- (9-phenanthryl) phenyl) carbazole)

질소 기류 하, 200㎖의 3구 플라스크에, 2-클로로카바졸 6.0g(30.1m㏖), 1-브로모-4-(9-페난트릴)벤젠 10.0g(30.1m㏖), 탄산 칼륨 6.2g(45.1m㏖), o-자일렌 40㎖, 아세트산 팔라듐 135㎎(0.60m㏖) 및 트라이(tert-뷰틸)포스핀 425㎎(2.1m㏖)을 첨가하고, 140℃에서 10시간 교반하였다. 실온까지 냉각 후, 순수 30㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:3))로 정제하여, 2-클로로-9-(4-(9-페난트릴)페닐)카바졸의 백색 분말을 7.5g(16.5m㏖) 단리하였다(수율 55%).In a 200 ml three-necked flask under a nitrogen stream, 6.0 g (30.1 mmol) of 2-chlorocarbazole, 10.0 g (30.1 mmol) of 1-bromo-4-(9-phenanthryl) benzene, 6.2 potassium carbonate g (45.1 mmol), o-xylene 40 ml, palladium acetate 135 mg (0.60 mmol) and tri(tert-butyl) phosphine 425 mg (2.1 mmol) were added, and the mixture was stirred at 140° C. for 10 hours. . After cooling to room temperature, 30 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:3)) to obtain a white powder of 2-chloro-9-(4-(9-phenanthryl)phenyl)carbazole. 7.5 g (16.5 mmol) was isolated (yield 55%).

FDMS(m/z); 453(M+)FDMS (m/z); 453 (M+)

1H-NMR(CDCl3)δ(ppm); 8.75(d, 1H), 8.68(d, 1H), 7.98-8.09(m, 3H), 7.89(d, 1H), 7.37-7.74(m, 12H), 7.23-7.32(m, 2H) 1 H-NMR (CDCl 3 )δ (ppm); 8.75(d, 1H), 8.68(d, 1H), 7.98-8.09(m, 3H), 7.89(d, 1H), 7.37-7.74(m, 12H), 7.23-7.32(m, 2H)

13C-NMR(CDCl3)δ(ppm); 141.76, 141.59, 140.69, 138.03, 136.61, 132.14, 131.99, 131.81, 131.19, 131.08, 130.45, 129.10, 128.23, 127.35, 127.22, 127.09, 127.04, 126.65, 123.42, 123.23, 122.94, 122.41, 121.56, 120.88, 120.68, 110.44, 110.35 13 C-NMR (CDCl 3 )δ (ppm); 141.76, 141.59, 140.69, 138.03, 136.61, 132.14, 131.99, 131.81, 131.19, 131.08, 130.45, 129.10, 128.23, 127.35, 127.22, 127.09, 127.04, 126.65, 123.42, 126.65, 123.42, 121.6894, 122.88, 122.6894, 120.88 110.44, 110.35

합성예 9B(2-클로로-9-(3-(9-페난트릴)페닐)카바졸의 합성)Synthesis Example 9B (synthesis of 2-chloro-9- (3- (9-phenanthryl) phenyl) carbazole)

질소 기류 하, 200㎖의 3구 플라스크에, 2-클로로카바졸 8.2g(41.0m㏖), 1-브로모-3-(9-페난트릴)벤젠 15.0g(45.1m㏖), 탄산 칼륨 8.5g(61.5m㏖), o-자일렌 60㎖, 아세트산 팔라듐 184㎎(0.82m㏖) 및 트라이(tert-뷰틸)포스핀 579㎎(2.8m㏖)을 첨가하고, 140℃에서 12시간 교반하였다. 실온까지 냉각 후, 순수 30㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하여, 2-클로로-9-(3-(9-페난트릴)페닐)카바졸의 백색 분말을 12.4g(27.3m㏖) 단리하였다(수율 66%).In a 200 ml three-necked flask under a nitrogen stream, 8.2 g (41.0 mmol) of 2-chlorocarbazole, 15.0 g (45.1 mmol) of 1-bromo-3-(9-phenanthryl) benzene, 8.5 of potassium carbonate g (61.5 mmol), o-xylene 60 ml, palladium acetate 184 mg (0.82 mmol) and tri(tert-butyl) phosphine 579 mg (2.8 mmol) were added, and the mixture was stirred at 140° C. for 12 hours. . After cooling to room temperature, 30 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (mixed solvent of toluene and hexane (volume ratio = 1:1)) to obtain a white powder of 2-chloro-9-(3-(9-phenanthryl)phenyl)carbazole. 12.4 g (27.3 mmol) was isolated (yield 66%).

FDMS(m/z); 453(M+)FDMS (m/z); 453 (M+)

1H-NMR(CDCl3)δ(ppm); 8.77(d, 1H), 8.71(d, 1H), 8.01-8.10(m, 3H), 7.90(d, 1H), 7.40-7.77(m, 12H), 7.23-7.31(m, 2H) 1 H-NMR (CDCl 3 )δ (ppm); 8.77(d, 1H), 8.71(d, 1H), 8.01-8.10(m, 3H), 7.90(d, 1H), 7.40-7.77(m, 12H), 7.23-7.31(m, 2H)

13C-NMR(CDCl3)δ(ppm); 143.20, 141.66, 141.45, 137.71, 137.46, 132.05, 131.66, 131.00, 130.40, 130.31, 129.76, 129.05, 128.73, 128.17, 127.29, 127.21, 127.07, 127.00, 126.82, 126.57, 126.10, 123.37, 123.15, 122.86, 122.31, 121.48, 120.78, 120.59, 110.27 13 C-NMR (CDCl 3 )δ (ppm); 143.20, 141.66, 141.45, 137.71, 137.46, 132.05, 131.66, 131.00, 130.40, 130.31, 129.76, 129.05, 128.73, 128.17, 127.29, 127.21, 127.07, 127.00, 126.82, 126.10, 123.57, 86, 126.15, 126.57, 86. 121.48, 120.78, 120.59, 110.27

합성예 10B(2-나이트로-5-(9-페난트릴)-4'-클로로바이페닐의 합성[하기 합성 경로 참조])Synthesis Example 10B (Synthesis of 2-nitro-5-(9-phenanthryl)-4'-chlorobiphenyl [see the following synthetic route])

질소 기류 하, 200㎖의 3구 플라스크에, 2-나이트로-5,4'-다이클로로바이페닐 9.6g(36.0m㏖), 9-페나트렌보론산 9.60g(43.2m㏖), 테트라키스(트라이페닐포스핀)팔라듐 0.41g(0.36m㏖), 테트라하이드로퓨란 40㎖ 및 40중량%의 인산3칼륨 수용액 47.7g(90.0m㏖)을 가하고, 24시간 가열 환류하였다. 실온까지 냉각한 후, 물층과 유기층을 분액시키고, 유기층을 포화 염화 암모니아 수용액과 포화 염화나트륨 수용액으로 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 용매를 증류 제거하였다. 얻어진 2-나이트로-5-(9-페난트릴)-4'-클로로바이페닐의 다갈색 오일 14g은, 정제하는 일 없이, 다음 공정의 원료로서 사용하였다.In a 200 ml three-necked flask under a nitrogen stream, 9.6 g (36.0 mmol) of 2-nitro-5,4'-dichlorobiphenyl, 9.60 g (43.2 mmol) of 9-phenathrenboronic acid, tetrakis 0.41 g (0.36 mmol) of (triphenylphosphine) palladium, 40 ml of tetrahydrofuran and 47.7 g (90.0 mmol) of a 40% by weight aqueous solution of tripotassium phosphate were added, followed by heating and refluxing for 24 hours. After cooling to room temperature, the water layer and the organic layer were separated, and the organic layer was washed with a saturated aqueous ammonia chloride solution and a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. 14 g of the obtained dark brown oil of 2-nitro-5-(9-phenanthryl)-4'-chlorobiphenyl was used as a raw material for the next step without purification.

합성예 11B(2-클로로-6-(9-페난트릴)카바졸의 합성[하기 합성 경로 참조])Synthesis Example 11B (Synthesis of 2-chloro-6- (9-phenanthryl) carbazole [see the following synthetic route])

질소 기류 하, 200㎖의 3구 플라스크에, 합성예 10B에서 얻어진 2-나이트로-5-(9-페난트릴)-4'-클로로바이페닐 11.0g(26.8m㏖), 트라이페닐포스핀 17.6g(67.2m㏖) 및 o-다이클로로벤젠 60㎖를 주입하고, 150℃에서 40시간 교반하였다. 감압 하에 o-다이클로로벤젠을 증류 제거하고, 이어서, 얻어진 잔사에 톨루엔을 첨가하고, 실리카겔 칼럼 크로마토그래피(톨루엔)로 정제하였다. 얻어진 옅은 황색 분말을 더욱 헥산으로 세정하고, 2-클로로-6-(9-페난트릴)카바졸의 옅은 황색 분말을 7.3g(19.3m㏖) 단리하였다(수율 72%).11.0 g (26.8 mmol) of 2-nitro-5-(9-phenanthryl)-4'-chlorobiphenyl obtained in Synthesis Example 10B, 17.6 triphenylphosphine in a 200 ml three-necked flask under a nitrogen stream g (67.2 mmol) and 60 ml of o-dichlorobenzene were injected, and the mixture was stirred at 150° C. for 40 hours. o-dichlorobenzene was distilled off under reduced pressure, and then toluene was added to the obtained residue, followed by purification by silica gel column chromatography (toluene). The obtained pale yellow powder was further washed with hexane, and 7.3 g (19.3 mmol) of a pale yellow powder of 2-chloro-6-(9-phenanthryl)carbazole was isolated (yield 72%).

1H-NMR(아세톤-d6); 10.81(s, 1H), 8.89(d, 1H), 8.83(d, 1H), 8.27(s, 1H), 8.14(d, 1H), 7.98(d, 2H), 7.81(s, 1H), 7.55-7.71(m,7H), 7.19(d, 1H) 1 H-NMR (acetone-d 6 ); 10.81(s, 1H), 8.89(d, 1H), 8.83(d, 1H), 8.27(s, 1H), 8.14(d, 1H), 7.98(d, 2H), 7.81(s, 1H), 7.55 -7.71(m,7H), 7.19(d, 1H)

13C-NMR(아세톤-d6); 141.49, 140.18, 139.73, 132.20, 132.08, 131.94, 131.17, 131.00, 130.09, 128.89, 128.46, 127.96, 127.22, 126.83, 123.31, 122.95, 122.86, 122.20, 121.73, 119.51, 111.21 13 C-NMR (acetone-d 6 ); 141.49, 140.18, 139.73, 132.20, 132.08, 131.94, 131.17, 131.00, 130.09, 128.89, 128.46, 127.96, 127.22, 126.83, 123.31, 122.95, 122.86, 122.20, 121.73, 119.51, 111.21.51

합성예 12B(2-클로로-6-(9-페난트릴)-9-페닐카바졸의 합성[하기 합성 경로 참조])Synthesis Example 12B (Synthesis of 2-chloro-6-(9-phenanthryl)-9-phenylcarbazole [see the following synthetic route])

질소 기류 하, 100㎖의 3구 플라스크에, 합성예 11B에서 얻어진 2-클로로-6-(9-페난트릴)카바졸 7.0g(18.5m㏖), 브로모벤젠 4.3g(27.8m㏖), 탄산 칼륨 7.6g(55.6m㏖), o-자일렌 50㎖, 아세트산 팔라듐 62㎎(0.27m㏖) 및 트라이(tert-뷰틸)포스핀 196㎎(0.97m㏖)을 첨가하고, 140℃에서 14시간 교반하였다. 실온까지 냉각 후, 순수 25㎖를 가하고, 유기층을 분리하였다. 유기층을 순수, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 용매를 증류 제거하였다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하여, 2-클로로-6-(9-페난트릴)-9-페닐카바졸의 백색 분말을 5.8g(12.8m㏖) 단리하였다(수율 69%).7.0 g (18.5 mmol) of 2-chloro-6-(9-phenanthryl) carbazole obtained in Synthesis Example 11B, 4.3 g (27.8 mmol) of bromobenzene, Potassium carbonate 7.6 g (55.6 mmol), o-xylene 50 ml, palladium acetate 62 mg (0.27 mmol) and tri(tert-butyl) phosphine 196 mg (0.97 mmol) were added, and 14 at 140° C. time was stirred. After cooling to room temperature, 25 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with pure water and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)) to obtain a white powder of 2-chloro-6-(9-phenanthryl)-9-phenylcarbazole to 5.8 g (12.8 mmol) was isolated (yield 69%).

1H-NMR(CDCl3); 8.79(d, 1H), 8.73(d, 1H), 8.25(s, 1H), 7.89-8.03(m, 3H), 7.78(s, 1H), 7.41-7.69(m, 12H), 7.25(d, 1H) 1 H-NMR (CDCl 3 ); 8.79(d, 1H), 8.73(d, 1H), 8.25(s, 1H), 7.89-8.03(m, 3H), 7.78(s, 1H), 7.41-7.69(m, 12H), 7.25(d, 1H)

13C-NMR(CDCl3); 142.17, 140.94, 139.40, 137.39, 133.42, 132.23, 131.96, 130.98, 130.42, 130.19, 128.91, 128.77, 128.29, 128.18, 127.43, 127.38, 127.15, 126.78, 126.70, 123.21, 123.16, 122.85, 122.20, 121.90, 121.57, 120.89, 110.35, 109.98 13 C-NMR (CDCl 3 ); 142.17, 140.94, 139.40, 137.39, 133.42, 132.23, 131.96, 130.98, 130.42, 130.19, 128.91, 128.77, 128.29, 128.18, 127.43, 127.38, 127.15, 126.78, 126.70, 123.57, 122.85, 122.20, 123.21, 123.16. 120.89, 110.35, 109.98

Figure 112021063299657-pat00023
Figure 112021063299657-pat00023

실시예 1A(화합물(A25)의 합성)Example 1A (Synthesis of Compound (A25))

질소 기류 하, 100㎖의 3구 플라스크에, 합성예 1A로 얻은 2-클로로-9-(4-(1-나프틸)페닐)카바졸 8.0g(19.8m㏖), N,N-비스(4-바이페닐)아민 6.3g(19.8m㏖), 나트륨-tert-뷰톡사이드 2.6g(27.7m㏖), o-자일렌 45㎖, 아세트산 팔라듐 44㎎(0.19m㏖) 및 트라이(tert-뷰틸)포스핀 139㎎(0.69m㏖)을 첨가하고, 140℃에서 4시간 교반하였다. 실온까지 냉각 후, 석출한 생성물을 여과하여 취하고, 순수 및 에탄올로 세정하였다. 또한, o-자일렌으로 재결정하고, 화합물(A25)의 담황색 분말을 11.0g(16.0m㏖) 단리하였다(수율 81%).8.0 g (19.8 mmol) of 2-chloro-9-(4-(1-naphthyl)phenyl)carbazole obtained in Synthesis Example 1A, N,N-bis( 4-biphenyl)amine 6.3g (19.8mmol), sodium-tert-butoxide 2.6g (27.7mmol), o-xylene 45ml, palladium acetate 44mg (0.19mmol) and tri(tert-butyl) ) Phosphine 139 mg (0.69 mmol) was added, and the mixture was stirred at 140° C. for 4 hours. After cooling to room temperature, the precipitated product was collected by filtration and washed with pure water and ethanol. Further, it was recrystallized from o-xylene, and 11.0 g (16.0 mmol) of a pale yellow powder of compound (A25) was isolated (yield 81%).

FDMS(m/z); 688(M+)FDMS (m/z); 688 (M+)

1H-NMR(CDCl3)δ(ppm); 8.06(t, 2H), 7.81-7.96(m, 3H), 7.11-7.59(m, 31H) 1 H-NMR (CDCl 3 )δ (ppm); 8.06 (t, 2H), 7.81-7.96 (m, 3H), 7.11-7.59 (m, 31H)

13C-NMR(CDCl3)δ(ppm); 146.84, 145.50, 141.40, 140.96, 140.10, 139.33, 138.67, 136.13, 134.57, 133.36, 131.04, 130.98, 128.29, 127.91, 127.52, 127.28, 126.68, 126.35, 126.17, 126.08, 125.84, 125.43, 125.29, 125.05, 124.94, 123.24, 123.00, 120.76, 119.92, 119.56, 119.46, 118.53, 109.43, 106.50 13 C-NMR (CDCl 3 )δ (ppm); 146.84, 145.50, 141.40, 140.96, 140.10, 139.33, 138.67, 136.13, 134.57, 133.36, 131.04, 130.98, 128.29, 127.91, 127.52, 127.28, 126.68, 126.35, 126.17, 125.84, 125.43, 125.29, 126.08, 125.05. 123.24, 123.00, 120.76, 119.92, 119.56, 119.46, 118.53, 109.43, 106.50

실시예 2A(화합물(A26)의 합성)Example 2A (Synthesis of Compound (A26))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 2A로 얻은 2-클로로-9-(4-(2-메틸나프탈렌-1-일)페닐)카바졸 3.5g(8.3m㏖), N,N-비스(4-바이페닐)아민 2.7g(8.3m㏖), 나트륨-tert-뷰톡사이드 1.1g(11.7m㏖), o-자일렌 20㎖, 아세트산 팔라듐 18㎎(0.08m㏖) 및 트라이(tert-뷰틸)포스핀 59㎎(0.29m㏖)을 첨가하고, 140℃에서 10시간 교반하였다. 실온까지 냉각 후, 석출한 생성물을 여과하여 취하고, 순수 및 에탄올로 세정하였다. 또한, o-자일렌으로 재결정하고, 화합물(A26)의 백색 분말을 3.5g(4.9m㏖) 단리하였다(수율 59%).3.5 g (8.3 mmol) of 2-chloro-9-(4-(2-methylnaphthalen-1-yl)phenyl)carbazole obtained in Synthesis Example 2A in a 50 ml three-necked flask under a nitrogen stream, N, N-bis(4-biphenyl)amine 2.7 g (8.3 mmol), sodium-tert-butoxide 1.1 g (11.7 mmol), o-xylene 20 ml, palladium acetate 18 mg (0.08 mmol) and tri 59 mg (0.29 mmol) of (tert-butyl)phosphine was added, and the mixture was stirred at 140°C for 10 hours. After cooling to room temperature, the precipitated product was collected by filtration and washed with pure water and ethanol. Further, it was recrystallized from o-xylene, and 3.5 g (4.9 mmol) of white powder of compound (A26) was isolated (yield: 59%).

FDMS(m/z); 702(M+)FDMS (m/z); 702 (M+)

1H-NMR(CDCl3)δ(ppm); 8.05(t, 2H), 7.12-7.85(m, 33H), 2.09(s, 3H) 1 H-NMR (CDCl 3 )δ (ppm); 8.05 (t, 2H), 7.12-7.85 (m, 33H), 2.09 (s, 3H)

실시예 3A(화합물(A27)의 합성)Example 3A (Synthesis of Compound (A27))

질소 기류 하, 100㎖의 3구 플라스크에, 합성예 3A로 얻은 2-클로로-9-(3-(1-나프틸)페닐)카바졸 5.0g(12.4m㏖), N,N-비스(4-바이페닐)아민 3.9g(12.4m㏖), 나트륨-tert-뷰톡사이드 1.6g(17.3m㏖), o-자일렌 30㎖, 아세트산 팔라듐 27㎎(0.12m㏖) 및 트라이(tert-뷰틸)포스핀 87㎎(0.43m㏖)을 첨가하고, 140℃에서 5시간 교반하였다. 실온까지 냉각 후, 순수 20㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하고, 화합물(A27)의 담황색 유리 형태 고체를 4.5g(6.5m㏖) 단리하였다(수율 52%).In a 100 ml three-necked flask under a nitrogen stream, 5.0 g (12.4 mmol) of 2-chloro-9-(3-(1-naphthyl)phenyl)carbazole obtained in Synthesis Example 3A, N,N-bis( 4-biphenyl)amine 3.9g (12.4mmol), sodium-tert-butoxide 1.6g (17.3mmol), o-xylene 30ml, palladium acetate 27mg (0.12mmol) and tri(tert-butyl) ) Phosphine 87 mg (0.43 mmol) was added, and the mixture was stirred at 140° C. for 5 hours. After cooling to room temperature, 20 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and 4.5 g (6.5 mmol) of a pale yellow free solid of compound (A27) was isolated (yield 52%).

FDMS(m/z); 688(M+)FDMS (m/z); 688 (M+)

1H-NMR(CDCl3)δ(ppm); 8.00(t, 2H), 7.88(d, 1H), 7.77(d, 1H), 7.68(t, 1H), 7.59(s, 1H), 7.05-7.51(m, 30H) 1 H-NMR (CDCl 3 )δ (ppm); 8.00(t, 2H), 7.88(d, 1H), 7.77(d, 1H), 7.68(t, 1H), 7.59(s, 1H), 7.05-751(m, 30H)

13C-NMR(CDCl3)δ(ppm); 146.88, 145.61, 142.23, 141.40, 140.91, 140.14, 138.47, 137.17, 134.65, 133.31, 130.89, 129.30, 128.68, 128.36, 127.94, 127.80, 127.63, 127.34, 126.61, 126.42, 126.24, 125.91, 125.49, 125.18, 125.05, 124.98, 123.44, 123.07, 120.80, 119.96, 119.51, 119.43, 118.31, 109.41, 106.15 13 C-NMR (CDCl 3 )δ (ppm); 146.88, 145.61, 142.23, 141.40, 140.91, 140.14, 138.47, 137.17, 134.65, 133.31, 130.89, 129.30, 128.68, 128.36, 127.94, 127.80, 127.63, 127.34, 126.61, 125.24, 125.18, 126. 124.98, 123.44, 123.07, 120.80, 119.96, 119.51, 119.43, 118.31, 109.41, 106.15

실시예 4A(화합물(A28)의 합성)Example 4A (Synthesis of Compound (A28))

질소 기류 하, 100㎖의 3구 플라스크에, 합성예 4A로 얻은 2-클로로-9-(3-(2-메틸나프탈렌-1-일)페닐)카바졸 10.0g(23.9m㏖), N,N-비스(4-바이페닐)아민7.6g(23.9m㏖), 나트륨-tert-뷰톡사이드 3.2g(33.5m㏖), o-자일렌 50㎖, 아세트산 팔라듐75㎎(0.12m㏖) 및 트라이(tert-뷰틸)포스핀 236㎎(1.1m㏖)을 첨가하고, 140℃에서 8시간 교반하였다. 실온까지 냉각 후, 순수 30㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하고, 화합물(A28)의 담황색 유리 형태 고체를 8.0g(11.3m㏖) 단리하였다(수율 47%).10.0 g (23.9 mmol) of 2-chloro-9-(3-(2-methylnaphthalen-1-yl)phenyl)carbazole obtained in Synthesis Example 4A in a 100 ml three-necked flask under a nitrogen stream, N, N-bis(4-biphenyl)amine 7.6 g (23.9 mmol), sodium-tert-butoxide 3.2 g (33.5 mmol), o-xylene 50 ml, palladium acetate 75 mg (0.12 mmol) and tri (tert-butyl)phosphine 236 mg (1.1 mmol) was added, and the mixture was stirred at 140° C. for 8 hours. After cooling to room temperature, 30 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and 8.0 g (11.3 mmol) of a pale yellow free solid of Compound (A28) was isolated (yield 47%).

FDMS(m/z); 702(M+)FDMS (m/z); 702 (M+)

1H-NMR(CDCl3)δ(ppm); 8.03(t, 2H), 7.76(d, 1H), 7.54-7.68(m,7H), 7.06-7.49(m, 25H), 2.04(s, 3H) 1 H-NMR (CDCl 3 )δ (ppm); 8.03(t, 2H), 7.76(d, 1H), 7.54-7.68(m,7H), 7.06-7.49(m, 25H), 2.04(s, 3H)

13C-NMR(CDCl3)δ(ppm); 146.71, 145.52, 141.27, 141.24, 140.69, 140.03, 137.08, 136.26, 134.55, 132.63, 132.08, 131.31, 129.37, 128.55, 128.22, 128.05, 127.81, 127.25, 127.16, 126.95, 126.31, 126.13, 125.53, 125.18, 124.84, 124.79, 124.30, 123.37, 122.96, 120.56, 119.76, 119.32, 119.14, 117.96, 109.23, 97.49, 20.19 13 C-NMR (CDCl 3 )δ (ppm); 146.71, 145.52, 141.27, 141.24, 140.69, 140.03, 137.08, 136.26, 134.55, 132.63, 132.08, 131.31, 129.37, 128.55, 128.22, 128.05, 127.81, 127.25, 127.16, 126.31, 125.13, 126.53, 126.95, 126.18 124.79, 124.30, 123.37, 122.96, 120.56, 119.76, 119.32, 119.14, 117.96, 109.23, 97.49, 20.19

실시예 5A(화합물(A29)의 합성)Example 5A (Synthesis of compound (A29))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 1A로 얻은 2-클로로-9-(4-(1-나프틸)페닐)카바졸 4.0g(9.9m㏖), N-페닐-N-(p-터페닐-4-일)아민 3.1g(9.9m㏖), 나트륨-tert-뷰톡사이드 1.3g(13.8m㏖), o-자일렌 25㎖, 아세트산 팔라듐 22㎎(0.09m㏖) 및 트라이(tert-뷰틸)포스핀 69㎎(0.34m㏖)을 첨가하고, 140℃에서 10시간 교반하였다. 실온까지 냉각 후, 순수 10㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하고, 화합물(A29)의 담황색 유리 형태 고체를 5.1g(7.4m㏖) 단리하였다(수율 75%).4.0 g (9.9 mmol) of 2-chloro-9-(4-(1-naphthyl)phenyl)carbazole obtained in Synthesis Example 1A, N-phenyl-N-, in a 50 ml three-necked flask under a nitrogen stream (p-terphenyl-4-yl)amine 3.1 g (9.9 mmol), sodium-tert-butoxide 1.3 g (13.8 mmol), o-xylene 25 ml, palladium acetate 22 mg (0.09 mmol) and Tri (tert-butyl) phosphine 69 mg (0.34 mmol) was added, and the mixture was stirred at 140°C for 10 hours. After cooling to room temperature, 10 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and 5.1 g (7.4 mmol) of a pale yellow free solid of Compound (A29) was isolated (yield 75%).

FDMS(m/z); 688(M+)FDMS (m/z); 688 (M+)

1H-NMR(CDCl3)δ(ppm); 8.04(t, 2H), 7.80-7.93(m, 3H), 7.10-7.57(m, 31H) 1 H-NMR (CDCl 3 )δ (ppm); 8.04 (t, 2H), 7.80-7.93 (m, 3H), 7.10-7.57 (m, 31H)

실시예 6A(화합물(A47)의 합성)Example 6A (Synthesis of compound (A47))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 3A로 얻은 2-클로로-9-(3-(1-나프틸)페닐)카바졸 1.0g(2.4m㏖), N-(4-바이페닐)-N-(m-터페닐-4-일)아민0.98g(2.4m㏖), 나트륨-tert-뷰톡사이드 0.32g(3.4m㏖), o-자일렌 10㎖, 아세트산 팔라듐 5㎎(0.02m㏖) 및 트라이(tert-뷰틸)포스핀 17㎎(0.08m㏖)을 첨가하고, 140℃에서 4시간 교반하였다. 실온까지 냉각 후, 순수 5㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하고, 화합물(A47)의 담황색 유리 형태 고체를 1.4g(1.9m㏖) 단리하였다(수율 79%).1.0 g (2.4 mmol) of 2-chloro-9- (3- (1-naphthyl) phenyl) carbazole obtained in Synthesis Example 3A in a 50 mL three-necked flask under a nitrogen stream, N- (4-bi Phenyl)-N-(m-terphenyl-4-yl)amine 0.98 g (2.4 mmol), sodium-tert-butoxide 0.32 g (3.4 mmol), o-xylene 10 ml, palladium acetate 5 mg ( 0.02 mmol) and tri(tert-butyl)phosphine 17 mg (0.08 mmol) were added, and the mixture was stirred at 140° C. for 4 hours. After cooling to room temperature, 5 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and 1.4 g (1.9 mmol) of a pale yellow free solid of Compound (A47) was isolated (yield 79%).

FDMS(m/z); 764(M+)FDMS (m/z); 764 (M+)

1H-NMR(CDCl3)δ(ppm); 8.01(t, 2H), 7.90(d, 1H), 7.05-7.79(m, 37H) 1 H-NMR (CDCl 3 )δ (ppm); 8.01 (t, 2H), 7.90 (d, 1H), 7.05-7.79 (m, 37H)

실시예 7A(화합물(A53)의 합성)Example 7A (Synthesis of Compound (A53))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 1A로 얻은 2-클로로-9-(4-(1-나프틸)페닐)카바졸 2.5g(6.2m㏖), N-페닐-N-(9,9-다이메틸플루오렌-2-일)아민 1.7g(6.2m㏖), 나트륨-tert-뷰톡사이드 0.8g(8.6m㏖), o-자일렌 15㎖, 아세트산 팔라듐 13㎎(0.06m㏖) 및 트라이(tert-뷰틸)포스핀 43㎎(0.21m㏖)을 첨가하고, 140℃에서 8시간 교반하였다. 실온까지 냉각 후, 순수 5㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하고, 화합물(A53)의 담황색 유리 형태 고체를 3.2g(5.0m㏖) 단리하였다(수율 81%).2.5 g (6.2 mmol) of 2-chloro-9-(4-(1-naphthyl)phenyl)carbazole obtained in Synthesis Example 1A, N-phenyl-N- (9,9-dimethylfluoren-2-yl)amine 1.7 g (6.2 mmol), sodium-tert-butoxide 0.8 g (8.6 mmol), o-xylene 15 ml, palladium acetate 13 mg (0.06) mmol) and tri(tert-butyl)phosphine 43 mg (0.21 mmol) were added, and the mixture was stirred at 140° C. for 8 hours. After cooling to room temperature, 5 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and 3.2 g (5.0 mmol) of a pale yellow free solid of compound (A53) was isolated (yield 81%).

FDMS(m/z); 652(M+)FDMS (m/z); 652 (M+)

실시예 1B(화합물(B25)의 합성)Example 1B (Synthesis of Compound (B25))

질소 기류 하, 100㎖의 3구 플라스크에, 합성예 1B에서 얻은 2-클로로-9-(4-(4-다이벤조티에닐)페닐)카바졸 5.5g(11.9m㏖), N,N-비스바이페닐아민 3.8g(11.9m㏖), 나트륨-tert-뷰톡사이드 1.6g(16.7m㏖), o-자일렌 35㎖, 아세트산 팔라듐 53㎎(0.23m㏖) 및 트라이(tert-뷰틸)포스핀 162㎎(0.80m㏖)을 첨가하고, 140℃에서 6시간 교반하였다. 실온까지 냉각 후, 석출한 생성물을 여과하여 취하고, 순수 및 에탄올로 세정하였다. 다음에, o-자일렌으로 재결정하고, 화합물(B25)의 담황색 분말을 6.5g(8.7m㏖) 단리하였다(수율 72%).5.5 g (11.9 mmol) of 2-chloro-9-(4-(4-dibenzothienyl)phenyl)carbazole obtained in Synthesis Example 1B, N,N- Bisbiphenylamine 3.8g (11.9mmol), sodium-tert-butoxide 1.6g (16.7mmol), o-xylene 35ml, palladium acetate 53mg (0.23mmol) and tri(tert-butyl)phos 162 mg (0.80 mmol) of a pin was added, and it stirred at 140 degreeC for 6 hours. After cooling to room temperature, the precipitated product was collected by filtration and washed with pure water and ethanol. Then, it was recrystallized from o-xylene, and 6.5 g (8.7 mmol) of a pale yellow powder of compound (B25) was isolated (yield 72%).

FDMS(m/z); 744(M+)FDMS (m/z); 744 (M+)

1H-NMR(CDCl3)δ(ppm); 8.01-8.13(m,4H), 7.83(d, 2H), 7.10-7.69(m, 30H) 1 H-NMR (CDCl 3 )δ (ppm); 8.01-8.13 (m, 4H), 7.83 (d, 2H), 7.10-7.69 (m, 30H)

13C-NMR(CDCl3)δ(ppm); 146.80, 145.56, 141.27, 140.80, 140.10, 138.97, 138.93, 137.92, 136.68, 135.89, 135.41, 135.19, 134.59, 129.22, 128.27, 127.28, 126.46, 126.39, 126.33, 126.17, 125.05, 124.72, 123.97, 123.31, 123.04, 122.19, 121.26, 120.73, 120.27, 119.96, 119.48, 119.45, 118.44, 109.41, 106.35 13 C-NMR (CDCl 3 )δ (ppm); 146.80, 145.56, 141.27, 140.80, 140.10, 138.97, 138.93, 137.92, 136.68, 135.89, 135.41, 135.19, 134.59, 129.22, 128.27, 127.28, 126.46, 126.39, 126.31, 125.05, 124.72. 122.19, 121.26, 120.73, 120.27, 119.96, 119.48, 119.45, 118.44, 109.41, 106.35

실시예 2B(화합물(B26)의 합성)Example 2B (Synthesis of Compound (B26))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 2B에서 얻은 2-클로로-9-(4-(4-다이벤조퓨라닐)페닐)카바졸 5.0g(11.2m㏖), N,N-비스바이페닐아민 3.6g(11.2m㏖), 나트륨-tert-뷰톡사이드 1.5g(15.7m㏖), o-자일렌 25㎖, 아세트산 팔라듐 50㎎(0.22m㏖) 및 트라이(tert-뷰틸)포스핀 155㎎(0.77m㏖)을 첨가하고, 140℃에서 6시간 교반하였다. 실온까지 냉각 후, 석출한 생성물을 여과하여 취하고, 순수 및 에탄올로 세정하였다. 다음에, o-자일렌으로 재결정하고, 화합물(B26)의 담황색 분말을 6.4g(8.7m㏖) 단리하였다(수율 77%).5.0 g (11.2 mmol) of 2-chloro-9-(4-(4-dibenzofuranyl)phenyl)carbazole obtained in Synthesis Example 2B, N,N- Bisbiphenylamine 3.6g (11.2mmol), sodium-tert-butoxide 1.5g (15.7mmol), o-xylene 25ml, palladium acetate 50mg (0.22mmol) and tri(tert-butyl)phos 155 mg (0.77 mmol) of a pin was added, and it stirred at 140 degreeC for 6 hours. After cooling to room temperature, the precipitated product was collected by filtration and washed with pure water and ethanol. Then, it was recrystallized from o-xylene, and 6.4 g (8.7 mmol) of a pale yellow powder of compound (B26) was isolated (yield 77%).

FDMS(m/z); 728(M+)FDMS (m/z); 728 (M+)

1H-NMR(CDCl3)δ(ppm); 7.98-8.07(m,4H), 7.87(t, 2H), 7.60(d, 2H), 7.09-7.54(m, 28H) 1 H-NMR (CDCl 3 )δ (ppm); 7.98-8.07 (m, 4H), 7.87 (t, 2H), 7.60 (d, 2H), 7.09-7.54 (m, 28H)

13C-NMR(CDCl3)δ(ppm); 155.65, 152.79, 146.90, 145.60, 141.35, 140.91, 140.14, 136.49, 134.90, 134.55, 129.74, 128.31, 127.32, 126.90, 126.39, 126.19, 125.10, 124.63, 124.26, 123.66, 123.27, 123.05, 122.91, 122.45, 120.80, 120.27, 119.98, 119.59, 119.48, 118.60, 111.46, 109.52, 106.61 13 C-NMR (CDCl 3 )δ (ppm); 155.65, 152.79, 146.90, 145.60, 141.35, 140.91, 140.14, 136.49, 134.90, 134.55, 129.74, 128.31, 127.32, 126.90, 126.39, 126.19, 125.10, 124.63, 124.26, 121, 122. 120.27, 119.98, 119.59, 119.48, 118.60, 111.46, 109.52, 106.61

실시예 3B(화합물(B27)의 합성)Example 3B (Synthesis of Compound (B27))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 3B에서 얻은 2-클로로-9-(3-(4-다이벤조티에닐)페닐)카바졸 1.8g(3.9m㏖), N,N-비스바이페닐아민 1.2g(3.9m㏖), 나트륨-tert-뷰톡사이드 0.5g(5.5m㏖), o-자일렌 10㎖, 아세트산 팔라듐 17㎎(0.07m㏖) 및 트라이(tert-뷰틸)포스핀 54㎎(0.26m㏖)을 첨가하고, 140℃에서 3시간 교반하였다. 실온까지 냉각 후, 순수 10㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하고, 화합물(B27)의 담황색 유리 형태 고체를 2.3g(3.1m㏖) 단리하였다(수율 81%).1.8 g (3.9 mmol) of 2-chloro-9-(3-(4-dibenzothienyl)phenyl)carbazole obtained in Synthesis Example 3B, N,N- Bisbiphenylamine 1.2g (3.9mmol), sodium-tert-butoxide 0.5g (5.5mmol), o-xylene 10ml, palladium acetate 17mg (0.07mmol) and tri(tert-butyl)phos Pin 54 mg (0.26 mmol) was added, and it stirred at 140 degreeC for 3 hours. After cooling to room temperature, 10 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and 2.3 g (3.1 mmol) of a pale yellow free solid of compound (B27) was isolated (yield 81%). ).

FDMS(m/z); 744(M+)FDMS (m/z); 744 (M+)

실시예 4B(화합물(B28)의 합성)Example 4B (Synthesis of Compound (B28))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 4B에서 얻은 2-클로로-9-(3-(4-다이벤조퓨라닐)페닐)카바졸 3.0g(6.7m㏖), N,N-비스바이페닐아민 2.1g(6.7m㏖), 나트륨-tert-뷰톡사이드 0.90g(9.4m㏖), o-자일렌 15㎖, 아세트산 팔라듐 30㎎(0.13m㏖) 및 트라이(tert-뷰틸)포스핀 93㎎(0.46m㏖)을 첨가하고, 140℃에서 5시간 교반하였다. 실온까지 냉각 후, 순수 10㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하고, 화합물(B28)의 담황색 분말을 4.2g(5.8m㏖) 단리하였다(수율 88%).3.0 g (6.7 mmol) of 2-chloro-9- (3- (4-dibenzofuranyl) phenyl) carbazole obtained in Synthesis Example 4B in a 50 mL three-neck flask under a nitrogen stream, N,N- Bisbiphenylamine 2.1g (6.7mmol), sodium-tert-butoxide 0.90g (9.4mmol), o-xylene 15ml, palladium acetate 30mg (0.13mmol) and tri(tert-butyl)phos Pin 93 mg (0.46 mmol) was added, followed by stirring at 140°C for 5 hours. After cooling to room temperature, 10 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and 4.2 g (5.8 mmol) of a pale yellow powder of compound (B28) was isolated (yield 88%).

FDMS(m/z); 728(M+)FDMS (m/z); 728 (M+)

실시예 5B(화합물(B29)의 합성)Example 5B (Synthesis of Compound (B29))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 1B에서 얻은 2-클로로-9-(4-(4-다이벤조티에닐)페닐)카바졸 1.1g(2.3m㏖), N-페닐-N-(p-터페닐아민) 0.73g(2.3m㏖), 나트륨-tert-뷰톡사이드 0.32g(3.3m㏖), o-자일렌 10㎖, 아세트산 팔라듐 10㎎(0.04m㏖) 및 트라이(tert-뷰틸)포스핀 32㎎(0.26m㏖)을 첨가하고, 140℃에서 4시간 교반하였다. 실온까지 냉각 후, 석출한 생성물을 여과하여 취하고, 순수 및 에탄올로 세정하였다. 다음에, o-자일렌으로 재결정하고, 화합물(B29)의 담황색 분말을 0.99g(1.3m㏖) 단리하였다(수율 58%).1.1 g (2.3 mmol) of 2-chloro-9-(4-(4-dibenzothienyl)phenyl)carbazole obtained in Synthesis Example 1B, N-phenyl- N-(p-terphenylamine) 0.73 g (2.3 mmol), sodium-tert-butoxide 0.32 g (3.3 mmol), o-xylene 10 ml, palladium acetate 10 mg (0.04 mmol) and tri( 32 mg (0.26 mmol) of tert-butyl) phosphine was added, and the mixture was stirred at 140°C for 4 hours. After cooling to room temperature, the precipitated product was collected by filtration and washed with pure water and ethanol. Then, it was recrystallized from o-xylene, and 0.99 g (1.3 mmol) of a pale yellow powder of compound (B29) was isolated (yield 58%).

FDMS(m/z); 744(M+)FDMS (m/z); 744 (M+)

실시예 6B(화합물(B34)의 합성)Example 6B (Synthesis of Compound (B34))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 2B에서 얻은 2-클로로-9-(4-(4-다이벤조퓨라닐)페닐)카바졸 2.5g(5.6m㏖), N-바이페닐-N-(p-터페닐)아민 2.2g(5.6m㏖), 나트륨-tert-뷰톡사이드 0.75g(7.8m㏖), o-자일렌 15㎖, 아세트산 팔라듐 25㎎(0.11m㏖) 및 트라이(tert-뷰틸)포스핀77㎎(0.38m㏖)을 첨가하고, 140℃에서 6시간 교반하였다. 실온까지 냉각 후, 석출한 생성물을 여과하여 취하고, 순수 및 에탄올로 세정하였다. 다음에, o-자일렌으로 재결정하고, 화합물(B34)의 담황색 분말을 3.1g(3.9m㏖) 단리하였다(수율 70%).2.5 g (5.6 mmol) of 2-chloro-9- (4- (4-dibenzofuranyl) phenyl) carbazole obtained in Synthesis Example 2B, N-biphenyl in a 50 mL three-necked flask under a nitrogen stream -N-(p-terphenyl)amine 2.2g (5.6mmol), sodium-tert-butoxide 0.75g (7.8mmol), o-xylene 15ml, palladium acetate 25mg (0.11mmol) and tri (tert-butyl)phosphine 77 mg (0.38 mmol) was added, and the mixture was stirred at 140°C for 6 hours. After cooling to room temperature, the precipitated product was collected by filtration and washed with pure water and ethanol. Then, it was recrystallized from o-xylene, and 3.1 g (3.9 mmol) of a pale yellow powder of compound (B34) was isolated (yield 70%).

FDMS(m/z); 804(M+)FDMS (m/z); 804 (M+)

실시예 7B(화합물(B46)의 합성)Example 7B (Synthesis of Compound (B46))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 2B에서 얻은 2-클로로-9-(4-(4-다이벤조퓨라닐)페닐)카바졸 1.0g(2.2m㏖), N-바이페닐-N-(m-터페닐)아민0.88g(2.2m㏖), 나트륨-tert-뷰톡사이드 0.3g(3.1m㏖), o-자일렌 10㎖, 아세트산 팔라듐 10㎎(0.04m㏖) 및 트라이(tert-뷰틸)포스핀 31㎎(0.15m㏖)을 첨가하고, 140℃에서 2시간 교반하였다. 실온까지 냉각 후, 순수 5㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하고, 화합물(B46)의 담황색 유리 형태 고체를 1.4g(1.8m㏖) 단리하였다(수율 83%).1.0 g (2.2 mmol) of 2-chloro-9- (4- (4-dibenzofuranyl) phenyl) carbazole obtained in Synthesis Example 2B, N-biphenyl in a 50 mL three-necked flask under a nitrogen stream -N-(m-terphenyl)amine 0.88g (2.2mmol), sodium-tert-butoxide 0.3g (3.1mmol), o-xylene 10ml, palladium acetate 10mg (0.04mmol) and tri 31 mg (0.15 mmol) of (tert-butyl)phosphine was added, and the mixture was stirred at 140°C for 2 hours. After cooling to room temperature, 5 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and 1.4 g (1.8 mmol) of a pale yellow free solid of compound (B46) was isolated (yield 83%). ).

FDMS(m/z); 804(M+)FDMS (m/z); 804 (M+)

실시예 8B(화합물(B53)의 합성)Example 8B (Synthesis of Compound (B53))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 1B에서 얻은 2-클로로-9-(4-(4-다이벤조티에닐)페닐)카바졸 1.1g(2.3m㏖), N-페닐-N-(9,9-다이메틸플루오렌-2-일)아민0.65g(2.3m㏖), 나트륨-tert-뷰톡사이드 0.32g(3.3m㏖), o-자일렌 10㎖, 아세트산 팔라듐 10㎎(0.04m㏖) 및 트라이(tert-뷰틸)포스핀 32㎎(0.16m㏖)을 첨가하고, 140℃에서 4시간 교반하였다. 실온까지 냉각 후, 순수 5㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 잔사를 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하고, 화합물(B53)의 담황색 유리 형태 고체를 1.2g(1.8m㏖) 단리하였다(수율 79%).1.1 g (2.3 mmol) of 2-chloro-9-(4-(4-dibenzothienyl)phenyl)carbazole obtained in Synthesis Example 1B, N-phenyl- N-(9,9-dimethylfluoren-2-yl)amine 0.65 g (2.3 mmol), sodium-tert-butoxide 0.32 g (3.3 mmol), o-xylene 10 ml, palladium acetate 10 mg (0.04 mmol) and tri(tert-butyl)phosphine 32 mg (0.16 mmol) were added, and the mixture was stirred at 140°C for 4 hours. After cooling to room temperature, 5 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and 1.2 g (1.8 mmol) of a pale yellow free solid of compound (B53) was isolated (yield 79%).

FDMS(m/z); 708(M+)FDMS (m/z); 708 (M+)

실시예 9B(화합물(B77)의 합성)Example 9B (Synthesis of Compound (B77))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 7B에서 얻은 2-클로로-6-(4-다이벤조티에닐)-9-페닐카바졸 4.0g(8.7m㏖), N,N-비스바이페닐아민 2.8g(8.7m㏖), 나트륨-tert-뷰톡사이드 1.1g(12.1m㏖), o-자일렌 25㎖, 아세트산 팔라듐 19㎎(0.08m㏖) 및 트라이(tert-뷰틸)포스핀 56㎎(0.28m㏖)을 첨가하고, 140℃에서 16시간 교반하였다. 실온까지 냉각 후, 순수 10㎖를 가하고, 유기층을 분리하였다.In a 50 ml three-necked flask under a nitrogen stream, 4.0 g (8.7 mmol) of 2-chloro-6-(4-dibenzothienyl)-9-phenylcarbazole obtained in Synthesis Example 7B, N,N-bis Biphenylamine 2.8g (8.7mmol), sodium-tert-butoxide 1.1g (12.1mmol), o-xylene 25ml, palladium acetate 19mg (0.08mmol) and tri(tert-butyl)phosphine 56 mg (0.28 mmol) was added, and it stirred at 140 degreeC for 16 hours. After cooling to room temperature, 10 ml of pure water was added, and the organic layer was separated.

유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하고, 화합물(B77)의 담황색 유리 형태 고체를 4.9g(6.5m㏖) 단리하였다(수율 75%).The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and 4.9 g (6.5 mmol) of a pale yellow free solid of compound (B77) was isolated (yield 75%). ).

FDMS(m/z); 744(M+)FDMS (m/z); 744 (M+)

1H-NMR(CDCl3)δ(ppm); 8.41(s, 1H), 8.11-8.20(m, 2H), 8.07(d, 1H), 7.81(t, 1H), 7.72(d, 1H), 7.10-7.59(m, 30H) 1 H-NMR (CDCl 3 )δ (ppm); 8.41(s, 1H), 8.11-8.20(m, 2H), 8.07(d, 1H), 7.81(t, 1H), 7.72(d, 1H), 7.10-7.59(m, 30H)

13C-NMR(CDCl3)δ(ppm); 146.73, 145.78, 141.88, 140.58, 140.08, 139.19, 138.56, 137.30, 136.84, 135.67, 135.47, 134.55, 132.41, 129.46, 128.25, 127.23, 127.06, 126.62, 126.33, 126.20, 126.13, 125.31, 124.65, 123.84, 123.24, 122.14, 121.26, 120.80, 119.46, 119.30, 119.12, 118.53, 109.47, 106.37 13 C-NMR (CDCl 3 )δ (ppm); 146.73, 145.78, 141.88, 140.58, 140.08, 139.19, 138.56, 137.30, 136.84, 135.67, 135.47, 134.55, 132.41, 129.46, 128.25, 127.23, 127.06, 126.62, 126.84, 126.13, 123. 122.14, 121.26, 120.80, 119.46, 119.30, 119.12, 118.53, 109.47, 106.37

실시예 10B(화합물(B79)의 합성)Example 10B (Synthesis of Compound (B79))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 7B에서 얻은 2-클로로-6-(4-다이벤조티에닐)-9-페닐카바졸 1.2g(2.6m㏖), N-페닐-N-(p-터페닐아민) 0.8g(2.6m㏖), 나트륨-tert-뷰톡사이드 0.33g(3.6m㏖), o-자일렌 10㎖, 아세트산 팔라듐 5㎎(0.02m㏖) 및 트라이(tert-뷰틸)포스핀 16㎎(0.08m㏖)을 첨가하고, 140℃에서 8시간 교반하였다. 실온까지 냉각 후, 순수 5㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하고, 화합물(B79)의 담황색 유리 형태 고체를 1.5g(2.1m㏖) 단리하였다(수율 81%).1.2 g (2.6 mmol) of 2-chloro-6-(4-dibenzothienyl)-9-phenylcarbazole obtained in Synthesis Example 7B, N-phenyl-N in a 50 ml three-necked flask under a nitrogen stream -(p-terphenylamine) 0.8 g (2.6 mmol), sodium-tert-butoxide 0.33 g (3.6 mmol), o-xylene 10 ml, palladium acetate 5 mg (0.02 mmol) and tri(tert) -Butyl)phosphine 16 mg (0.08 mmol) was added, and the mixture was stirred at 140° C. for 8 hours. After cooling to room temperature, 5 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and 1.5 g (2.1 mmol) of a pale yellow free solid of compound (B79) was isolated (yield 81%). ).

FDMS(m/z); 744(M+)FDMS (m/z); 744 (M+)

실시예 11B(화합물(B2)의 합성)Example 11B (Synthesis of Compound (B2))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 2B에서 얻은 2-클로로-9-(4-(4-다이벤조퓨라닐)페닐)카바졸 1.0g(2.2m㏖), N-페닐-N-(1-나프틸)아민0.48g(2.2m㏖), 나트륨-tert-뷰톡사이드 0.3g(3.1m㏖), o-자일렌 10㎖, 아세트산 팔라듐 10㎎(0.04m㏖) 및 트라이(tert-뷰틸)포스핀 31㎎(0.15m㏖)을 첨가하고, 140℃에서 3시간 교반하였다. 실온까지 냉각 후, 순수 5㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=2:3))로 정제하고, 화합물(B2)의 담황색 유리 형태 고체를 1.0g(1.6m㏖) 단리하였다(수율 74%).1.0 g (2.2 mmol) of 2-chloro-9-(4-(4-dibenzofuranyl)phenyl)carbazole obtained in Synthesis Example 2B, N-phenyl- N-(1-naphthyl)amine 0.48 g (2.2 mmol), sodium-tert-butoxide 0.3 g (3.1 mmol), o-xylene 10 ml, palladium acetate 10 mg (0.04 mmol) and tri( 31 mg (0.15 mmol) of tert-butyl) phosphine was added, and the mixture was stirred at 140° C. for 3 hours. After cooling to room temperature, 5 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 2:3)), and 1.0 g (1.6 mmol) of a pale yellow free solid of compound (B2) was isolated (yield 74%). ).

FDMS(m/z); 626(M+)FDMS (m/z); 626 (M+)

실시예 12B(화합물(B5)의 합성)Example 12B (Synthesis of Compound (B5))

질소 기류 하, 50㎖의 3구 플라스크에, 합성예 1B에서 얻은 2-클로로-9-(4-(4-다이벤조티에닐)페닐)카바졸 4.0g(8.7m㏖), N-페닐-N-(9-페난트릴)아민 2.3g(8.7m㏖), 나트륨-tert-뷰톡사이드 1.1g(12.1m㏖), o-자일렌 25㎖, 아세트산 팔라듐 19㎎(0.08m㏖) 및 트라이(tert-뷰틸)포스핀 56㎎(0.28m㏖)을 첨가하고, 140℃에서 16시간 교반하였다. 실온까지 냉각 후, 순수 15㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하고, 화합물(B5)의 담황색 유리 형태 고체를 4.7g(6.8m㏖) 단리하였다(수율 79%).In a 50 ml three-necked flask under a nitrogen stream, 4.0 g (8.7 mmol) of 2-chloro-9-(4-(4-dibenzothienyl)phenyl)carbazole obtained in Synthesis Example 1B, N-phenyl- N-(9-phenanthryl)amine 2.3g (8.7mmol), sodium-tert-butoxide 1.1g (12.1mmol), o-xylene 25ml, palladium acetate 19mg (0.08mmol) and tri( 56 mg (0.28 mmol) of tert-butyl) phosphine was added, and the mixture was stirred at 140° C. for 16 hours. After cooling to room temperature, 15 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and 4.7 g (6.8 mmol) of a pale yellow free solid of compound (B5) was isolated (yield 79%). ).

FDMS(m/z); 692(M+)FDMS (m/z); 692 (M+)

실시예 13B(화합물(B103)의 합성)Example 13B (Synthesis of compound (B103))

질소 기류 하, 100㎖의 3구 플라스크에, 합성예 8B에서 얻은 2-클로로-9-(4-(9-페난트릴)페닐)카바졸 1.0g(2.2m㏖), N-(4-메틸페닐)-N-(4-바이페닐)아민0.57g(2.2m㏖), 나트륨-tert-뷰톡사이드 0.28g(3.0m㏖), o-자일렌 10㎖, 아세트산 팔라듐 5㎎(0.02m㏖) 및 트라이(tert-뷰틸)포스핀 15㎎(0.07m㏖)을 첨가하고, 140℃에서 2시간 교반하였다. 실온까지 냉각 후, 순수 5㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=4:5))로 정제하고, 화합물(B103)의 담황색 유리 형태 고체를 1.2g(1.8m㏖) 단리하였다(수율 83%).1.0 g (2.2 mmol) of 2-chloro-9-(4-(9-phenanthryl)phenyl)carbazole obtained in Synthesis Example 8B, N-(4-methylphenyl) in a 100 ml three-necked flask under a nitrogen stream )-N-(4-biphenyl)amine 0.57 g (2.2 mmol), sodium-tert-butoxide 0.28 g (3.0 mmol), o-xylene 10 ml, palladium acetate 5 mg (0.02 mmol) and Tri (tert-butyl) phosphine 15 mg (0.07 mmol) was added, and the mixture was stirred at 140°C for 2 hours. After cooling to room temperature, 5 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 4:5)), and 1.2 g (1.8 mmol) of a pale yellow free solid of compound (B103) was isolated (yield 83%). ).

FDMS(m/z); 676(M+)FDMS (m/z); 676 (M+)

실시예 14B(화합물(B106)의 합성)Example 14B (Synthesis of Compound (B106))

질소 기류 하, 100㎖의 3구 플라스크에, 합성예 8B에서 얻은 2-클로로-9-(4-(9-페난트릴)페닐)카바졸 7.0g(15.4m㏖), N,N-비스(4-바이페닐)아민 4.6g(15.4m㏖), 나트륨-tert-뷰톡사이드 2.0g(21.6m㏖), o-자일렌 35㎖, 아세트산 팔라듐 34㎎(0.15m㏖) 및 트라이(tert-뷰틸)포스핀 108㎎(0.54m㏖)을 첨가하고, 140℃에서 9시간 교반하였다. 실온까지 냉각 후, 석출한 생성물을 여과하여 취하고, 순수 및 에탄올로 세정하였다. 다음에, o-자일렌으로 재결정하고, 화합물(B106)의 백색 분말을 10.4g(14.0m㏖) 단리하였다(수율 91%).7.0 g (15.4 mmol) of 2-chloro-9-(4-(9-phenanthryl)phenyl)carbazole obtained in Synthesis Example 8B, N,N-bis( 4-biphenyl)amine 4.6g (15.4mmol), sodium-tert-butoxide 2.0g (21.6mmol), o-xylene 35ml, palladium acetate 34mg (0.15mmol) and tri(tert-butyl) ) 108 mg (0.54 mmol) of phosphine was added, and the mixture was stirred at 140°C for 9 hours. After cooling to room temperature, the precipitated product was collected by filtration and washed with pure water and ethanol. Next, it was recrystallized from o-xylene, and 10.4 g (14.0 mmol) of white powder of compound (B106) was isolated (yield 91%).

FDMS(m/z); 738(M+)FDMS (m/z); 738 (M+)

1H-NMR(CDCl3)δ(ppm); 8.77(d, 1H), 8.71(d, 1H), 8.09(d, 2H), 7.98(d, 1H), 7.86(d, 1H), 7.17-7.73(m, 32H) 1 H-NMR (CDCl 3 )δ (ppm); 8.77 (d, 1H), 8.71 (d, 1H), 8.09 (d, 2H), 7.98 (d, 1H), 7.86 (d, 1H), 7.17-7.73 (m, 32H)

13C-NMR(CDCl3)δ(ppm); 147.62, 146.25, 142.17, 141.72, 140.87, 140.15, 138.01, 136.99, 135.31, 131.82, 131.12, 130.95, 130.32, 129.03, 128.12, 128.01, 127.19, 127.09, 126.91, 125.78, 123.93, 123.71, 123.25, 122.81, 121.48, 120.62, 120.30, 120.19, 119.32, 110.13, 107.28 13 C-NMR (CDCl 3 )δ (ppm); 147.62, 146.25, 142.17, 141.72, 140.87, 140.15, 138.01, 136.99, 135.31, 131.82, 131.12, 130.95, 130.32, 129.03, 128.12, 128.01, 127.19, 127.09, 126.91, 125.78, 123.25, 123.78, 123.93, 12 120.62, 120.30, 120.19, 119.32, 110.13, 107.28

실시예 15B(화합물(B122)의 합성)Example 15B (Synthesis of compound (B122))

질소 기류 하, 100㎖의 3구 플라스크에, 합성예 9B에서 얻은 2-클로로-9-(3-(9-페난트릴)페닐)카바졸 8.0g(17.6m㏖), N,N-비스(4-바이페닐)아민5.3g(17.6m㏖), 나트륨-tert-뷰톡사이드 2.3g(17.6m㏖), o-자일렌 40㎖, 아세트산 팔라듐 39㎎(0.017m㏖) 및 트라이(tert-뷰틸)포스핀 124㎎(0.61m㏖)을 첨가하고, 140℃에서 10시간 교반하였다. 실온까지 냉각 후, 순수 30㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=1:1))로 정제하고, 화합물(B122)의 담황색 유리 형태 고체를 9.0g(12.1m㏖) 단리하였다(수율 69%).8.0 g (17.6 mmol) of 2-chloro-9-(3-(9-phenanthryl)phenyl)carbazole obtained in Synthesis Example 9B, N,N-bis( 4-biphenyl)amine 5.3g (17.6mmol), sodium-tert-butoxide 2.3g (17.6mmol), o-xylene 40ml, palladium acetate 39mg (0.017mmol) and tri(tert-butyl) ) Phosphine 124 mg (0.61 mmol) was added, and the mixture was stirred at 140° C. for 10 hours. After cooling to room temperature, 30 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 1:1)), and 9.0 g (12.1 mmol) of a pale yellow free solid of compound (B122) was isolated (yield 69%). ).

FDMS(m/z); 738(M+)FDMS (m/z); 738 (M+)

1H-NMR(CDCl3)δ(ppm); 8.70(d, 1H), 8.65(d, 1H), 8.01-8.08(m, 2H), 7.92(d, 1H), 7.78(d, 1H), 7.09-7.71(m, 32H) 1 H-NMR (CDCl 3 )δ (ppm); 8.70 (d, 1H), 8.65 (d, 1H), 8.01-8.08 (m, 2H), 7.92 (d, 1H), 7.78 (d, 1H), 7.09-7.71 (m, 32H)

13C-NMR(CDCl3)δ(ppm); 147.60, 146.23, 143.00, 142.18, 141.71, 140.87, 137.89, 137.82, 135.28, 131.61, 131.01, 130.88, 130.32, 130.10, 129.46, 129.04, 128.61, 128.00, 127.21, 127.08, 127.01, 126.91, 126.80, 126.02, 125.77, 123.95, 123.69, 123.25, 122.80, 121.48, 120.60, 120.17, 119.29, 110.06, 107.15 13 C-NMR (CDCl 3 )δ (ppm); 147.60, 146.23, 143.00, 142.18, 141.71, 140.87, 137.89, 137.82, 135.28, 131.61, 131.01, 130.88, 130.32, 130.10, 129.46, 129.04, 128.61, 128.00, 127.21, 126.80, 127.08, 127.80, 127.08, 127. 123.95, 123.69, 123.25, 122.80, 121.48, 120.60, 120.17, 119.29, 110.06, 107.15

실시예 16B(화합물(B138)의 합성)Example 16B (Synthesis of Compound (B138))

질소 기류 하, 100㎖의 3구 플라스크에, 합성예 12B에서 얻은 2-클로로-6-(9-페난트릴)-9-페닐카바졸 5.5g(12.1m㏖), N,N-비스(4-바이페닐)아민 3.8g(12.1m㏖), 나트륨-tert-뷰톡사이드 1.6g(16.7m㏖), o-자일렌 30㎖, 아세트산 팔라듐 27㎎(0.12m㏖) 및 트라이(tert-뷰틸)포스핀 85㎎(0.42m㏖)을 첨가하고, 140℃에서 11시간 교반하였다. 실온까지 냉각 후, 순수 20㎖를 가하고, 유기층을 분리하였다. 유기층을 물, 포화 식염수로 순차 세정한 후, 무수 황산 마그네슘으로 건조시키고, 감압 하에 농축시켰다. 얻어진 잔사를, 실리카겔 칼럼 크로마토그래피(톨루엔과 헥산의 혼합 용매(체적비=2:3))로 정제하고, 화합물(B138)의 담황색 유리 형태 고체를 4.6g(6.2m㏖) 단리하였다(수율 51%).In a 100 ml three-necked flask under a nitrogen stream, 5.5 g (12.1 mmol) of 2-chloro-6-(9-phenanthryl)-9-phenylcarbazole obtained in Synthesis Example 12B, N,N-bis(4) -Biphenyl)amine 3.8g (12.1mmol), sodium-tert-butoxide 1.6g (16.7mmol), o-xylene 30ml, palladium acetate 27mg (0.12mmol) and tri(tert-butyl) 85 mg (0.42 mmol) of phosphine was added, and the mixture was stirred at 140°C for 11 hours. After cooling to room temperature, 20 ml of pure water was added, and the organic layer was separated. The organic layer was washed sequentially with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (a mixed solvent of toluene and hexane (volume ratio = 2:3)), and 4.6 g (6.2 mmol) of a pale yellow free solid of compound (B138) was isolated (yield 51%). ).

FDMS(m/z); 738(M+)FDMS (m/z); 738 (M+)

1H-NMR(CDCl3)δ(ppm); 8.78(d, 1H), 8.72(d, 1H), 8.22(s, 1H), 8.02(d, 2H), 7.89(d, 1H), 7.78(s, 1H), 7.09-7.67(m, 31H) 1 H-NMR (CDCl 3 )δ (ppm); 8.78(d, 1H), 8.72(d, 1H), 8.22(s, 1H), 8.02(d, 2H), 7.89(d, 1H), 7.78(s, 1H), 7.09-7.67(m, 31H)

13C-NMR(CDCl3)δ(ppm); 147.60, 146.51, 142.64, 141.11, 140.92, 139.69, 137.78, 135.36, 133.21, 132.11, 132.03, 131.01, 130.29, 130.19, 129.07, 128.94, 128.12, 128.05, 127.83, 127.56, 127.13, 126.94, 126.78, 126.70, 124.01, 123.71, 123.21, 122.87, 121.56, 120.07, 119.31, 109.75, 107.19 13 C-NMR (CDCl 3 )δ (ppm); 147.60, 146.51, 142.64, 141.11, 140.92, 139.69, 137.78, 135.36, 133.21, 132.11, 132.03, 131.01, 130.29, 130.19, 129.07, 128.94, 128.12, 128.05, 127.83, 127.76, 126.94, 124.78. 123.71, 123.21, 122.87, 121.56, 120.07, 119.31, 109.75, 107.19

실시예 8A(화합물(A25)의 소자 평가)Example 8A (device evaluation of compound (A25))

두께 200㎚의 ITO 투명전극(양극)을 적층한 유리 기판을, 아세톤 및 순수에 의한 초음파 세정, 및 아이소프로필 알코올에 의한 비등 세정을 행하였다. 또한, 자외선/오존 세정을 행하고, 진공증착장치에 설치한 후, 1×10-4㎩이 될 때까지 진공 펌프로 배기하였다. 우선, ITO 투명전극 상에 구리 프탈로사이아닌을 증착 속도 0.1㎚/초로 증착하여, 10㎚의 정공 주입층으로 하고, 이어서, 화합물(A25)를 증착 속도 0.3㎚/초로 30㎚ 증착해서 정공 수송층으로 하였다. 이어서, 인광 도펀트 재료인 트리스(2-페닐피리딘)이리듐(Ir(ppy))3)과 호스트 재료인 4,4'-비스(N-카바졸릴)바이페닐(CBP)을, 중량비가 1:11.5가 되도록 증착 속도 0.25㎚/초로 공증착하여, 30㎚의 발광층으로 하였다. 다음에, BAlq(비스(2-메틸-8-퀴놀리놀라토)(p-페닐페놀라토)알루미늄)를 증착 속도 0.3㎚/초로 증착하여, 5㎚의 엑시톤 블록층으로 한 후, 또한, Alq3(트리스(8-퀴놀리놀라토)알루미늄)을 증착 속도 0.3㎚/초로 증착하여, 45㎚의 전자 수송층으로 하였다. 이어서, 전자 주입층으로서 플루오르화리튬을 증착 속도 0.01㎚/초로 1㎚증착하고, 또한, 알루미늄을 증착 속도 0.25㎚/초로 100㎚ 증착해서 음극을 형성하였다. 또, 질소 분위기 하, 밀봉용의 유리판을 UV 경화 수지로 접착하여, 평가용의 유기 EL 소자로 하였다. 이와 같이 해서 제작한 소자에, 20 ㎃/㎠의 전류를 인가하고, 구동 전압 및 전류효율을 측정하였다. 또한, 소자의 휘도 반감 시간은, 6.25 ㎃/㎠의 전류를 인가해서 평가하였다. 결과를 표 1에 나타내었다.A glass substrate on which an ITO transparent electrode (anode) having a thickness of 200 nm was laminated was subjected to ultrasonic cleaning with acetone and pure water and boiling cleaning with isopropyl alcohol. Furthermore, after UV/ozone cleaning was performed and installed in a vacuum vapor deposition apparatus, it was evacuated with a vacuum pump until it became 1×10 −4 Pa. First, copper phthalocyanine is deposited on an ITO transparent electrode at a deposition rate of 0.1 nm/sec to form a 10 nm hole injection layer, and then Compound (A25) is vapor-deposited at a deposition rate of 0.3 nm/sec to 30 nm at a deposition rate of 0.3 nm/sec to form a hole transport layer was done with Subsequently, tris(2-phenylpyridine)iridium (Ir(ppy)) 3 ) as a phosphorescent dopant material and 4,4'-bis(N-carbazolyl)biphenyl (CBP) as a host material were mixed in a weight ratio of 1:11.5 It was co-deposited at a deposition rate of 0.25 nm/sec so as to become a light emitting layer of 30 nm. Next, BAlq (bis(2-methyl-8-quinolinolato)(p-phenylphenollato)aluminum) was vapor-deposited at a deposition rate of 0.3 nm/sec to form an exciton-blocking layer of 5 nm, and then Alq3 (Tris(8-quinolinolato)aluminum) was vapor-deposited at a vapor deposition rate of 0.3 nm/sec to obtain an electron transport layer of 45 nm. Next, as an electron injection layer, 1 nm of lithium fluoride was vapor-deposited at the deposition rate of 0.01 nm/sec, and 100 nm of aluminum was vapor-deposited at the vapor deposition rate of 0.25 nm/sec, and the cathode was formed. Moreover, the glass plate for sealing was adhere|attached with UV curing resin in nitrogen atmosphere, and it was set as the organic electroluminescent element for evaluation. A current of 20 mA/cm 2 was applied to the device thus fabricated, and the driving voltage and current efficiency were measured. In addition, the luminance half-life time of the device was evaluated by applying a current of 6.25 mA/cm 2 . The results are shown in Table 1.

실시예 9A 내지 14A(소자 평가)Examples 9A to 14A (element evaluation)

화합물(A25) 대신에, 화합물(A26), (A27), (A28), (A29), (A47) 또는 (A53)을 이용한 이외에는, 실시예 8A와 같은 방법으로 유기 EL 소자를 제작하였다. 20 ㎃/㎠의 전류를 인가했을 때의 구동 전압 및 전류효율 및 6.25 ㎃/㎠의 전류를 인가했을 때의 휘도 반감 시간을 표 1에 정리해서 나타내었다.An organic EL device was fabricated in the same manner as in Example 8A except that Compound (A26), (A27), (A28), (A29), (A47) or (A53) was used instead of Compound (A25). Table 1 shows the driving voltage and current efficiency when a current of 20 mA/cm 2 is applied and the luminance half-life time when a current of 6.25 mA/cm 2 is applied.

실시예 17B 내지 41B(소자 평가)Examples 17B to 41B (element evaluation)

화합물(A25) 대신에, 화합물(B25), (B26), (B27), (B28), (B29), (B34), (B46), (B53), (B77), (B79), (B2), (B5), (B103), (B106), (B122) 또는 (B138)로 변경한 이외에는, 실시예 8A와 같은 방법으로 유기 EL 소자를 제작하였다. 20 ㎃/㎠의 전류를 인가했을 때의 구동 전압 및 전류효율 및 6.25 ㎃/㎠의 전류를 인가했을 때의 휘도 반감 시간을 표 1에 정리해서 나타내었다.Instead of compound (A25), compound (B25), (B26), (B27), (B28), (B29), (B34), (B46), (B53), (B77), (B79), (B2) ), (B5), (B103), (B106), (B122) or (B138), an organic EL device was fabricated in the same manner as in Example 8A. Table 1 shows the driving voltage and current efficiency when a current of 20 mA/cm 2 is applied and the luminance half-life time when a current of 6.25 mA/cm 2 is applied.

비교예 1(NPD의 소자 평가)Comparative Example 1 (Evaluation of NPD devices)

화합물(A25)를 NPD(4,4'-비스[N-(1-나프틸)-N-페닐아미노]바이페닐)로 변경한 이외에는, 실시예 8A와 같은 방법으로 유기 EL 소자를 제작하였다. 20 ㎃/㎠의 전류를 인가했을 때의 구동 전압 및 전류효율 및 6.25 ㎃/㎠의 전류를 인가했을 때의 휘도 반감 시간을 표 1에 나타내었다.An organic EL device was fabricated in the same manner as in Example 8A except that compound (A25) was changed to NPD (4,4'-bis[N-(1-naphthyl)-N-phenylamino]biphenyl). Table 1 shows the driving voltage and current efficiency when a current of 20 mA/cm 2 was applied and the luminance half-life time when a current of 6.25 mA/cm 2 was applied.

비교예 2(화합물(a)의 소자 평가)Comparative Example 2 (Device evaluation of compound (a))

화합물(A25)를 하기의 화합물(a)로 변경한 이외에는, 실시예 8A와 같은 방법으로 유기 EL 소자를 제작하였다. 20 ㎃/㎠의 전류를 인가했을 때의 구동 전압 및 전류효율 및 6.25 ㎃/㎠의 전류를 인가했을 때의 휘도 반감 시간을 표 1에 나타내었다.An organic EL device was fabricated in the same manner as in Example 8A except that the compound (A25) was changed to the following compound (a). Table 1 shows the driving voltage and current efficiency when a current of 20 mA/cm 2 was applied and the luminance half-life time when a current of 6.25 mA/cm 2 was applied.

참고예 1(화합물(b)의 소자 평가)Reference Example 1 (Device evaluation of compound (b))

화합물(A25)를 하기의 화합물(b)로 변경한 이외에는, 실시예 8A와 같은 방법으로 유기 EL 소자를 제작하였다. 20 ㎃/㎠의 전류를 인가했을 때의 구동 전압 및 전류효율 및 6.25 ㎃/㎠의 전류를 인가했을 때의 휘도 반감 시간을 표 1에 나타내었다.An organic EL device was fabricated in the same manner as in Example 8A except that the compound (A25) was changed to the following compound (b). Table 1 shows the driving voltage and current efficiency when a current of 20 mA/cm 2 was applied and the luminance half-life time when a current of 6.25 mA/cm 2 was applied.

Figure 112021063299657-pat00024
Figure 112021063299657-pat00024

Figure 112021063299657-pat00025
Figure 112021063299657-pat00025

본 발명의 2-아미노카바졸 화합물을 이용한 유기 EL 소자는, 소자 수명이 현저하게 우수하고, 내구성이 우수한 유기 EL 재료로서 이용이 가능하다.The organic EL device using the 2-aminocarbazole compound of the present invention is remarkably excellent in device lifetime and can be used as an organic EL material having excellent durability.

또, 본 발명의 2-아미노카바졸 화합물을 정공 수송 재료로서 이용한 유기 EL 소자는, 장수명화, 저구동 전압화 및 고발광 효율화가 가능하고, 소비 전력이 낮으며, 소자 수명이 우수하여, 휴대 기기 등의 디스플레이 분야에 있어서 이용가능하다.In addition, the organic EL device using the 2-aminocarbazole compound of the present invention as a hole transport material can achieve long life, low driving voltage and high luminous efficiency, low power consumption, excellent device lifetime, and portable It can be used in the field of a display such as a device.

또한, 2013년 9월 9일에 출원된 일본 특허출원 2013-186686호, 2013년 10월 17일에 출원된 일본 특허출원 2013-216683호 및 2014년 2월 18일에 출원된 일본 특허출원 2014-028366호의 명세서, 특허청구의 범위 및 요약서의 전체 내용을 여기에 인용하고, 본 발명의 명세서의 개시로서, 받아들이는 것이다.Further, Japanese Patent Application No. 2013-186686 filed on September 9, 2013, Japanese Patent Application No. 2013-216683 filed on October 17, 2013, and Japanese Patent Application 2014- filed on February 18, 2014 The entire contents of the specification, claims and abstract of No. 028366 are incorporated herein by reference and are hereby incorporated as a disclosure of the specification of the present invention.

Claims (10)

하기 식 (1B)로 표시되는, 2-아미노카바졸 화합물;
Figure 112021063299657-pat00026

식 중, R1B 내지 R3B 중 어느 하나는 4-다이벤조티에닐기이고, 나머지는 수소 원자이며;
Ar1 및 Ar2가, 각각 독립적으로, 메틸기 또는 메톡시기를 가지고 있어도 되는 페닐기, 메틸기 또는 메톡시기를 가지고 있어도 되는 나프틸기, 메틸기 또는 메톡시기를 가지고 있어도 되는 페난트릴기, 메틸기 또는 메톡시기를 가지고 있어도 되는 바이페닐릴기, 메틸기 또는 메톡시기를 가지고 있어도 되는 터페닐기 또는 메틸기 또는 메톡시기를 가지고 있어도 되는 플루오레닐기이다.
A 2-aminocarbazole compound represented by the following formula (1B);
Figure 112021063299657-pat00026

wherein, any one of R 1B to R 3B is a 4-dibenzothienyl group, and the rest is a hydrogen atom;
Ar 1 and Ar 2 are each independently a phenyl group which may have a methyl group or a methoxy group, a naphthyl group which may have a methyl group or a methoxy group, a phenanthryl group which may have a methyl group or a methoxy group, a methyl group or a methoxy group, It is the terphenyl group which may have the biphenylyl group which may have a methyl group, or a methoxy group, or the fluorenyl group which may have a methyl group or a methoxy group.
하기 식 (1B)로 표시되는, 2-아미노카바졸 화합물;
Figure 112021063299657-pat00027

식 중, R1B 내지 R3B 중 어느 하나는 4-다이벤조퓨라닐기이고, 나머지는 수소 원자이며;
Ar1 및 Ar2가, 각각 독립적으로, 메틸기 또는 메톡시기를 가지고 있어도 되는 페닐기, 메틸기 또는 메톡시기를 가지고 있어도 되는 나프틸기, 메틸기 또는 메톡시기를 가지고 있어도 되는 페난트릴기, 메틸기 또는 메톡시기를 가지고 있어도 되는 바이페닐릴기, 메틸기 또는 메톡시기를 가지고 있어도 되는 터페닐기 또는 메틸기 또는 메톡시기를 가지고 있어도 되는 플루오레닐기이다.
A 2-aminocarbazole compound represented by the following formula (1B);
Figure 112021063299657-pat00027

wherein, any one of R 1B to R 3B is a 4-dibenzofuranyl group, and the remainder is a hydrogen atom;
Ar 1 and Ar 2 are each independently a phenyl group which may have a methyl group or a methoxy group, a naphthyl group which may have a methyl group or a methoxy group, a phenanthryl group which may have a methyl group or a methoxy group, a methyl group or a methoxy group, It is the terphenyl group which may have the biphenylyl group which may have a methyl group, or a methoxy group, or the fluorenyl group which may have a methyl group or a methoxy group.
삭제delete 하기 식 (1A)로 표시되는, 2-아미노카바졸 화합물:
Figure 112021063299657-pat00029

식 중, R1A, R2A, R4A, R5A, R6A 및 R7A가 메틸기이고;
R3A는 수소 원자 또는 메틸기를 나타내고,
Ar1 및 Ar2는, 각각 독립적으로, 메틸기 또는 메톡시기를 가지고 있어도 되는 페닐기, 메틸기 또는 메톡시기를 가지고 있어도 되는 나프틸기, 메틸기 또는 메톡시기를 가지고 있어도 되는 페난트릴기, 메틸기 또는 메톡시기를 가지고 있어도 되는 바이페닐릴기, 메틸기 또는 메톡 시기를 가지고 있어도 되는 터페닐기, 또는 메틸기 또는 메톡시기를 가지고 있어도 되는 플루오레닐기이고;
R8A 및 R9A는, 어느 한쪽이 하기 식 (2A) 로 표시되는 기이고, 다른 쪽이 수소 원자이다:
Figure 112021063299657-pat00030

식 중, R 10A는 수소 원자 또는 메틸기를 나타낸다.
A 2-aminocarbazole compound represented by the following formula (1A):
Figure 112021063299657-pat00029

wherein R 1A , R 2A , R 4A , R 5A , R 6A and R 7A are methyl groups;
R 3A represents a hydrogen atom or a methyl group,
Ar 1 and Ar 2 are each independently a phenyl group which may have a methyl group or a methoxy group, a naphthyl group which may have a methyl group or a methoxy group, a phenanthryl group which may have a methyl group or a methoxy group, a methyl group or a methoxy group, a terphenyl group which may have an optionally biphenylyl group, a methyl group or a methoxy group, or a fluorenyl group which may have a methyl group or a methoxy group;
R 8A and R 9A are either a group represented by the following formula (2A), and the other is a hydrogen atom:
Figure 112021063299657-pat00030

In the formula, R 10A represents a hydrogen atom or a methyl group.
제1항, 제2항, 제4항 중 어느 한 항에 있어서, Ar1 및 Ar2가, 각각 독립적으로, 페닐기, 나프틸기, 페난트릴기, 바이페닐릴기, 터페닐기 또는 플루오레닐기인 것인, 2-아미노카바졸 화합물.
The method according to any one of claims 1, 2, and 4, wherein Ar 1 and Ar 2 are each independently a phenyl group, a naphthyl group, a phenanthryl group, a biphenylyl group, a terphenyl group, or a fluorenyl group. A phosphorus, 2-aminocarbazole compound.
제1항, 제2항, 제4항 중 어느 한 항에 있어서, Ar1 및 Ar2가, 각각 독립적으로, 페닐기, 4-메틸페닐기, 1-나프틸기, 9-페난트릴기, 4-바이페닐릴기, p-터페닐-4-일기, m-터페닐-4-일기 또는 9,9-다이메틸-9H-플루오렌-2-일기인 것인, 2-아미노카바졸 화합물.
The method according to any one of claims 1, 2, and 4, wherein Ar 1 and Ar 2 are each independently a phenyl group, 4-methylphenyl group, 1-naphthyl group, 9-phenanthryl group, 4-bi A phenylyl group, a p-terphenyl-4-yl group, a m-terphenyl-4-yl group, or a 9,9-dimethyl-9H-fluoren-2-yl group, the 2-aminocarbazole compound.
하기 식으로 표시되는 화합물 중 어느 하나인, 2-아미노카바졸 화합물:
Figure 112022064409113-pat00034
.
A 2-aminocarbazole compound, which is any one of the compounds represented by the following formula:
Figure 112022064409113-pat00034
.
제1항, 제2항, 제4항 중 어느 한 항에 기재된 2-아미노카바졸 화합물을 포함하는, 정공 수송 재료, 정공 주입 재료 또는 발광 호스트 재료.
A hole transporting material, a hole injecting material, or a light emitting host material comprising the 2-aminocarbazole compound according to any one of claims 1, 2, and 4.
제1항, 제2항, 제4항 중 어느 한 항에 기재된 2-아미노카바졸 화합물을, 발광층, 정공 수송층 및 정공 주입층 중 어느 1층 또는 2층 이상에 포함하는 유기 EL 소자.
An organic EL device comprising the 2-aminocarbazole compound according to any one of claims 1, 2, and 4 in any one layer, two or more layers of a light emitting layer, a hole transport layer, and a hole injection layer.
제1항, 제2항, 제4항 중 어느 한 항에 기재된 2-아미노카바졸 화합물을 정공 수송층에 포함하는 유기 EL 소자. An organic EL device comprising the 2-aminocarbazole compound according to any one of claims 1 to 4 in a hole transporting layer.
KR1020217016773A 2013-09-09 2014-09-08 2-aminocarbazole compound and use thereof KR102424458B1 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP2013186686 2013-09-09
JPJP-P-2013-186686 2013-09-09
JPJP-P-2013-216683 2013-10-17
JP2013216683A JP6311266B2 (en) 2013-10-17 2013-10-17 Carbazole compounds and uses thereof
JPJP-P-2014-028366 2014-02-18
JP2014028366A JP2015071582A (en) 2013-09-09 2014-02-18 2-aminocarbazole compound and use thereof
PCT/JP2014/073718 WO2015034093A1 (en) 2013-09-09 2014-09-08 2-aminocarbazole compound and use thereof
KR1020167003993A KR102280834B1 (en) 2013-09-09 2014-09-08 2-aminocarbazole compound and use thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020167003993A Division KR102280834B1 (en) 2013-09-09 2014-09-08 2-aminocarbazole compound and use thereof

Publications (2)

Publication Number Publication Date
KR20210068160A KR20210068160A (en) 2021-06-08
KR102424458B1 true KR102424458B1 (en) 2022-07-22

Family

ID=55220813

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020217016773A KR102424458B1 (en) 2013-09-09 2014-09-08 2-aminocarbazole compound and use thereof
KR1020167003993A KR102280834B1 (en) 2013-09-09 2014-09-08 2-aminocarbazole compound and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020167003993A KR102280834B1 (en) 2013-09-09 2014-09-08 2-aminocarbazole compound and use thereof

Country Status (3)

Country Link
KR (2) KR102424458B1 (en)
CN (1) CN105531262B (en)
TW (1) TW201542524A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190065652A (en) * 2017-12-04 2019-06-12 주식회사 동진쎄미켐 Novel compound and organic electroluminescent divice including the same
CN112368856A (en) * 2018-07-05 2021-02-12 日产化学株式会社 Composition for forming charge-transporting thin film
CN109232382B (en) * 2018-11-15 2021-12-28 长春海谱润斯科技股份有限公司 Carbazole derivative and organic electroluminescent device thereof
CN110105337B (en) * 2019-05-31 2022-12-23 湖南大学 Quinoline triarylamine and preparation method thereof
CN110444667A (en) * 2019-08-06 2019-11-12 太仓碧奇新材料研发有限公司 A kind of preparation method of organic diode laminated film

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011001349A (en) * 2009-05-20 2011-01-06 Tosoh Corp 2-aminocarbazole compound and application thereof
JP2013010749A (en) * 2011-05-27 2013-01-17 Semiconductor Energy Lab Co Ltd Carbazole compound, light-emitting element, light-emitting device, electronic device and lighting system
JP2013075891A (en) * 2011-09-15 2013-04-25 Idemitsu Kosan Co Ltd Aromatic amine derivative and organic electroluminescence element using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4830750B2 (en) 2006-09-21 2011-12-07 東レ株式会社 Light emitting device material and light emitting device
JP2008195841A (en) 2007-02-14 2008-08-28 Toray Ind Inc Material for light-emitting element and the resulting light-emitting element
KR101026173B1 (en) 2008-06-13 2011-04-05 덕산하이메탈(주) Novel carbazole derivatives and organic electroluminescent device comprising same
WO2011049123A1 (en) * 2009-10-20 2011-04-28 東ソー株式会社 Carbazole compound and use thereof
KR101202410B1 (en) * 2010-01-19 2012-11-16 주식회사 이엘엠 Organic Light Emitting Material and Organic Light Emitting Diode Having The Same
CN102823015B (en) * 2010-03-31 2014-05-14 出光兴产株式会社 Material for organic electroluminescent element and organic electroluminescent element using same
CN104011022B (en) * 2011-10-26 2016-08-24 东曹株式会社 4-aminocarbazole compound and application thereof
KR101483933B1 (en) * 2012-10-17 2015-01-19 롬엔드하스전자재료코리아유한회사 Novel organic electroluminescence compounds and organic electroluminescence device containing the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011001349A (en) * 2009-05-20 2011-01-06 Tosoh Corp 2-aminocarbazole compound and application thereof
JP2013010749A (en) * 2011-05-27 2013-01-17 Semiconductor Energy Lab Co Ltd Carbazole compound, light-emitting element, light-emitting device, electronic device and lighting system
JP2013075891A (en) * 2011-09-15 2013-04-25 Idemitsu Kosan Co Ltd Aromatic amine derivative and organic electroluminescence element using the same

Also Published As

Publication number Publication date
KR20160051742A (en) 2016-05-11
KR102280834B1 (en) 2021-07-22
TW201542524A (en) 2015-11-16
CN105531262A (en) 2016-04-27
KR20210068160A (en) 2021-06-08
CN105531262B (en) 2018-05-08

Similar Documents

Publication Publication Date Title
JP6584058B2 (en) Material for organic electroluminescence device and organic electroluminescence device using the same
US11111244B2 (en) Organic compound and organic electroluminescence device using the same
US20150179943A1 (en) Organic electroluminescence device
KR102424458B1 (en) 2-aminocarbazole compound and use thereof
JP2017141216A (en) Cyclic azine compound, and use therefor
US9698352B2 (en) Amine compound and use thereof
CN106255695B (en) Compound and organic light-emitting element comprising same
JP2016012675A (en) Material for organic electroluminescent devices, and organic electroluminescent device arranged by use thereof
JP2016108290A (en) Amine derivative and organic electroluminescent element
JP2016012676A (en) Material for organic electroluminescent devices, and organic electroluminescent device arranged by use thereof
JP2016122792A (en) Material for organic electroluminescent devices and organic electroluminescent device arranged by use thereof
WO2018155275A1 (en) Oxygen-bridged triarylamine compound, precursor thereof and light-emitting material
JP6672774B2 (en) Novel carbazole compounds and their uses
KR20160055671A (en) Material for organic electroluminiescent device and organic electroluminiscent device using the same
JP2016136581A (en) Material for organic electroluminescent device, organic electroluminescent device using the same, and amine derivatives
JP2016127072A (en) Material for organic electroluminescent elements, and organic electric field light-emitting element using the same
JP2017109929A (en) Aminocarbazole compound and use therefor
TW202128719A (en) Pyrromethene boron complex, light-emitting element containing same, light-emitting element, display device, and illumination device
JP2023011526A (en) Compound, and luminous element material, luminous element, color conversion composition, color conversion sheet, optical unit, display device and lighting device that are based thereon
WO2015034093A1 (en) 2-aminocarbazole compound and use thereof
JP6350191B2 (en) Arylamine compounds and uses thereof
JP7215065B2 (en) Aminocarbazole compound and use thereof
JP7285663B2 (en) Triazine compound having a 2&#39;-arylbiphenylyl group
JP6848424B2 (en) Carbazole compounds and their uses
JP6890882B2 (en) Triazine compound and organic electroluminescent device using it

Legal Events

Date Code Title Description
A107 Divisional application of patent
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant